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ABSTRACT for Degree of Ph.D. 1990 ALISON LOUISE ALDERSON 
~~?guence analvsis and molecular cloning of enzvme inhibitors from 
seeds of rve (Secale cereale L). 
Inhibitors of trypsin IEC 3.4.21.4) and a-amylase (1,4-a-D-glucan 
glucanohydrolase, EC 3.2.1.1) were purified from seeds of rye and 
their complete and partial amino-acid sequences, respectively, were 
determined, in part by homology. The trypsin inhibitor was a single 
polypeptide chain of ~ 13753. Both proteins exhibited sequence 
homology with a group of cereal seed proteins that include inhibitors 
of proteinases and a-amylase. The trypsin inhibitor was most closely 
related to the barley trypsin inhibitor (76% identity) and the 
a-amylase inhibitor to CMa of barley (also an inhibitor of a-amylase 
activity) and to CM1 and CM2 of wheat (no known inhibitory activity). 
Antisera raised against the two inhibitors did not cross react, but 
the a-amylase inhibitor reacted with an antiserum raised against the 
0.28 a-amylase inhibitor of wheat. The rye inhibitors had similar 
secondary structure contents with about 36-39% a-helix and 11-19% 
~-sheet. These are the first amino-acid sequence and conformation 
studies reported for enzyme inhibitors from rye. 
Poly(A)-rich RNA from total polysomes, prepared from rye endo-
sperms, was used as a template for eDNA synthesis and a eDNA library 
was constructed in Agt10. The library was screened using two 
oligonucleotide probes which encoded two regions of the trypsin 
inhibitor (from amino-acids 38-42 and 44-48). One clone was isolated 
that hybridised to both probes. The nucleotide sequence of the clone 
AC(C.In) was determined. 1709 bp were sequenced showing an open 
reading frame that extended from the 5' end to 1621 and encoded a 
protein of 540 residues. The predicted amino-acid sequence showed 
striking sequence similarity to the serine/threonine SNFl subfamily of 
protein kinases with 62% and 48% identity, respectively, to the 
catalytic domains of SNF1 and niml+, The functions of the SNFl 
subfamily are discussed. 
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INTRODUCTION 
1.1 General Introduction · 
Plant protein inhibitors of enzymes appear to be ubiquitous. A 
representative list of enzymes known to be inhibited is shown in Table 
1. The list is continually expanding as more inhibitors are characte-
rised. At present the best studied group of inhibitors are those 
which inhibit proteinases. Proteinases are defined as all enzymes 
which catalyse the hydrolytic cleavage of peptide bonds. Any substan-
ces which disable or reduce this catalytic activity are proteinase 
inhibitors. Most proteinase inhibitors are proteins (Laskowski et 
al., 1978) but other substances are known to inhlbit proteinases eg. 
polyphenols (Fernandez et al., 1982), phytic acid (Singh and Krikor-
ian, 1982) and short peptides (Hafez and Mohamed, 1983). Laskowski 
(1986) broadly classified protein proteinase inhibitors as shown: 
1) Macroglobulins which "inhibit" proteinases of all mechanistic 
classes (Sottrup-Jensen et al., 1984). They trap the enzyme but 
leave the active site fully accessible to small substrates. They 
are high molecular weight proteins present in the plasma of 
mammals and some invertebrates (Travis and Salvesen, 1983). 
2) Inhibitors of a single mechanistic class. Inhibitors are 
known for the four major classes of proteases: 
a) Serine protei~ase 
b) Cysteine/Sulphydryl proteinase 
c) Aspartic Acid proteinase 
d) Metallo proteinase. 
These inhibitors possess a "reactive site" which is a region 
which combines with the enzyme, resulting in a loss of catalytic 
\ 
activity. The inhibitor acts as a substrate for the enzyme but the 
enzyme/inhibitor complex is very stable and does not readily 
18 
Table 1: 
A representative list of the range of enzymes known to be 
inhibited by plant protein inhibitors 
1) Hydroxylases 
Proteinases 
a} Serine 
(numerous 
examples) 
b) Acidic 
c) Sulphydryl 
d) Metalloenzymes 
Other enzymes: 
Enzyme Source 
Trypsin Job's Tears 
Chymotrypsin Potato 
Subtilisin Broad bean 
Cathepsin D Potato 
Pepsin Bauhinia 
Papain Rice 
Bromelain Pineapple 
Carboxypeptidase A Potato 
Tomato 
a-Amylase Wheat 
(numerous examples} 
Urease Melon 
Lipase Cereals 
19 
Reference 
Ary et al 
1988 
Melville and 
Ryan 1972 
Svendsen et 
al 1984 
Keilova and 
Tomasak 
1976 a,b 
Goldstein 
et al 1973 
Abe et al 
1987a,b,c 
Reddy et al 
1975 
Graham and 
Ryan 1981 
Hass and Her-
modson 1981 
Buonocore et 
al 1977 
Makkar et al 
1980 
Lairon et al 
1985 
Table 1 cont: 
Other enzymes 
cont: 
2) Oxidoreductases 
3) Transferases 
4) Lyases 
Enzyme 
Endopoly-
galacturonase 
DNase 
Acid invertase 
Catalase 
Ornithine amino-
transferase 
Phospho-inositol 
kinase 
Pectin lyase 
Guanylate cyclase 
20 
Source 
Red kidney 
bean 
Tobacco 
Potato 
Maize 
Legumes 
Mung bean 
Cucumber 
Bitter melon 
Reference 
Fisher et al 
1973 
Szopa and 
Wagner 1980 
Anderson et 
al 1980 
Tsaftaris et 
al 1980 
Dullo 1980 
Majunder and 
Biswas 1973 
Bock et al 
1975 
Vesely et al 
1977 
dissociate. The inhibitors are s1rictly competitive. A proteinase 
inhibitor may have more than one reactive site per molecule and hence 
be able to inhibit enzymes of more than one mechanistic class, but 
never at the same reactive site (Laskowski, 1986). The most studied 
group of inhibitors is those of serine proteinases, and a model for 
their mechanism of action has been proposed (Laskowski and Kato, 
1980). 
Another enzyme for which large numbers of inhibitors have been 
characterised is a-amylase. A large number of types of naturally 
occuring a-amylase inhibitors have been identified eg. low molecular 
weight compounds (salicylic _acid, Hemberg and Larsson, 1961; acetyl-
salicylic acid or "aspirin", Bandyopadhyah et al., 1983; abscisic 
acid, Hemberg, 1975; and oligosaccharide MWt 1500 produced by Strepto-
myces, Fukuhara et al., 1982), drugs (Nojirimycin, Niwa et al., 1970), 
polyanions (Ramesh et al., 1982) and some end-products of the action 
of a-amylase on starch (maltose, Buonocore et al., 1977). Protein or 
glycoprotein inhibitors of a-amylase have also been detected in a 
large number of plants including legumes and cereals {reviews include 
Buonocore et al., 1977, Silano, 1986, Buonocore and Silano, 1986, 
Garcia-Olmeda et al., 1987 and Richardson, 1990). Many a-amylase 
inhibitors have been found to have attached carbohydrate eg. a-amylase 
inhibitors from Phaseolus seeds have between 8-15% (Wilcox and 
Whitaker, 1984b, Lajolo and Finardi-Filho, 1985). The mechanism of 
action of the a-amylase inhibitors remains unclear but the carbo-
hydrate residues may play a role. The current models for the 
inhibitory mechanisms of the proteinase and a-amylase inhibitors are 
further discussed in section 1.3. 
1.2 Historical Perspective 
Proteinases can be defined as all enzymes which catalyse the 
21 
hydrolytic cleavage of peptide bonds and substances which disable that 
catalytic capacity are proteinase inhibitors. The existence of a 
naturally occuring inhibitor of proteolytic activity was first recor-
ded by Weinland in 1903. He termed the inhibitors "antienzymes" as 
they appeared to protect certain nematodes against digestion by 
gastrointestinal enzymes. Awareness then grew concerning antinutri-
tional components in raw food. Osborne and Mendel in 1917 found that 
heat treatment increased the food value of soybean meal and this, in 
turn~ led Read and Hass (1938) to isolate an antitryptic fraction from 
soybean flour. Other proteinase inhibitor fractions were then isola-
ted by Bowman (4944) and Ham and Sandstedt (1944). The trypsin 
inhibitors were also crystallised; bovine pancreatic trypsin inhibitor 
by Kunitz and Northrop (1936) and soybean trypsin inhibitor by Kunitz 
(1945, 1946). The proteinase inhibitors were able to bind trypsin 
with a stoichiometry of 1:1,forming reversible complexes which could 
also be crystallised (Kunitz and Northrop, 1936, Kunitz, 1947). The 
first review dedicated to naturally occuring trypsin inhibitors 
appeared in 1954 by Laskowski and Laskowski. General reviews on 
proteinase inhibitors include Ryan (1973, 1979, 1981), Richardson 
(1977, 1981a,b, 1990), Laskowski and Kato (1980), Ryan and Walker-
Simmons (1981) and Mossor et al. {1984). A number of reviews focus 
on cereals; these include Boisen {1983), Stauffer (1986) and Pattabir-
aman (1986). 
The first research on plant a-amylase inhibitors was that of 
Chrzaszcz and Janicki (1933) and the inhibitors were termed "sisto-
amylase". Early studies by Kneen and Sandstedt (1943, 1946) and 
Militzer et al. (1946) confirmed the protein nature of a-amylase 
inhibitors from wheat flour. Pancreatic amylase inhibitors were 
identified in aqueous extracts of navy bean by Bowman (1945). Cereals 
22 
are now known to contain m~ny proteins with inhibitory activity 
against animal a-amylase (f.neen and Sandstedt, 1943, 1946, Shainkin 
and Birk, 1970, Silane et al., 1973, Deponte et al., 1976). Inhibi-
tors of endogenous cereal a-amylase have only recently been reported. 
Warchalewski (1976) reported that multiple forms of inhibitors of 
native a-amylases from malted wheat were present in wheat kernels. 
These endogenous inhibitors have since been isolated from barley 
(Weselake et al., 1983a,b, Hejgaard et al., 1983, Mundy et al., 1983) 
maize (Blanco-Labra and Iturbe-Chinas, 1981) and wheat (Mundy, 1984). 
Recent reviews of a-amylase inhibitors in cereals include Buono-
core et al. (1977), Warchalewski (1983), Silano (1986) and Buonocore 
and Silano (1986). 
1.3 Inhibitor Families defined on Sequence Relationships 
The primary structures for many plant protein inhibitors have now 
been determined. On the basis of sequence similarity, location of 
disulphide bonds and reactive site position, Laskowski and Kato (1980) 
proposed that sequences of serine proteinase inhibitors could be 
grouped into families. In total these workers proposed nine families, 
of which four families included plant inhibitors. At present at least 
ten plant families are proposed (Richardson, 1990). The major 
characteristics of these plant families and any cereal examples are 
shown in Table 2. The original families as proposed by Laskowski and 
Kato (1980) only included serine proteinase inhibitors. However, it 
has since become clear that many a-amylase inhibitors as well as 
proteins with no known inhibitory activity also show sequence similar-
ity that warrants their inclusion within these families. 
Bowman-Birk Inhibitor Family 
Bowman-Birk inhibitors are present in the seeds of many legumin-
ous plants. Birk (1961) first characterised this family in soybean. 
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Table 2: 
Plant protein inhibitor families defined by sequence homology 
showing major characteristics, major sources and cereal examples 
of each family. 
FAMILY 
Bowman-Birk 
Kunitz 
Potato I 
Potato 2 
Cucurbit 
(Squash) 
CHARACTERISTICS 
Low Mr 8-9000 
High cysteine content 
7 disulphide bridges 
Generally double-headed 
Mr 21000 
2 disulphide bridges 
STI is single-headed for 
trypsin, double-headed 
weakly for chymotrypsin 
Reactive peptide bond 
Arg(63)-Ile(64) in STI 
Pentamer Mr 8000 protomer 
Inhibits subtilisin, 
chymotrypsin 
One disulphide bond 
Reactive peptide bond 
Met/Leu(47)-Asp(48) 
Potato II (Mr 12000) 
Tomato II 
Reactive peptide bond 
Arg(38l-Asnl39) in 
aubergine TI or Leu-Asn/ 
Phe-Asn for chymotrypsin 
Potato II 16 cysteine 
Mr 3000 
Inhibit trypsin and Hageman 
factor 
3 disulphide bonds 
Reactive peptide bond 
Arg-Ile or Lys-Ile 
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MAJOR SOURCES 
Leguminosae 
Leguminosae 
Widespread 
Solanaceae 
Gramineae 
Leguminoseae 
Polygonaceae 
Animal (leech) 
Potato 
Tomato 
Cucurbitaceae 
Table 2: 
CEREAL EXAMPLES 
Source 
Wheat germ 
Wheat kernel 
Rice bran 
Jobs tears seed 
Barley rootlet 
Barley seed a-
amylase/subtilisin 
inhibitors (BASI) 
Wheat seed (WAS!) 
Rice seed (RPI) 
Reference 
Odani et al 1986 
Poerio et al 1989 
Tashiro et al 1987 
Ary et al 1988 
Nagasua et al 1988 
Yoshikawa et al 1976 
Hejgaard et al 1983 
Svendsen et al 1986 
Mundy et al 1984 
Maeda 1986 
Kato et al 1972 
Barley seed (Cl-1, Cl-2) Svendsen et al 1980, 
subtilisin 1982 
Very weak homology 
in short section 
between aubergine 
exocarp TI and 
barley seed PAPI 
Mundy and Rogers 1986 
No known affinities to other families 
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Table 2 cont: 
FAMILY 
Ragi I-2 
Maize 22000 
Cystatin 
Carboxypeptidase 
Cereal Inhibitor 
Superfamily 
CHARACTERISTICS 
Mr 10000 
7-8 cysteines 
Inhibits a-amylase 
(protease?) 
Mr 22-23000 
16 cysteines 
Inhibits amylase/trypsin 
Inhibitor of cysteine 
proteinases 
Mr 4000 
6 cysteines 
Inhibits carboxypeptidase 
Show weak homology to 
Potato II family 
Mr 12-13000 
Includes inhibitors of 
proteinases, a-amylase 
and Hageman factor 
The proteinase inhibitors 
reactive peptide bond is 
Arg(33)-Leu(34) as in 
barley TI 
10 cysteines 
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MAJOR SOURCES 
Gramineae 
Gramineae 
Solanaceae 
Pineapple 
Potato, Rice 
Corn 
Solanaceae 
Graminaeae 
Table 2 cont: 
CEREAL EXAMPLES 
Source 
Ragi seed a-amylase 
inhibitor I-2 
Rice seed (PAPI) 
Barley seed (PAPI) 
Maize seed 
Rice seed 
Corn seed 
Barley seed 
tryps~n inhibitor 
Ragi seed bifunct-
ional trypsin/a-
amylase inhibitor 
Maize seed trypsin 
inhibitor 
Wheat seed a-amylase 
inhibitors 0.19 
0.28 
0.53 
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Reference 
Campos & Richardson 1984 
Yu et al 1988 
Mundy and Rogers 1986 
Svensson et al 1986 
Blanco-Labra and 
Iturbe-Chinas 1981 
Richardson et al 1987 
Abe et al 1985, 1987 a,b,c 
Abe and Whitaker 1988 
Odani et al 1983a 
Campos and Richardson 1983 
Mahoney et al 1984 
Maeda et al 1985 
Kashlan and Richardson 1981 
Maeda et al 1983 
In soybean there is also a related family of isoinhibitors (protease 
inhibitors I-IV) (Odani and Ikenaka, 1977, Hwang et al., 1977). These 
isoinhibitors appear to result from multiple gene products (Tan-Wilson 
and Wilson, 1986) and be produced by partial proteolysis during seed 
development (Yoshikawa et al., 1979, Wilson and Tan-Wilson, 1983, 
Madden et al., 1985). These inhibitors contain 20% sulphur amino 
acids, which are the limiting essential amino acids in soybean. The 
Bowman-Birk inhibitors are mainly double-headed inhibitors, containing 
two reactive site domains in the same polypeptide. Odani and Ikenaka 
(1973) separated the two domains by making two specific peptide bond 
cleavages (using CNBr and pepsin) and showed that the two peptides 
retained separate activity. The Bowman-Birk inhibitor has trypsin 
(Lys-Ser) and chymotrypsin (Leu-Ser) inhibitory sites (Birk et al., 
1963) whereas the protease inhibitors I-IV have two trypsin (Arg-Ser) 
inhibitory sites (Hwang et al., 1977). The homology between the two 
domains suggests that they have arisen as a result of a tandem gene 
duplication (Birk, 1985). 
Recently examples of proteins with sequence similarity to the 
legume inhibitors have been found in the cereals, eg wheat germ (Odani 
et al., 1986), wheat kernel (Poerio et al., 1989), rice bran (Tashiro 
et al., 1987), seeds of Job's tears (Ary et al., 1988) and barley 
rootlets (Nagasue et al., 1988). In wheat germ two classes of 
inhibitor were isolated, I (Mr 14500) and II (Mr 7000), and were found 
to inhibit bovine trypsin at an enzyme to inhibitor ratio of 2 and 1 
respectively. Inhibitor I appears to have a duplicated structure of 
inhibitor II. Inhibitor II is a single-headed inhibitor corresponding 
to one inhibitory domain of the Bowman-Birk type double-headed 
inhibitor, and is perhaps a relic of an ancestral single-headed 
inhibitor present before the gene duplication. The barley rootlet 
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inhibitor (Mr 16000) has two domains, as have the wheat I inhibitors 
and shows 85% sequence homology with the wheat I inhibitors (Nagasue 
et al., 1988). The rice bran inhibitor (Mr 14000) (Tashiro et al., 
1987), however, appears to have four domains: domains I and III and 
domains II and IV being homologous respectively to the first and 
second domains of the soybean Bowman-Birk inhibitor. Thus the rice 
bran inhibitor is a duplicated Bowman-Birk inhibitor. 
A wheat kernel inhibitor (Mr 8500) (Poerio et al., 1989) was 
found to be active against exogenous and endogenous trypsin, and may 
play a regulatory role in protein metabolism. 
Kunitz inhibitor family 
The soybean trypsin inhibitor (STI) (Kunitz) was the first plant 
inhibitor to be well characterised with its crystallisation achieved 
by Kunitz in 1945. The sequence was determined by Koide and Ikenaka 
(1973 a,b) and Koide et al. (1973). This inhibitor was shown to 
consist of three genetic variants (Freed and Ryan, 1980). The STI is 
a single chain polypeptide with 180 residues (Mr 21000) with two 
disulphide bridges. In the subfamily Mimosoideae of the Leguminosae 
the inhibitors consist of a larger a-chain (Mr 16000) and a smaller a-
chain (Mr 5000) which result from proteolytic cleavage (Kortt and 
Jermyn, 1981, Joubert, 1983). The reactive site of the STI is 
Arg(63)-Ile(64) (Koide and Ikenaka, 1973a) and similar reactive site 
can be identified in all homologous inhibitors. 
Most of the Kunitz-type inhibitors that have been sequenced are 
from legume seeds, eg. winged bean Psophocarpus tetragonolobus 
(Yamamoto et al., 1983), Erythrina latissina (Joubert et al., 1985) 
and Brazilian Carolina tree, Adenanthera pavonina (Richardson et al., 
1986). Proteins with sequence similarity to the Kunitz family are 
also found in cereals,(see Table 2 for refs) but the similarity within 
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the legumes is closer than between the legumes and the cereals. For 
example the similarity.between the STI and the winged bean trypsin 
inhibitor is 45% identical residues compared to the STI and the wheat 
endogenous a-amylase inhibitor at 31% identical residues or the STI 
and the barley a-amylase/subtilisin inhibitor at 26% identical resi-
dues. 
Potato Inhibitor Families I and II 
The potato I inhibitor family occurs in a wide range of plant 
families: Solanaceae (potato tubers, Richardson, 1974; tomato, Graham 
et al., 1985a), Gramineae (barley, Svendsen et al., 1980, 1982), 
Leguminoseae (broad bean, Svendsen et al., 1984), Polygonaceae 
(buckwheat, Kiyohara and Iwasaki, 1985) and in an animal (leech, 
Seemuller et al., 1980). This inhibitor family was first isolated 
from potato tubers (Melville and Ryan, 1972) and was found to inhibit 
chymotrypsin and subtilisin. The potato inhibitor is a pentamer 
composed of Mr 8000 (70-71 residues) monomers with many isoelectric 
forms (Richardson et al., 1976 a,b). The potato inhibitor had one 
disulphide bond and the reactive site was identified as Met/Leu (47)-
Asp(48) (Richardson et al., 1977). 
Cereal inhibitors of this type are present in barley. Barley 
grains contain two inhibitors of chymotrypsin and subtilisin named CI-
1 and CI-2 (Svendsen et al., 1980, 1982). CI-1 has a single reactive 
site for the two enzymes whereas CI-2 has one site for chymotrypsin 
and two for subtilisin (Jonassen and Svendsen, 1982). CI-2 and the 
inhibitor from leech (eglin) lack stabilizing disulphide bonds and 
thus their three dimensional structure were determined in order to 
determine the features that contribute to their stability and inhibi-
tory properties. The molecular structure of both CI-2 and the 
subtilisin/CI-2 complex have been determined by X-ray crystallography 
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(McPhalen and James, 1987, McPhalen et al., 1985a); also the secondary 
structure of CI-2 using lH-NMR (Clore et al., 1987a,b; Kjaer and 
Poulsen, 1987). The structural gene for barley CI-2 gene is located 
at the Ica-2 locus on chromosome 5 (Hejgaard et al., 1984). The 
nucleotide sequence of CI-2 and its expression in normal and high-
lysine barleys (20-fold increased content of CI-2) has been determined 
(Williamson et al., 1987) and it has been shown that CI-2 is encoded 
by a small multigene family. 
Wounding of tomato leaves induces the accumulation of two non-
homologous serine proteinase inhibitors called Inhibitor I (Mr 8100) 
and Inhibitor II (Mr 12300} (Plunkett et al., 1982). Inhibitor I 
belongs to the Potato I family, the amino acid sequence was deduced 
from a eDNA and found to be 71% homologous to the potato protein 
(Graham et al., 1985a). The larger inhibitor II proteins belong to 
the Potato II family. Sequences were deduced from potato and tomato 
eDNA or genomic clones and showed 54-84% homology (Graham et al., 
1985b, Sanchez-Serrano et al., 1986, Keil et al., 1986). 
The first member of the Potato II family to be sequenced was from 
aubergine Solanum melongena (Richardson, 1979) with a reactive site of 
Arg(38)-Asn(39). Members of the Potato II family show limited 
similarity with N-terminal regions of the carboxypeptidase inhibitors 
present in tomato (Hass and Hermodson, 1981) and potato (Hass et al., 
1975); and also very weak similarity to a short section of the 
probable amylase/protease inhibitor (PAPI) from barley (Mundy and 
Rogers, 1986). 
Cucurbit (Squash) family 
This family was found only recently and is apparently present 
only in seeds of the Cucurbitaceae (Polanowski et al., 1980, Hojima et 
al., 1980, 1982, Leluk et al., 1983). The inhibitors consist of about 
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29 amino acids with three disulphide bonds and either Arg-Ile or Lys-
Ile at the reactive site (Wilusz et al., 1983, Joubert, 1984, 
Wieczorek et al., 1985). They are very strong inhibitors. 
Ragi I-2 family 
Two proteinaceous a-amylase inhibitors, I-1 and I-2, were isola-
ted from ragi (Eleusine coracana, a common Indian millet) (Shivaraj 
and Pattabiraman, 1980). The complete amino acid sequence of I-2 was 
determined by Campos and Richardson (1984) who found no sequence 
homology with the bifunctional a-amylase/trypsin inhibitor previously 
isolated from the same seed (Campos and Richardson, 1983) or with any 
other a-amylase inhibito~. These workers therefore proposed a new 
family for the ragi I-2 inhibitor. The sequence contained evidence of 
gene duplication, two regions of weakly homologous sequence. Putative. 
amylase/protease inhibitors from rice (Yu et al., 1988) (Mr 9000) and 
from barley (Mundy and Rogers, 1986) have since been found to be 
highly homologous to the I-2 inhibitor from ragi (76% and 50% 
respectively). The ragi and rice proteins are rich in serine and 
alanine, but lack methionine, phenylalanine, histidine and tryptophan; 
they contain 7 or 8 cysteines. The barley protein, however, showed no 
inhibitory activity against a wide range of hydrolytic enzymes that 
were tested (Svensson et al., 1986). 
Cystatin family 
Cysteine proteinase inhibitors (cystatins) are found in animal 
tissues eg. plasma and chicken egg white (Barrett, 1981). Most of the 
endopeptidases inhibited belong to the papain superfamily (Mr 25000), 
plant enzymes including papain, chymopapain, ficin and actinidin, 
although bromelain is not inhibited. Cystatins are reversible, 
competitive inhibitors with high affinities for their target enzymes. 
They form tight complexes with the cy~eine endopeptidase even after 
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the active site of the enzyme has been reacted with a thiol-blocking 
agent. This contrasts with serine proteinase inhibitors which are 
unable to form a complex with a blocked enzyme. The cystatins have 
been grouped into three families: 
Type 1 
Type 2 
Type 3 
100 amino acids (~ 11000) no disulphide bonds 
115 amino acids (Mr 13000) two disulphide bonds 
3 Type 2-like domains probably resulting from two 
duplications of genetic material. 355 amino acids with 
additional disulphide bonds. 
The identification and partial characterisation of cystatins in 
plants has been described for pineapple (Reddy et al., 1975) corn (Abe 
et al., 1980, Abe and Whitaker, 1988), rice (Abe and Arai, 1985, Abe 
et al., 1987a,b,c} and foxtail millet (Tashiro and Maki, 1986). Rice 
seeds also contain a cysteine proteinase that may hydrolyse glutelin 
during germination (Abe et al., 1987a). Abe et al. (1987b) sequenced 
a eDNA clone for a cystatin from rice (oryzacystatin) and found it to 
be 30% homologous to human cystatin A. Oryzacystatin resembled the 
family 1 in containing no disulphide bond, but sequence homology 
suggests that it is more closely related to family 2. 
Maize (Mwt 22000) Family 
Blanco-Labra and Iturbe-Chinas (1981) purified an a-amylase 
inhibitor from maize with an apparent molecular weight of 30,400. Its 
properties differed from previously purified a-amylase inhibitors as 
it was active against a-amylase from maize as well as from Bacillus 
subtilis and from the insects Tribolium castaneum, Sitophilus zeamais 
and Rhyzopertha dominica. Richardson et al. (1987) purified and 
sequenced a bifunctional a-amylase/trypsin inhibitor from maize using 
a modification of the Blanco-Labra and Iturbe-Chinas method. The 
maize bifunctional inhibitor contained 206 amino acids (Mr 22077) with 
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high contents of Ala, Gly and Cys. The inhibitor showed very limited 
homology in two short regions with the ragi 1-2 inhibitor and the 
probable a-amylase/proteinase inhibitor from barley aleurone. When 
compared to a protein databank homology was found to osmotin (59%), a 
protein that accumulates during adaptation of cells to high osmotic 
stress (Singh et al., 1987, King et al., 1988, Singh et al., 1989); a 
PR protein (57%) induced in tobacco plants following infection by 
tobacco mosaic virus (Cornelissen et al., 1986); and thaumatin II 
(52%), an intensely sweet protein produced in arils of Thaumatococcus 
danielli (Edens et al., 1982). Richardson et al. (1987) suggested 
that the sequence homology to the maize inhibitor indicates functions 
for the homologous proteins, which are presumed to have arisen from a 
common ancestor, as inhibitors of hydrolytic enzymes. However when 
tested the PR proteins were found to have no inhibitory effects on 
trypsin (Pierpoint et al., 1987). 
Signal peptide homology has been found between thaumatin II 
(which is homologous to the maize bifunctional inhibitor family) and 
the cereal a-amylase/trypsin inhibitors of the cereal inhibitor 
superfamily (see below), although the mature proteins show no homology 
(Lazaro et al., 1988). These workers concluded that intragenic 
recombination (perhaps exon shuffling) involving the ancestral genes 
of the two inhibitor families may have occurred. 
Cereal Inhibitor Superfamily 
A number of inhibitors of proteinases and a-amylase as well as 
proteins with no known inhibitory activity are, on the basis of 
sequence homology, grouped together in a family; the cereal inhibitor 
superfamily. Many inhibitors and proteins from this family have now 
been sequenced, including some deduced from cloned eDNA eg. barley 
pUP44 (Paz-Ares et al., 1986) and CMd (Halford et al., 1988). 
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Wheat contains a complex of albumin protein that inhibit a-
amylases from a variety of organisms (Silano et al., 1975). This 
complex consists of three families of isoinhibitors with molecular 
weights of 12000 (0.28 family), 24000 (dimeric inhibitors composed of 
two 12000 subunits, 0.19 family) and 60000 (probably tetrameric) 
(Deponte et al 1976). The three families exhibit different specifi-
cities. The Mr 12000 0.28 family act only on insect a-amylases 
whereas the Mr 24000 0.19 family act on mammalian and insect a-
amylases. The Mr 60000 family is not well characterised but as much 
as 80% of this fraction dissociates reversibly into Mr 12000 subunits 
(Deponte et al., 1976). 
In barley, wheat and rye a high proportion of the members of this 
group of proteins can be selectively extracted by chloroform/ methanol 
mixtures and have been called eM-proteins (Garcia-Olmedo et al., 
1982). Many of these eM-proteins have no known inhibitory activity 
but their homology to cereal a-amylase/proteinase inhibitors suggests 
a function. eMa was found to be an inhibitor of a-amylase from the 
insect Tenebrio molitor while eMc and eMe inhibit trypsin (Barber et 
al., 1986a). A tetrameric inhibitor (equivalent to the Mr 60000 
family of wheat) has been characterised which consists of eMa 
(inhibitory by itself) eMb and eMd (no inhibitory activity on their 
own), with the mixture of all three subunits being twice as active as 
eMa by itself (Sanchez-Mange et al., 1986a). In wheat and barley 
these proteins are encoded by a multi-gene family dispersed over 
several chromosomes (Fra-Mon et al., 1984, Salcedo et al., 1984, 
Lazaro et al., 1985, Barber et al., 1986a,b, Sanchez-Mange et al., 
1986b, 1987). 
The first complete sequence of a member of this family to be 
determined was that of the 0.31 (monomeric, Mr 13000, 0.28 family) a-
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amylase inhibitor from wheat (Kashlan and Richardson, 1981). In 
monomeric form all the inhibitors of this family have molecular 
weights 12000-13000 and are characterised by high cysteine content. 
Several wheat a-amylase inhibitors have now been sequenced and found 
to be highly homologous (Maeda et al., 1983a, 1985). These a-amylase 
inhibitors are also homologous (24-26% identity) with the trypsin 
inhibitors from barley (Odani et al., 1982, 1983a), maize (Mahoney et 
al., 1984) and a bifunctional a-amylase/trypsin inhibitor from ragi 
(Campos and Richardson, 1983). These proteinase inhibitors from 
barley, maize and ragi are highly homologous (50-76% identity). The 
proteinase inhibitors were found to have the same reactive site 
peptide bond, Arg (33)-Leu (34), as the barley trypsin inhibitor 
(CMe). 
1.4 Inhibitor Reaction Mechanism 
The most studied group is the serine proteinase inhibitors. 
Reviews by Laskowski and Kato (1980) and Laskowski (1986) proposed a 
standard mechanism of inhibition based on kinetic and biochemical 
data. The inhibition is strictly competitive. Inhibitors are found 
to bind to the enzyme in the manner of a good substrate, but are 
hydrolysed at the reactive site peptide bond at a very slow rate. The 
kcat/Km for hydrolysis of the peptide bond at the reactive site by the 
cognate enzyme at neutral pH is very high 104 - 106 M-ls- 1 (Estell et 
al., 1980) compared to 103 M-ls-1 for normal substrates. The 
hydrolysis does not proceed to completion at neutral pH, but there is 
an equilibrium between the modified inhibitor (reactive bond cleaved) 
and the virgin inhibitor (bond intact). The reactive site peptide 
bond can be located by incubating the native inhibitor with the 
protease at acid pH (2-3) for 20-48 h (Laskowski and Sealock, 1971). 
A stable complex can be formed between the modified or virgin 
36 
inhibitor and the enzyme, as both are thermodynamically strong 
inhibitors (Laskowski and Sealock, 1971). 
The inhibition is the result of very tight binding (kassoc = 
1QlO_ 1Ql3 M-1) and slow release of the inhibitor from the enzyme. 
The overall mechanism of the enzyme/inhibitor interaction can be 
expressed as: 
E + I L c X L* E + I* 
where E is the enzyme, I and I* are virgin and modified inhibitors 
respectively, L and L* are loose, noncovalent (rapidly dissociable) 
complexes of E with I and I* respectively, X is a relatively long-
lived intermediate formed during the reaction of E + I* and C is the 
stable enzyme inhibitor complex. 
As the mechanism resembles that of peptide bond hydrolysis by 
serine proteinases it was assumed that the stable complex C was an 
acyl enzyme or a tetrahedral intermediate. However X-ray crystallo-
graphy has shown that the reactive site peptide bond of the inhibitor 
is intact within the complex C, therefore excluding the existence of 
an acyl enzyme. It was also shown that there is a close approach of 
the Oy of the active site serine to the carbonyl-carbon atom of the P1 
(see footnote!) residue of the inhibitor. A tetrahedral enzyme-
inhibitor adduct is not formed, there is disagreement over the actual 
structure: either fully trigonal (Read and James, 1986) or partially 
tetrahedral (Marquart et al., 1983). 
X-ray crystallography (McPhalen et al., 1985, Read and James, 
1986) and NMR studies (Baillargeon et al., 1980) have been carried out 
in order to determine why these small proteins are inhibitors rather 
!Nomenclature of Schecter and Berger (1967). Amino acid residues of 
substrates are numbered P1, P2, PJ, etc., toward the NH2 terminus, 
and P'1, P'2, etc., toward the COOH terminus from the reactive-site 
bond. 
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than good substrates. The results show that only 10-15 residues of 
the inhibitor are in contact with the enzyme forming an interaction as 
in the "lock and key" mechanism of enzyme substrate binding. Compar-
ison of the structures of the free inhibitor and the enzyme-inhibitor 
complex have been performed (Marquart et al., 1983, Hirono et al., 
1984, Read et al., 1983, Bode et al., 1985 and McPhalen eta~., 
1985a,b). The binding of the inhibitor to the enzyme occurs with a 
minimal conformational change in either (Huber et al., 1974, Huber and 
Bode, 1978, Read et a1.,1983). The major differences in the structu-
res of most free and complexed inhibitors are in the relative 
flexibilities of the reactive site loops, which are more rigid in the 
complexed forms. The majority of proteinase inhibitor families have 
disulphide bonds which flank the reactive site bond and are thought to 
stabilise the complex formation (Laskowski and Kato, 1980). However 
members of the potato inhibitor I family (including the chymotrypsin 
inhibitor 2 from b~~ley) lack any stabilising disulphide bonds and 
networks of hydrogen bonds and electrostatic interactions stabilise 
the reactive loop conformations of the complexed inhibitors (McPhalen 
and James, 1987). 
The "standard" mechanism for inhibition is supported by X-ray 
crystallography, as although the members of different families have 
very different three-dimensional structures, the geometries of their 
reactive site regions have proved to be similar. This is the case 
even though serine proteinase inhibitors are surprisingly tolerant to 
substi\-l\.ion of the amino acid residues involved in the reactive site 
region by other amino acids. These residues are referred to as hyper-
variable as they are not highly conserved (Laskoski, 1986). 
The reaction mechanism for the inhibition of a-amylase by plant 
protein inhibitors is less well understood (Wilcox and Whitaker, 
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1984a,b, Buonocore and Silano, 1986, Silano, 1986). These naturally 
occurring inhibitors bind tightly to the amylases to form stable 
inactive enzyme-inhibitor complexes (Buonocore et al., 1980) in which 
the molar ratios of enzymes and inhibitors vary. 
Pre-incubation of the enzyme with the inhibitor is often required 
(except in the inhibition of human pancreatic a-amylase by In 3 and In 
4 from wheat, O'Connor and McGeeney, 1981) to achieve maximum 
inhibition. Warchalewski (1976, 1978) reported pre-incubation times 
of 10-120 min for the wheat endogenous a-amylase inhibitors and Frels 
and Rupnow (1985) found that I-1 and I-2 from black bean (Phaseolus 
vulgaris) required 12 h and 6 h respectively for maximum inhibition. 
The importance of the order of addition of reactants during the assay 
(inhibitor, enzyme and then starch) has been stressed (Militzer et 
al., 1946, Shainkin and Birk, 1970, O'Donnell and McGeeney, 1976, 
O'Connor and McGeeney, 1981). This is probably a result of the slow 
rate of complex formation as compared to starch hydrolysis (Buonocore 
et al., 1977, Blanco-Labra and Iturbe-Chinas, 1981) although the 
decrease in inhibition has also been attributed to the inhibitor 
binding with polysaccharides. 
The interaction between the a-amylase inhibitor from red kidney 
bean (Phaseolus vulgaris) and porcine pancreatic a-amylase is proposed 
to proceed through two steps. The first (second order) has a constant 
of 3.1 x 10-s M and the second (first order, unimolecular) has a 
forward constant of 3.05 min-I at pH 6.9 and 30°C (Wilcox and 
Whitaker, 1984a). The slow association of inhibitors with amylases has 
been thought to indicate that a conformational change in the enzyme 
and/or the inhibitor, rather than the diffusion rate (as the rate 
constants are too small), may be the rate-controlling step in complex 
formation (Powers and Whitaker, 197-7). 
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Tight binding with dissociation constants near 10-11 is also 
characteristic of the combination of amylase inhibitors with amylases 
(Powers and Whitaker, 1977). As a result of the inhibitors being slow 
and tight binding, the steady-state kinetics of Michaelis-Menten are 
not readily applicable. Bieth (1974) designed a kinetic treatment for 
slow reacting, reversible enzyme-inhibitor systems which has been 
applied in a few cases: wheat (Buonocore et al., 1980,1984), barley 
amylase II-BASI (Mundy et al., 1983) and hog pancreatic amylase-red 
kidney bean inhibitor (Powers and Whitaker, 1977). 
The interactions between protein inhibitors and amylases are also 
dependent on pH and ionic strength. Buonocore et al. (1980) showed 
that ionic binding forces which result from charge differences between 
the inhibitor and the amylase were important in stabilising the 
protein-protein interactions of Tenebrio molitor amylase and wheat 
0.19 and 0.28 inhibitors. Also the complex stability, as measured by 
difference spectroscopy, was greatly decreased with increasing salt 
concentration in the interaction of barley a-amylase II with an 
endogenous a-amylase inhibitor from barley, further suggesting that 
binding involves an ionic interaction (Halayko et al., 1986). However 
O'Donnell and McGeeney (1976) found that changes in phosphate buffer 
concentration from 0.1 to 50 mM, in the absence of chloride ions, had 
no effect on the inhibition of salivary a-amylase by wheat inhibitor 
In 1. 
Optimal pH values for inhibitory activity are found to lie 
between 5.5 and 6.5. In many interactions it is found that the 
optimal pH value for inhibition is intermediate between the enzyme and 
. the inhibitor isoelectric points, and as a result they would have 
opposite net charges. Weselake et al. (1985) found that hydrogen ion 
concentration and charge effects were important in the endogenous a-
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amylase-barley inhibitor (BASI) interaction. It is possible that pH 
and/or ionic effects may bring about conformational changes in the 
enzyme or inhibitor that are necessary for complex formation. 
It has been proposed that the tight binding of amylase and 
inhibitors may be due to the binding specificity of the enzyme to the 
carbohydrate moiety on the glycoprotein inhibitors in addition to the 
stabilising effects of the protein-protein interactions (Marshall and 
Lauda, 1975, Powers and Whitaker, 1977, Buonocore et al., 1980). The 
ability of maltose to reduce the affinity of inhibitor for the 
amylase, in many cases, suggests that reducing sugar covalently bound 
to the inhibitor polypeptide chain plays a role in the inhibition 
mechanism (Petrucci et al., 1976, Buonocore et al., 1976, 1980, 
O'Connor and McGeeney, 1984). The possibility that the maltose may 
affect the amylase conformation, thus making inhibitor binding less 
likely, should not be ignored. It has been suggested that the slow 
steps involved in dissociation of the inhibitor-enzyme complex are 
probably also due to conformational changes. 
Wilcox and Whitaker (1984) found that intact glyco-chains, 
isolated by pronase digestion of the red kidney bean inhibitor, did 
not inhibit a-amylase or resemble known substrates of a-amylase; 
whereas oxidation of tryptophan and modification of histidine residues 
in the bean glycoprotein inhibitor led to a reduction in inhibitory 
activity. Buonocore et al. (1980, 1984) have shown, using difference 
spectra, the involvement of tryptophan side chains in the binding of 
wheat albumin inhibitors with a-amylase from yellow mealworm and 
chicken pancreas. Halayko et al. (1986) have shown that when the 
.endogenous a-amylase inhibitor from barley·binds with barley a-amylase 
II, it affects a tryptophan residue of the enzyme. The tryptophan 
residue appears to· be essential in the maintenance of the three-
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dimensional structure that facilitates productive substrate binding. 
Vittozzi et al. (1987) also showed, by using solvent perturbation 
spectra, that binding of enzyme and inhibitor also affects a trypto-
phan residue. It was shown that the equivalent of one tryptophan 
residue per molecule of inhibitor (0.28 inhibitor from wheat) was 
buried when interacting with the yellow mealworm amylase. A hypothe-
tical model for the interaction between the yellow mealworm a-amylase 
and the monomeric (0.28) and dimeric (0.19) protein inhibitors from 
wheat has been proposed (Silano et al., 1977). The model provides a 
theoretical background to explain observed differences in stoichio-
metry, and the higher inhibitory activity and heat stability of 0.28 
compared to 0.19. The two molecules of 0.28 (Mr 12000) would be able 
to adjust more freely to the two binding sites on the amylase than the 
more rigid 0.19 dimer (two non-covalently bound subunits, Mr 12000). 
Therefore the interactions of the 0.28 inhibitor should be stronger 
and faster, accounting for the increased inhibition and heat 
stability. 
1.5 Evolutionary Aspects of Protein Inhibitors 
Studies of the sequence and structure of plant proteinase 
inhibitors have stimulated interest in their evolution. The increased 
knowledge of a common reaction mechanism for serine endoproteinase 
inhibitors and the fact that that the proteinase inhibitors can be 
grouped into families on the basis of their amino acid sequences 
(Laskowski and Kato, 1980); has lead to the conclusion that these 
proteins are suited for studies of protein evolution. Laskowski et 
al. (1974) suggested the following reasons why the proteinase inhibi-
tors are ideal for evolutionary studies: 
1) _They appear to be ubiquitous, giving large numbers for 
comparative studies throughout the animal and plant 
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kingdoms. 
2) They are relatively easy to purify and are generally 
stable. 
3) Most are small enough for easy sequencing. 
4) The reactive site regions are easily identified and can 
be modified to investigate reaction mechanisms 
5) They have many interesting features eg. gene duplication 
giving rise to domains and multiple reactive sites. 
Evolutionary studies have been used to show relationships among 
the Bowman-Birk inhibitor family (Odani and Ikenaka, 1978a,b), the 
Kunitz STI family, (Yamamato et al., 1983, Hejgaard et al., 1983), the 
cystatins (Barrett et al., 1986), potato inhibitors (Ryan, 1981) and 
the Cucurbitaceae family (Joubert, 1984). Norioka et al. (1988) 
screened 34 leguminous species by gel filtration and the results 
indicate that the Kunitz family of inhibitors have gradually been 
replaced by the Bowman-Birk family of inhibitors in the process of 
evolution from trees to herbs. 
Tropical 
Tropical / trees ~ 
Temperate 
h~rbs~ 
/Temperate 
trees 
herbs 
/ Kunitz family 
Kuni tz family ~ 
Bowman-Birk 
./Bowman-Birk family 
family 
The Bowman-Birk family appear to be more advanced than the Kunitz 
family due to their more compact structures and their high cysteine 
contents. Williams (1982) proposed that disulphide bonds are often 
gained but seldom lost during the evolution of a protein. 
The phylogenetic relationships of the wheat genomes have been 
investigated using a-amylase inhibitor patterns. Results indicate a 
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significant homology between the a-amylase inhibitor coding genes of 
the wheat D genome and those of the Aegilops D genome. This is 
consistent with Aegilops squarrosa being the donor of the D genome of 
Triticum aestivum (Bedetti et al., 1974). A comparison of the 
inhibitor types in Triticum and the genetically related Aegilops 
(Bedetti et al., 1974, Vittozzi and Silano, 1976) revealed five 
inhibitor classes (Mr 12000, 12000, 24000, 44000, 60000). A simple 
hypothesis suggested that genes for these classes were derived from a 
limited number of ancestral genes coding for peptide units of Mr 
12000; the resulting distribution of inhibitor types being due to the 
duplication of these ancestral genes followed by the divergence of the 
duplicated genes through mutation (Buonocore et al., 1977). 
Kushnir et al. (1984) reported that the pattern of inhibition of 
the amphidiploid Aegilops sharonenis (putative B genome donor) x 
Triticum monococcum (related closely to A genome donor) was not merely 
the summation of the two species pattern, and so advocated caution in 
using patterns of a-amylase inhibition in evolutionary studies. 
1.6.Biological Role of Plant Enzyme Inhibitors 
The exact role of enzyme inhibitors within the plant still 
remains unclear. The possible roles that have been proposed are: 
1) Storage proteins 
2) Regulators of endogenous enzymes 
3) Defence against insect pests and pathogenic micro-
organisms 
1) Storage Proteins 
A number of features of the protein inhibitors have led to the 
suggestion that they may act as storage proteins. Protein inhibitors 
are, in general, relatively stable to heat and extremes of pH. Many 
are resistant to d~gestion by trypsin and chymotrypsin: a. few are 
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resistant to pepsin (Pattabiraman, 1986, Silano, 1986). Thus they are 
robust proteins that could be resistant to digestion until germina-
tion. The high levels of inhibitors present in some seeds (5-10% of 
the water-soluble protein in some Gramineaeous seeds, (Mikola and 
Kirsi, 1972) tends to support this role (Ryan, 1973, Weder, 1981). 
When the inhibitors have a high cysteine content (eg. members of the 
Bowman-Birk family have seven disulphide bridges) they may act as 
sulphur depots in the seed (Pusztai, 1972, Hartl et al., 1986). 
The primary role for these inhibitors may be metabolic but their 
high levels also suggests a secondary storage role. Any protein which 
is present at high levels in the seed and is then degraded at 
germination is de facto a storage protein. Pace et al. (1978) 
followed the accumulation of wheat a-amylase inhibitors during kernel 
development. The amounts increased rapidly until maturation and 
decreased rapidly on germination. Carasco and Xavier-Filho (1981) 
found that synthesis of protein inhibitors occured at the same stage 
as that of the reserve proteins in developing seeds of cowpea (Vigna 
unguiculata). Protein inhibitors and reserve proteins also appear to 
show parallel production in developing seeds of other species (Kute et 
al., 1984, Mundy and Rogers, 1986, Buonocore and Silano, 1986). This 
pattern of accumulation is typical of storage proteins whose biologi-
cal role is to be broken down during germination. However, the levels 
of some proteinase inhibitors have also been found to increase with 
germination (Pusztai, 1972, Xavier-Filho and Negreiros, 1979, Boisen, 
1983, Nielsen and Liener, 1984), which discredits the storage postu-
late. During barley seed development the levels of mRNA for the 
endogenous a-amylase II inhibitor peak between 15 to 30 days after 
anthesis (Mundy, 1984) which is also the case with many reserve 
proteins (eg. barley hordein, Brandt and Ingversen, 1978). It has 
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been suggested that the heterogeneity of forms displayed by inhibitors 
may be a result of the high tolerance of mutations due to the non-
crucial relationship between structure and function in storage pro-
teins (Petrucci et al., 1978). 
2) Regulators of Endogenous Enzymes 
Inhibitors that are active in vitro on plant endogenous enzymes 
may have a regulatory role in vivo. Several inhibitors of endogenous 
(trypsin) proteases in seeds have been isolated (Ryan and Walker-
Simmons, 1981, Mikola, 1983, Tipisaeva and Popov, 1984, and Poerio et 
al., 1989). The wheat trypsin inhibitor (Poerio et al., 1989) is 
fully active against both exogenous and endogenous trypsin, and it has 
been suggested that it may play a defence role in the plant against 
attack from micro-organisms, insects and higher animals as well as a 
regulatory role in controlling protein metabolism during development 
and. germination of the kernel by forming inactive trypsin/inhibitor 
·complexes (Preston and Kruger, 1976). It has been shown, however, 
that most plant proteinases belong to the thiol and acidic mechanistic 
classes (Preston and Kruger, 1979, Ryan and Walker-Simmons, 1981) so 
the inhibitors of serine endoproteinases would have little effect. 
The occurence of inhibitors of endogenous a-amylase in cereals 
has lead to speculation as to their physiological role. It has been 
suggested that they may be able to control endogenous a-amylase 
activity and thus be responsible for regulating starch metabolism in 
the seed. Weselake et al. (1985) showed that the endogenous barley a-
amylase II inhibitor was effective in vitro in reducing the hydrolysis 
of starch granules by a-amylase II. This inhibition was independent of 
starch concentration so the inhibitor could be effective in the seed 
where starch concentrations would be high. In. the case of the 
endogenous a-amylase/trypsin inhibitor from wheat, it was found that 
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over 80% of the inhibitor adhered to starch granules at neutral pH, 
which supports the suggestion that endogenous inhibitors play a role 
in starch metabolism. 
Precocious germination is a major agricultural problem in the 
growth and storage of barley, wheat, rye and triticale in wet 
temperate climates, as it leads to degradation of starch by a-
amylases. Starch degradation, in turn, has adverse affects on the 
baking quality of wheat (eg caving in of the top and side walls of the 
loaf and a sticky crumb texture) and on malting of barley. Endogenous 
a-amylase inhibitors may be important in regulating this starch 
degradation. Zawistowska et al. (1988) also demonstrated that excess-
ive a-amylase activity in wheat flour could be neutralised in the 
baking process by the addition of a natural proteinaceous a-amylase 
inhibitor from barley (BASI). Abdul-Hussain and Paulsen (1989) 
compared a-amylase inhibitors in wheat genotypes that differed in 
susceptibility to precocious sprouting. They found that only proteins 
from sprouting-resistant genotypes were able to inhibit the wheat a-
amylases. This result suggested that inhibitors may play a role in 
preharvest sprouting, but as they have no effect on the germination 
rate of excised embryos they cannot be the major influence on 
sprouting. The precise physiological role of inhibitors of endogenous 
enzymes remains a subject for speculation. 
3) Defence against insect pests and mica-organisms 
Plant enzyme inhibitors are thought to play an active role in the 
defence of the plant against herbivorous insects. These defences are 
considered to be either constitutive (Janzen, 1979, Yetter et al., 
1979) or induced (Ryan, 1983). There are many reports where the 
inhibitors have been shown to inhibit in vitro the gut enzymes of 
insect predators (Silano et al., 1975, Gatehouse et al., 1979, 1986, 
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Yetter et al., 1979, Powers and Culbertson, 1982, Gatehouse and 
Boulter, 1983, Vittozzi et al., 1987, Baker, 1982, 1987, 1988). 
Applebaum and co-workers {Applebaum, 1964, Applebaum et al., 
1964, 1965, 1967) showed that a crude protein extract from wheat, when 
used in a synthetic diet, caused increased mortality of cereal pests 
including yellow mealworm larvae (Tenebrio monitor). The effects were 
assumed to be due to the in vivo action of an a-amylase inhibitor. 
Silano et al. (1975) found that insect species normally attacking 
wheat grains had higher amylase activities, and were more susceptible 
to inhibition by wheat inhibitors than the amylases of insects that 
did not attack wheat. Gatehouse et al. (1986) tested wheat a-amylase 
inhibitors in vitro with a-amylases from two insect pests (Tribolium 
confusum, an insect storage pest of wheat and Callosobruchus macula-
tus, a storage pest of legumes) and found the inhibitors to inhibit 
efficiently in vitro. The inhibitors were then used in feeding trials 
to assess their activity in vivo, which showed that they were only 
effective against one of the pests, C. maculatus. Thus T. confusum 
appears to be able to: ameliorate the effects of the inhibitor. 
Campos et al. (1989) showed that starch digestion in C. maculatus 
is catalysed by at least four types of a-amylase (Mr's 58000, 45000, 
36000 and 33000). The a-amylases showed different susceptibilities to 
inhibitors. The diversity of a-amylases indicates that the seed would 
need a broad spectrum of inhibitors to act as a defence against the 
full range of insect enzymes. 
Insect feeding trials have also been used to test proteinase 
inhibitors in: Glycine max/Tribolium castaneum (Birk and Gertler, 
1971), Hordeum vulgare/Camnulla pellucida (Weiel and Hapner, 1976) and 
Vigna unguiculata/Callosobruchus maculatus (Gatehouse and Boulter, 
1983). Gatehouse et al. (1979) attributed the resistance of cowpea 
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(V. unguiculata, cultivar TVu 2027) to the bruchid beetle (C. 
maculatus) to the elevated levels of trypsin inhibitor present in 
resistant varieties compared to susceptible varieties. The feeding 
trials confirmed the trypsin inhibitor (a member of the Bowman-Birk 
serine endoproteinase inhibitor family) as an antimetabolite effective 
against C. maculatus. During the feeding trials the addition of 
methionine or cysteine to the meal of the resistant variety of cowpea 
resulted in an increase in adult beetle survival of between 43 to 89% 
relative to the controls. Ingestion of inhibitors is known to cause a 
hyperproduction of trypsin which may lead to a depletion of sulphur 
containing amino acids (Gallaher and Schneeman, 1986). This depletion 
may be negated by the addition of methionine or cysteine (Broadway and 
Duffey, 1986). 
Xavier-Filho et al. (1987) examined the levels of trypsin 
inhibitor in cultivars of V.unguiculata and found no correlation 
between the levels of inhibitor and resistance to attack by C. 
maculatus. It was thought that serine endoproteinases were the major 
gut proteinases of insect pests (Ryan, 1973), but only limited studies 
have been carried out on the proteinases and a-amylases actually found 
in insect guts (Xavier-Filho and Coelho, 1980, Baker and Woo, 1985, 
Gatehouse et al., 1985, Baker, 1986, 1987, Kitch and Murdock, 1986, 
Lemos et al., 1987). Campos et al. (1989) isolated three proteinases 
and four a-amylases from the midgut of the brucid beetle (C. 
maculatus). All the proteinases belonged to the cysteine proteinase 
family (E.C. 3.4.22) so it seems unlikely that the level of a serine 
proteinase inhibitor present in cowpea would have an effect on 
resistance to the bruchid beetle. Wolfson and Murdock (1987) found 
that cysteine proteinase inhibitors inhibited enzymes found in the 
midgut of the Colorado beetle (Leptinotarsa decemlineata). Plant 
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cysteine inhibitors have been purified from cowpea (Rele et al., 1980) 
pineapple (Heinrikson and Kezdy, 1976), potato (Rodis and Hoff, 1984); 
and the cereals maize (Abe and Whitaker, 1988) and rice (Abe and Arai, 
1985). Cysteine proteinase inhibitors are present at very low 
concentrations, and the insect pests appear to thrive on the seeds. An 
increase in their level of expression would be required to have an 
effect on the insect survival rate. 
It is interesting to note that Hilder et al. (1987) transferred 
the gene encoding the cowpea trypsin inhibitor into tobacco and found 
that this gene alone was sufficient to increase resistance t~ its 
natural insect pests which presumably contain serine proteases. 
When leaves of plants from the Solanaceae and Leguminosae are 
damaged by insect attack or mechanical damage they accumulate serine 
proteinase inhibitors (Green and Ryan 1972, Plunckett et al 1982, 
Brown et al 1985). A 1 kilobase restriction fragment from the 5' 
flanking region of the pot·ato inhibitor IlK gene, which is wound 
inducible, was fused to the chloramphenicol acetyltransferase (CAT) 
gene (An, 1986). The inhibitor/CAT construct was used to transform 
tobacco plants which then showed wound-inducible CAT activity 
(Thornburg et al., 1987). This work showed that a 1 kilobase 5' 
fragment was sufficient to confer wound inducibility. The production 
of inhibitors in response to wounding is systemic and is thought to be 
triggered by a putative signal that is released at the site of damage 
(Ryan 1974). The signal is called the "proteinase inhibitor inducing 
factor" (PIIF). The inducing activity of the PIIF was found to be 
associated with fragments of the plant cell wall released by the 
action of endopolygalacturonases (Ryan et al., 1981, Bishop et al., 
1984). Similar effects can be induced by chitosan which is a mixture 
of water-insoluble a, 1-4 glucosamine polymers produced from arthropod 
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cuticles and fungal cell walls (Walker-Simmons et al., 1983, Walker-
Simmons and Ryan, 1984). 
It is likely that proteinases produced by phytopathogenic micro-
organisms play a role in the digestion of the host (Sikes and Maxcy, 
1979, Ayers et al., 1985). Many plant proteinase inhibitors from 
cereals have been shown to be active against microbial proteinases 
(see Table 3). Many endogenous a-amylase inhibitors from cereals are 
also active against bacterial or fungal enzymes (Silano, 1986) hence 
they may play a protective function by inhibiting microbial protease. 
Table 3: 
Cereal Proteinase inhibitors known to inhibit microbial proteases 
Cereal 
Barley 
Maize 
Wheat 
Rye/Triticale 
Protease/Source 
Subtilisin/ 
Bacillus subtilis 
Protease/ 
Aspergillus 
Pronase/ 
Streptomyces griseus 
Protease/ 
Fusarium moliniforme 
Protease/ 
Fusarium solani 
Subtilisin/ 
Bacillus subtilis 
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Reference 
Yoshikawa et al 1976 
Mikola and Suolinna 1969, 
1971 
Kirsi 1973,1974 
Boisen et al 1981 
Boisen and Djurtoft 1982 
Kolaczkowska et al 1980 
Mosolov et al 1976 
Mosolov and Shulgin 1986 
1.7 Nutritional and Metabolic Effects of Plant Inhibitors of 
Digestive Enzymes 
Much of man's food intake is derived directly from plants. Ever 
since the discovery of plant protein inhibitors of digestive enzymes 
studies have been carried out to evaluate their effects on man and 
other animals. Increasing our knowledge of the nutritional and 
metabolic effects of these inhibitors requires a multidisciplinary 
approach, many aspects of which have been collated in a recent book to 
which the reader is referred (Friedman, 1986). 
Numerous studies have been carried out on the nutritional 
response to the consumption of protein inhibitors. Osborne and Mendel 
in 1917 first established that raw soybean meal led to a depression of 
growth rate when fed to rats. The discovery of a heat-labile trypsin 
inhibitor in soybean (Ham and Sandstedt, 1944, Bowman, 1944) 
suggested that this protein was responsible for the depression in the 
growth rate·~·· Diets containing raw soybean are now known to cause: · 
a) a reduction in growth 
b) pancreatic enlargement 
c) hypersecretion of digestive enzymes 
d) enlargement of intestinal segments 
These effects are known to vary between species (Nitsan and Nir, 
1986). Growth depression with raw soybean meal has been noted with 
many species including guinea pigs (Patten et al., 1973), goslings 
(Nitsan and Nir, 1977), growing swine (Yen et al., 1974) and calves 
(Gorrill and Thomas, 1967). 
Proteolysis of endogenously secreted enzymes as well as of 
dietary proteins may be reduced by inhibitors. Lyman and Lepkovsky 
(1957) found that dietary soybean trypsin inhibitor increased the 
secretion of pancreatic enzymes, but that these enzymes were not 
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degraded and as a result essential amino acids were lost to the 
animal. In particrilar, as the cysteine content of the digestive 
enzymes is high then the loss of these proteins would result in a 
depletion of sulphur. Growth. rates are often improved by the addition 
of methionine to an inhibitor-rich diet (Borchers, 1961). A diet that 
is rich in protein also helps to overcome the growth depression by 
compensating for the endogenous losses (Roy and Schneeman, 1981). 
Soybean proteins are themselves relatively difficult to digest 
(Bozzini and Silano, 1978) and their prolonged presence in the gut may 
also cause hypersecretion of enzymes (Green et al., 1973, Percival and 
Schneeman, 1979). Heat trea~ment of the soybean meal (which is known 
to improve the growth rate) not only inactivate the inhibitors but 
also denatures the soybean proteins and increases their digestibility. 
Effects on the pancreas are noticed when animals are fed a diet 
containing proteolytic inhibitors. Pancreatic enlargement is noted in 
chicks (Nitsan and Nir, 1977) and rats (Rackis, 1965). The 
enlargement is primarily due to hypertrophy (abnormal enlargement of 
cells) with some hyperplasia (excessive production of cells) (Melmed 
et al., 1976, Kakade et al., 1967). The levels of free trypsin and 
chymotrypsin are known to regulate pancreatic secretion by negative 
feedback inhibition (Green and Lyman, 1972, Lyman et al., 1974). As 
the inhibitors bind almost irreversibly to the enzymes they reduce the 
amount of free enzyme which, via the feedback mechanism, causes hyper-
secretion. However pancreatic enlargement does not always occur. 
Kakade et al. 1976 suggested a relationship between pancreas size and 
body weight; namely, that in animals where the pancreas is less than 
0.3% of the body weight (eg. adult guinea pigs, pig, dog, calf) 
pancreatic enlargement does not occur. This, however, remains to be 
clearly established. 
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Legume protease inhibitors are able to inactivate trypsin and 
chymotrypsin in humans if they reach the small intestine undigested. 
This may be possible as many inhibitors are resistant to pepsin and to 
low pH (Weder, 1986). Conventional cooking and processing do, 
however, largely denature these inhibitors (Liener and Kakado, 1980, 
Rackis et al., 1986). When the inhibitors have been denatured by 
cooking etc. they are highly nutritious, well balanced proteins which 
are rich in sulphur amino acids (Tan-Wilson and Wilson, 1986). 
Attempts to remove these inhibitors (Hymowitz, 1986) by genetic 
engineering because of their adverse effects must be weighed against 
the nutritional benefits. Friedman and Gumbmann (1986) modified 
soybean proteins through the formation of mixed disulphide bonds 
between added.sulphydryl compounds, proteolytic enzyme inhibitors and 
other legume proteins. This modification completely removes 
inhibitory activity, and increases protein digestibility and 
nutritional value. Because of the heat inactivation of inhibitors 
there has been a tendancy to dismiss the metabolic significance of the 
residual inhibitory activity. Gumbmann et al. (1986) studied the 
effects on the rat pancreas of a two-year exposure to raw and heated 
soybean flour. The major pathological findings were nodular 
hyperplasia and benign neoplastic lesions, acinir adenoma (berrylike 
gland tumour}. As this work was exclusively carried out on rats a 
direct comparison with humans is not possible. Troll et al. (1986), 
however, have shown that protease inhibitors present in the diet seem 
to contribute to the prevention of three major human cancers (breast, 
colon and prostate). Further human studies are necessary before a 
full understanding of the role of inhibitors in carcinogenic processes 
is possible. 
The nutritional effects of a-amylase inhibitors in humans and 
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animals are difficult to assess. The inhibitors are relatively 
thermostable with up to 20% amylase inhibition still present in bread 
after baking (Granum, 1979). They also show varying susceptibility to 
acid pH and animal proteases (Silano, 1986). When large doses of a-
amylase inhibitors from wheat were given, they survived digestion in 
man and other mammals (Puls and Keup, 1973, Lang et al., 1974, 
Saunders, 1975). High levels of these inhibitors decreased starch 
availability in a starch-rich diet fed to rats (Lang et al., 1974), 
but also brought about a lowering in the expected blood glucose level. 
The level of amylase activity is controlled by the quantity of 
digestion products absorbed (Lavau et al., 1974). Amylase inhibitors 
should lower the amounts of products by inhibiting starch digestion 
and hence lower the concentration of pancreatic amylase. Using a 
microbial amylase inhibitor (a complex oligosaccharide Mr 500-5000) a 
decrease in the amylase concentration occurred (Puls and Keup, 1974, 
Folsch et al., 1981), but chicks fed on encapsulated wheat albumin 
inhibitors showed pancreactic hypertrophy and increased amylase 
activity. These results appear to be in conflict but further 
consideration of the specificities of the inhibitors used may be 
necessary. 
Amylase inhibitors have been used for a variety of medical 
applications with varying success. They seemed to offer an attractive 
method for decreasing the glucose absorption from starch, reducing the 
calorific intake from a meal and thus help in controlling obesity. 
One such application were slimming pills known as "starch-blockers" 
derived from kidney beans (Granum et al., 1983) which claimed to 
decrease amylolytic digestion of starch and as a result cause loss of 
weight. Human trials showed that "starch-blockers" did not inhibit 
the digestion and absorption of starch in vivo (Bo-Linn et al., 1982). 
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The failure could be due to destruction of the inhibitor by pepsin or 
the acid pH in the stomach. The pH of the small intestine is far 
from optimal for enzyme/inhibitor complex formation, and 
preincubation of the enzyme/inhibitor in the absence of starch is also 
necessary to achieve enzyme inhibition. The pancreas is also known to 
secrete ten times more amylase than is required to bring about 
complete digestion of the starch in a meal (Gray, 1971). Hence, at 
the doses present in the "starch-blocker" tablets, only a fraction of 
the amylase present would be inhibited. 
Amylase inhibitors have also been used in an attempt to control 
diabetes. The wheat albumin inhibitors can reduce hyperglycemia and 
hyperinsulinism when raw starch is given to diabetic and obese 
patients. However a much greater amount of the inhibitor was needed 
when cooked starch was used; so it was concluded that the amylase 
inhibitors were of limited therapeutic value (Puls and Keup, 1973}. 
Other uses for· a-amylase inhibitors include efficient puri-
fication of amylases by affinity chromatography, eg. human salivary 
amylase (Buonocore et al., 1975). a-Amylase inhibitors have also been 
used for diagnosing pancreatic disorders and other forms of 
hyperamylasemia where it is necessary to differentiate between the 
activities of salivary and pancreatic types of amylase isozymes 
present in sera. In the past these were separated by electrophoresis, 
electrofocusing and chromatography, all of which were time consuming 
(Henderson, 1981). O'Donnell et al., (1977) developed a method based 
on the differential inhibition of the wheat inhibitor 0.20 (Mr 26000) 
which inhibits salivary amylase by 80% and pancreatic amylase by 20%. 
This inhibitor assay provided a simple, quick and accurate method when 
compared to other methods (Berk et al., 1982, Ellis et al., 1982), but 
Gordon et al. (1984) reported some anomalous results. An a-amylase 
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inhibitor from proso millet (Panicium miliaceum) may prove to be more 
useful in the future as it is more specific for the pancreatic isozyme 
than the wheat inhibitor (Nagaraj and Pattabiraman, 1986). 
1.8 Context and Aims of the Project 
Cereals have been an important crop for thousands of years. They 
are important sources of protein for man and his livestock; the seed 
storage proteins of the Triticeae (wheat, barley and rye) contributing 
about 55% of man's protein intake (Kreis et al., 1985). Because of 
the nutritional importance of cereal seeds much work has been 
undertaken on structure and molecular biology of their storage 
proteins. Only one species of rye, Secale cereale L. is cultivated, 
and it is second only to wheat in its use in bread making. Although 
it is inferior to wheat because the dough lacks elasticity and gas 
retention properties, it is still used extensively in Russia, Poland 
and Germany (Bushuk, 1976), often as rye/wheat mixtures. Rye is the 
most widely distributed cereal crop as it is a hardy plant which can 
be grown in marginal soils. It is also drought resistant due to an 
extensive root system. As well as its use in breadmaking, rye is used 
as an animal feed,both as a grain and the green plant for pasture,and 
for crispbread in the UK. 
Rye is known to contain many anti-nutritional factors including 
5-alkyl resorcinols (Munck, 1969), phytic acid (Gontzea and Sutzescu, 
1968), and proteinaceous enzyme inhibitors. The latter group of 
enzyme inhibitors, present within all cereal grains, have received 
particular attention: because of their potentially deleterious effects 
in animal and human nutrition; and their possible role in the defence 
of plants against microbial and insect pests (Richardson, 1980). 
Polanowski (1967) first reported a trypsin inhibitor in rye 
endosperm, and the seeds have since been reported to contain four 
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trypsin inhibitors in the embryo (Hochstrasser and Werle, 1969, Mr 
17000) and at least two in the endosperm (Mikola and Kirsi, 1972, Mr 
13500; Polanowski, 1974, Mr 10000). Boisen and Djurtoft (1981) 
isolated the most abundant of the endosperm inhibitors with a Mr of 
12500, which appeared to be identical to the trypsin inhibitor 
isolated by Chang and Tsen (1981a,b). Comparative physico-chemical 
studies carried out by Boisen (1983) indicated a partial 
immunochemical identity between the rye and barley trypsin inhibitors 
with no cross reaction with the wheat trypsin inhibitor. 
Kneen and Sandstedt (1943, 1946) first reported the presence of 
a-amylase inhibitors in the seeds of rye and wheat. The rye inhibitor 
was active against salivary, pancreatic and bacterial a-amylase; and 
was partially purified by Strumeyer (1972). Marshall (1977) purified 
two a-amylase inhibitors; one inhibited human salivary, Bacillus 
subtilis and Tenebrio molitor amylases, while the second was active 
against human pancreatic, porcine pancreatic and Tenebrio molitor 
amylases but inactive towards human salivary amylase. Granum (1978) 
purified to homogeneity an a-amylase inhibitor from rye with a 
.molecular weight of 28000, composed of two subunits identical in size 
(Mr 14000). The inhibitor was active towards human salivary and hog 
pancreatic a-amylases. The amino acid composition, isoelectric point 
and pH optimum of the inhibitor was similar to those of the wheat 0.19 
a-amylase inhibitor, which is also a dimer with two subunits of Mr 
12000. 
Inhibitors of subtilisin and endogenous a-amylase are also 
present in rye (Mosolov and Shulgin, 1986, Weselake et al., 1985). 
The aim of this project was to determine the primary structure of 
enzyme inhibitors from rye. Previous reports showed that rye grains 
contained inhibitors of both proteinases and a-amylases. This was, at 
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the time, the only cereal in which the presence of both types of 
·inhibitor had been clearly established • No primary sequence data had 
been determined and.it was not possible to assign them to families. 
However, their amino acid composition, molecular weights and 
inhibitory properties indicated that some at least were members of the 
cereal inhibitor superfamily. I therefore decided to determine the 
sequences of inhibitors of trypsin and a-amylase, in order to compare 
their structures and evolutionary relationships with each other and 
with other inhibitors. The sequence analysis was approached via two 
methods. Firstly the trypsin and a-amylase inhibitors were purified 
and sequenced at the protein level. Secondly, a eDNA library was 
prepared in order to isolate and characterise corresponding eDNA 
clones. 
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CHAFfER 2 
MATERIALS AND METHODS 
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MATERIALS 
2.1 Chemicals 
Acetic acid (glacial) (AR grade) 
Acetonitrile (HPLC grade S) 
Acrylamide (gel grade) 
Adenosine 2'.3'. monophosphate 
(2' .3' .A.M.P) 
Agarose (medium EEO) 
Agarose (low gelling temp.) 
Ammonium acetate (AR grade) 
Ammonium bicarbonate (ammonium 
hydrogen carbonate) (AR grade) 
Ammonium hydroxide 
Ammonium persulphate 
(electrophoresis grade) 
Ampicillin 
Bacto agar 
Bacto tryptone 
Bacto yeast extract 
BApNA (a-N-benzoyl-DL-arginine-p-
nitroanilide-HCl) 
Bio-gel P2, P6 
Bis acrylamide (electran grade) 
Boric acid (AR grade) 
Bromophenol blue 
~-D pyranoside (X-gal) 
Butan-1-ol 
Butyl acetate (AR grade) 
Caesium chloride (CsCl) 
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Manufacturer 
Fisons 
Rathburn Chemicals Ltd 
Sigma 
Sigma 
Sigma 
Biorad 
Fisons 
BDH 
BDH 
Fisons 
Sigma 
Difco 
Difco 
Difco 
Sigma 
Bio-Rad 
BDH 
Fisons 
Sigma 
Sigma 
Sigma 
BDH 
Chemetall, Frankfurt 
Calcium chloride (CaCl2.6H20)(AR grade) Fisons 
Chloroform 
CM Bio-gel 
Coomassie Brilliant blue R 
Cyanogen bromide 
Dansyl chloride (5-dimethylaminonaph-
thalene-1-sulphonyl chloride) 
4-Dimethylaminoazobenzene-4'-
isothiocyanate (DABITC) 
DABTC -diethylamine standard 
Dimethylamino benzaldehyde 
Dimethylsulphoxide 
Dinitrosalicylic acid 
Decon 90 
Dithiothreitol (D.T.T.) 
Ethylenediaminetetra-acetic acid 
disodium salt (E.D.T.A.)(AR grade) 
Fisons 
Biorad 
Sigma 
Koch-Light Lab. 
B.D. H. 
Fluka 
Prepared by 
Dr. M. Richardson. 
Sigma 
BDH 
Sigma 
Decon laboratories 
BRL 
BDH 
Ethanol Fisons 
Ether Fisons 
Ethidium bromide Sigma 
Ethyl acetate BDH 
Ficoll Pharmacia 
Formamide BRL 
Formic acid (AR grade) 
Glycerol 
Glycine 
Guanidine hydrochloride 
(Sequencer grade) 
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BDH 
Fisons 
Sigma 
Pierce (USA) 
Heptane (n-) (GPR grade) 
Hexane (60°-80°C fraction from 
petroleum) 
Hydrochloric acid 
Iodoacetic acid 
Isopropanol (propan-2-ol) 
Isopropyl b-D-thiogalactopyranoside 
(IPTG) 
Magnesium acetate 
Magnesium chloride 
Magnesium sulphate (MgS04.7H20) 
Maltose 
2-Mercaptoethanol 
Methanol 
NaCl 
NaOAc 
NaOH 
Oligo-dT-cellulose 
Phenol 
Phenylisothiocyanate (PITC) 
(Sequencer grade) 
Polyethyleneglycol 6000 (PEG 6000) 
Polyvinyl pyrollidone 
Potassium chloride 
Protein A Sepharose 
Pyridine (AR grade) 
Salicylic Acid 
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BDH 
BDH 
Fisons 
BDH 
Fisons 
Sigma 
Fisons 
Fisons 
Fisons 
Sigma 
Sigma 
Fisons 
Fisons 
BDH 
BDH 
BDH 
Fisons 
Sigma 
Fisons 
Rathburn Chemicals Ltd 
BDH 
Sigma 
Fisons 
Pharmacia 
Rathburn Chemicals Ltd 
Sigma 
Sephadex G-50 
Sodium acetate 
Sodium chloride 
Sodium dodecyl sulphate 
di-Sodium hydrogen phosphate 
Sodium hydrogen phosphate 
Sodium hydroxide 
Spermidine 
Starch 
Sucrose 
TEMED (N,N,N',N',-tetra methylene 
diamine) 
Pharmacia 
BDH 
Fisons 
Sigma 
BDH 
BDH 
Fisons 
Sigma 
Sigma 
Fisons 
Sigma 
Thiamine-HCl Sigma 
Toluene (AR grade) BDH 
Trichloroacetic acid (TCA) BDH 
Trifluoroacetic acid (Sequencer grade) Rathburn Chemicals Ltd 
Triton X-100 BDH 
Tris/Trizma 7-9 Sigma 
Tri-sodium citrate Fisons 
Urea BRL 
Xylene cyanol Sigma 
2.2 Enzymes and other biological reagents 
AMY reverse transcriptase 
a-Amylase (E.G. 3.2.1.1.) Type I-A 
from hog pancreas 
Bovine serum albumin 
a-Chymotrypsin (E.C. 3.4.21.1) 
DNA ligase (E.coli) 
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Life Sciences 
Sigma 
BRL 
Worthington Bioch. Corp. 
DNA polymerase I, Klenow fragment 
(E. coli) 
Herring sperm DNA 
A/Hind III DNA size markers 
Lyzozyme 
~X174/Haeiii DNA size markers 
123 bp DNA ladder 
Proteinase K 
Restriction endonucleases 
Ribonuclease A 
RNAase H 
T4 DNA ligase 
T4 DNA polymerase 
T4 polynucleotide kinase 
Trypsin (E.C. 3.4.21.4) TPCK-treated 
Trypsin (E.C.3.4.21.4.) Type XI 
from porcine pancreas 
Wheat tRNA 
2.3 Radiochemicals 
Amersham 
Sigma 
BRL 
Sigma 
BRL 
BRL 
Sigma 
Amersham/BRL 
Sigma 
Amersham 
BRL 
Amersham 
Amersham 
Worthington Biochemical 
Corporation 
Sigma 
Amersham 
Adenosine 5'[a-32p] triphosphate ([a-32P]dATP), Amersham 
(>3000Ci/mmol in 50% aqueous ethanol). 
Adenosine 5'[a-35S] triphosphate ([a-35S] dATP), Amersham 
(410Ci/mmol in aqueous solution). 
Leucine [3H], (1 mCi/ml), Amersham. 
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METHODS 
PROTEIN PURIFICATION AND SEQUENCING OF HOMOLOGOUS INHIBITORS OF 
TRYPSIN AND a-AMYLASE FROM SEEDS OF RYE (Secale cereale cv. Gazelle) 
Protein purification 
2.4 Purification of a trypsin inhibitor from rye flour (Secale 
cereale cv. Gazelle). 
The rye trypsin inhibitor was purified essentially as described by 
Boisen and Djurtoft (1981). Seeds of rye (S. cereale cv. Gazelle 
from Rothamsted Experimental Station, Herts.) were ground in a hammer 
mill, using a 0.1 mm sieve. 250g of the meal was stirred with 1 litre 
of 0.1 M sodium acetate buffer (pH 4.9) for 16 hat 4°C. The extract 
was centrifuged at 10000 x g for 15 min. The supernatant was filtered 
through muslin and subjected to fractional precipitation with 
(NH4)2S04 to 30% (w/v). The 0-30% protein fraction was collected by 
centrifugation at 10000 x g for 15 min. The precipitate was dissolved 
in 200 ml of 0.1 M sodium acetate buffer (pH 4.9) and heat-treated for 
5 min in a boiling water-bath, rapidly cooled in an ice-bath and 
filtered through Whatman No. 1 filter paper. The filtrate was 
dialysed against 8 l of 0.05 M sodium acetate buffer (pH 5.5) and then 
applied to a column (3 x 25 em) of SP-Sephadex equilibrated with the 
same buffer. After extensive washing with the equilibration buffer 
(400 ml) the column was eluted with a linear gradient of 0-0.5 M NaCl 
(400 ml of each) at a flow rate of 35 ml/h. The elution profiles were 
followed by measurement of the absorbance at 280 nm or 230 nm and by 
assaying for trypsin inhibitory activity. 
The single major peak of anti-trypsin activity which eluted 
between 0.31 and 0.34 M NaCl was collected, dialysed against distilled 
water and lyophilized. This crude trypsin inhibitor fraction was 
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dissolved in a small volume of 0.1 M sodium acetate buffer (pH 5.0) 
and applied to a column (2.5 x 87 em) of Bio-Gel P-60 equilibrated and 
eluted with the same buffer at a flow rate of 30 ml/h. The single 
peak of anti-trypsin activity was collected, diluted with distilled 
water to give a final buffer concentration of 0.05 M and applied to a 
column (1 x 25 em) of CM Bio-Gel equilibrated with the same buffer. 
When eluted with a linear gradient of 0-0.2 M NaCl (500 ml of each) at 
a flow rate of 20 ml/h, the single peak of anti-trypsin activity 
emerged at a concentration of 0.07 M NaCl. After dialysis against 
distilled water and lyophilization, the trypsin inhibitor was finally 
purified by reverse-phase HPLC using a Varian 5000 HPLC fitted with a 
Vydac C1a column (25 ml x 4.6 mm). The protein samples for injection 
(3-5 mg) were dissolved in 500 pl of 0.1% trifluoroacetic acid, 6 M 
guanidine-HCl. The column was eluted with a gradient of acetonitrile 
in 0.1% trifluoroacetic acid. 
2.5 Purification of an a-amylase inhibitor from seeds of rye (Secale 
cereale cv. Gazelle) 
The initial purification procedure was based on Granum (1978). 
230 g of seed meal was stirred with 1 litre of 70% (v/v) aq. ethanol 
for 2 h at room temperature. The suspension was filtered through 
muslin and the supernatant, after centrifugation (10000 x g for 30 min 
at 4°C), was dialysed for 16 h against 0.02 M Na phosphate buffer (pH 
6.9). The supernatant was recentrifuged and subjected to fractional 
precipitation with (NH4)2S04. The 20-50% precipitate was dissolved in 
200 ml of 0.005 M phosphate buffer (pH 6.9) and dialysed against the 
same buffer for 16 h. It was then applied to a column (2.5 x 25 em) 
of DEAE-Sepharose equilibrated with the same buffer. The column was 
then extensively washed with 0.005 M buffer and eluted with a two step 
gradient (0.005 M to 0.02 M to 0.2 M, 500 ml of each). The fractions 
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containing the inhibitor were then bulked and dialysed against 0.05 M 
Tris-HCl buffer (pH 8.6). The inhibitory fractions were reapplied to 
the DEAE-Sepharose column (equilibrated with 0.05 M Tris-HCl pH 8.6) 
and eluted with a linear gradient of 0 to 0.5 M NaCl (500 ml of each}. 
The inhibitory fractions were again bulked and applied first to a 
column of DEAE-cellulose (2.5 x 34 em} in 0.025 M Tris-HCl buffer (pH 
8.6, elution with 0 to 0.5 M NaCl), and then to CM-Bio-Gel (1.5 x 25 
em} in 0.05 M sodium acetate buffer (pH 5.0) eluted with 0.05 to 0.5 M 
buffer (500 ml of each). The inhibitory peak was finally dialysed 
against dHzO, lyophilized and homogeneity assessed by RP-HPLC. 
In further purifications the DEAE-Sepharose columns were 
omitted. 
2.6 Assay of trypsin inhibitor activity 
Trypsin inhibitory activity was determined, using the method of 
Erlanger et al. (1961) as described by Campos and Richardson (1983), 
by measuring the hydrolysis of N-benzoyl-DL-arginine-p-nitroanilide 
(BApNA) at pH8.0. 
To prepare the BApNA solution, 50 mg of BApNA was dissolved in 1 
ml dimethylsulfoxide and diluted to 100 ml with assay buffer (0.1 M 
Tris-HCl pH 8.0, 0.01 M CaClz). 
Assay mixture: 20 pl trypsin (0.3 mg/ml in 2.5 mM HCl) 
0.38 ml assay buffer 
0.5 ml inhibitor solution (in column buffer) 
The enzyme and the inhibitor were preincubated for 10 min at 
37°C. The substrate was added (2 ml BApNA solution) and the reactants 
were incubated for 20 min at 37°C. The reaction was stopped by the 
addition of 1 ml 10% acetic acid. The absorbance of the solution was 
measured at 410 nm. 
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2.7 Assay of a-amylase inhibitor activity 
The inhibition of starch hydrolysis by hog pancreatic a-amylase 
was determined as described by Bernfeld (1955). 
Assay buffer: 0.05 M sodium acetate pH 7.0 
Starch solution: 
1% soluble starch w/v was prepared by dissolving 1 g of 
starch in 10 ml dH20, this solution was boiled gently for 
15-30 sec and then made up to 100ml with distilled water. 
Dinitrosalicylate solution: 
1 g dinitrosalicylic acid was dissolved in 20 ml 2 N NaOH. 
The solution was then diluted with 50 ml dH20, 30 g 
potassium tartrate was added and dissolved. 
Assay mixture; 0.5 ml a-amylase (1.25pg/ml in assay buffer) 
0.5 ml inhibitor (varying concentra~ions in 
assay buffer) 
0.5 ml assay buffer 
1.5 ml (+ 0.5 ml starch solution) 
The enzyme and the inhibitor were preincubated at 30°C for 25 
min. The substrate (0.5 ml starch solution) was added and the 
reaction incubated at 30°C for 10 min. The reaction was stopped by 
the addition of 2.0 ml dinitrosalicylate solution. 
The reaction mixture was boiled for 10 min, allowed to cool, and 
then 10 ml dH20 was added. The reaction was left to stand for at 
least 10 min before the absorbance was measured at 530 nm. 
2.8 SDS-Polyacrylamide gel electrophoresis 
Sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis 
using a modified Laemmli (Laemmli, 1970) system with the addition of 4 
M urea to the gels was used as described in Bunce et al. (1985). Mr 
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values were calculated as described in Bunce et al. (1985). 
2.9 Isoelectric Focusing 
The IEF system used was as described by Shewry et al. (1988). A 
gel was prepared by dissolving 22.34 g urea (6 M) in 30 ml 10% 
acrylamide, 0.5% bisacrylamide, with 3 ml 3.5-10 ampholyte made up to 
60 ml. Once the urea was dissolved 300 pl of 10% (w/v) ammonium 
persulphate and 20 pl of TEMED were added as catalysts and the gel 
poured with 24 sample wells (each 5 mm 2 x 1 mm deep and 5 mm apart). 
The 1% (w/v) protein sample was dissolved in 10 mM glycine, 6 M urea 
with Tris to give pH 8.0. Anode and cathode buffers were respecti-
vely; 1 M H3P04 and 1 M NaOH. 
The gel was pre-run for 1 h at 10 W with 30 pl 1% (w/v) 3.5-10 
ampholyte in each well which was removed after the pre-run. The 
protein sample (20 pl) was loaded into the wells and the gel run for 3 
h at 13 W. In order to calculate the pH gradient across the gel, the 
gel was cut into 0.5 em strips (at each end 15 mm of gel were 
discarded} and placed in a test-tube. The gel was disrupted with a 
glass rod then 1 ml dHzO added, mixed, left to stand for at least 30 
min and the pH reading taken (the pH reading is affected by the urea 
present in the gel hence the reading obtained is an estimated value). 
2.10 Immunochemical methods 
1 mg protein was dissolved in 1 ml of phosphate-buffered saline 
PBS (20 mM NazHP04/0.85 M NaCl/HCl to pH 7.4), mixed with an equal 
volume of Freund's complete adjuvant, and injected into the leg muscle 
of a New Zealand white rabbit (1 ml/leg). Booster injections with a 
similar preparation mixed with Freund's incomplete adjuvant were given 
after 4 weeks. Blood was taken every two weeks. The blood was 
allowed to clot at 37°C for 1 h in 30 ml centrifuge tubes. After 
removing the clot the serum was left at 4°C for 5-16 h. The serum was 
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centrifuged at 5000 rpm for 10 min and the supernatant was stored at 
-20°C. The serum was diluted two-fold with PBS before assay. Protein 
fractions were dissolved in PBS (0.125 mg/ml) and assayed for reaction 
with the antiserum by immunodiffusion in 2.0% (w/v} agarose in PBS. 
Ten pl each of antiserum and protein were loaded into the wells and 
left in a moist environment for 48 h. The plates were washed for 24 h 
in 0.85 M NaCl (to remove any protein not bound in the protein/ 
antibody complex}, then washed for 1 h in dH20 and allowed to dry on a 
glass plate. The gel was immersed in stain (9 g amido black lOB in 
1.5 1 rinsing solution} for 5 min. To destain the gel it was washed 5 
x for 5 min each in rinsing solution (45:10:45 v/v methanol, acetic 
acid, dH20). 
Protein Sequence Determination 
2.11 Reduction and S-carboxymethylation 
The two inhibitors were reduced and S-carboxymethylated using a 
modification of the method of Crestfield et al. (1963) as described by 
Campos and Richardson (1983). 
The protein (10-40 mg) was dissolved in 6 M guanidine hydrochlor-
ide buffered at pH 8.6 with 0.6 M Tris-HCl (up to 2 ml). Ten pl 
2-mercaptoethanol/10 mg protein was added and the mixture left 
standing at room temperature, under a constant stream of nitrogen, for 
3 h. Then 100-300 pl of iodoacetic acid (0.268 g/ml in 1 M NaOH) was 
added and the reaction kept in the dark for 30 min. The reduced and 
S-carboxymethylated protein was recovered by desalting in the dark on 
a Bio-Gel P2 column (1 x 10 em) in dH20 (trypsin inhibitor) or 0.05 M 
NH4HC03 pH 8.25 (a-amylase inhibitor). The eluted protein was 
lyophilized in vacuo over NaOH. 
2.12 Chemical cleavage with cyanogen bromide (CNBr) 
The CNBr cleavage was carried out using the method of Steers et 
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al. (1965) as described by Campos and Richardson (1983). The reduced 
and S-carboxymethylated trypsin inhibitor was dissolved in 1 ml 70% 
(v/v) formic acid containing 10 pl of 2-mercaptoethanol and a 20-fold 
molar excess (relative to the expected number of methionine residues) 
of CNBr added. The reaction was kept in the dark for 24 h at room 
temperature. After this time the reaction was diluted 10-fold with 
dHzO and lyophilized. 
2.13 Enzymic hydrolysis 
Samples (3.5 mg) of the reduced and S-carboxymethylated trypsin 
inhibitor were digested separately with trypsin and chymotrypsin as in 
Richardson et al. (1984). A sample (3.5 mg) of the S-carboxymethyla-
ted a-amylase inhibitor was also digested with trypsin. 
2.13.1 Trypsin (E.C. 3.4.21.4) 
Trypsin catalyses the hydrolysis of peptide bonds on the carboxyl 
side of lysine and arginine (except where the following residue is a 
proline). The trypsin used had been treated with L-1-chloro-3-
tosylamido-4-phenylbutan-2-one (TPCK) to inhibit contaminating chymo-
trypsin-like activity (Inagami and Sturtvant, 1960). 
The protein was dissolved in a minimal volume of 0.2 M N-
ethylmorpholine buffer pH 8.5 and trypsin (TPCK-treated) added to give 
a 2% (w/w) enzyme/substrate ratio. The solution was incubated for 2-4 
h at 37°C. The reaction was either stopped by lyophilization or the 
solution was directly applied to a gel filtration column. 
2.13.2 Chymotrypsin (E.C. 3.4.21.1) 
The digestion conditions were the same as for trypsin. Cleavage 
with chymotrypsin is less specific than with trypsin; cleavage usually 
occurs on the carboxyl side of leucine, tyrosine, phenylalanine, 
tryptophan and methonine (except where the following residue is 
proline) but may also occur at other sites. 
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2.14 Purification of protein or peptide mixtures 
Two methods were employed to facilitate the separation of 
proteins and peptides produced by chemical or enzymic digestion: 
2.14.1 Gel filtration 
2.14.2 High performance liquid chromatography. 
2.14.1 Gel Filtration 
The samples were dissolved in a minimal volume ( 0. 5 - 1 ml) ot' 
0.1 M ammonium bicarbonate and applied to a Bio-Gel P-6 column (1 x 
200 em) equilibrated and eluted with the same buffer. Peptides were 
detected by measuring the absorbance at 280 and/or 230 nm. Further 
purification was achieved by reverse-phase HPLC. 
2.14.2 Reverse-phase high performance liquid chromatography 
RP-HPLC was carried out using a VYDAC 218TP54 C18 column (25 em x 
4.6 mm) using variable gradients of 0-70% acetonitrile in 0.1% 
trifluoroacetic acid (TFA). Samples were dissolved in 0.1% TFA or, 
where insoluble in this solvent, in 100 pl 6 M guanidine hydrochloride 
in 0.1% TFA. Peptides were detected by measuring the absorbance of 
the eluting solvent at 214 nm. Peaks were collected manually and 
lyophilised. 
2.15 Semi-quantitative amino acid composition of peptides 
Small aliquots of the peptides purified by RP-HPLC were dried in 
vacuo over solid NaOH in Durham tubes, 50 pl 6 M HCl was added, the 
tubes were sealed in an oxygen flame, and heated for 18-20 h at 105°C. 
After cooling the tubes were opened and the acid was removed by drying 
in vacuo over solid NaOH. When dry 10 pl 0.3 M NaHC03 was added and 
dried again. Once dry 10 pl of a 1:1 mixture of dH20 and dansyl 
chloride solution (5 mg/ml in acetone) was added and the tubes, 
covered in parafilm were incubated for 1 h at 45°C. After drying the 
dansyl derivatives of the amino acids present were separated and 
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identified by using thin layer chromatography. 
The dansylated samples were dissolved in 10 pl 50% aq. pyridine, 
then spotted on both sides of a polyamide sheet (15 x 15 em), 80% on 
one side and 20% on the standard side, and allowed to dry. One pl of 
a marker solution was applied to the standard side (0.1 mglml in 95% 
ethanol containing: dansyl-proline, dansyl-leucine, dansyl-phenylalan-
ine, dansyl-glycine, dansyl-glutamic acid, dansyl-threonine and 
dansyl-arginine). Frames which supported 5 sheets simultaneously were 
used (Smith, 1958). The solvent systems used were: 
Solvent for 1° Formic acid 1. 5% 
(45 min) ( ___.) dH20 98.5% 
Solvent for 2° Acetic acid 10% 
(45 min) (.!.) Toluene 90% 
Solvent for 3° Methanol 39% 
(30 min) (.!.) Butylacetate 59% 
Acetic acid 2% 
The sheets were examined after the 2nd solvent (Fig. 1) and after 
the 3rd solvent (Fig. 2). After examination the sheets were washed 
with 1.4 1 dH20 I 100 ml ammonia solution I 1.5 1 acetone. 
2.16 Quantitative amino acid composition of a protein and peptides 
The amino acid compositions of both proteins were determined after 
hydrolysis with 5.9 M HCl under nitrogen at 110°C for 21 h using an 
LKB 440 amino acid analyser. The amino acid composition of selected 
peptides were confirmed using a Waters PICO-TAG system (work carried 
out by Dr. M. Richardson at Durham University). 
2.17 N-terminal and Sequence determination using the DABITC/PITC 
double coupling method 
The intact inhibitors and peptides derived from them were 
sequenced using the 4-N,N-dimethylaminoazobenzene-4'-isothiocyanate 
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Figure 1: 
Two dimensional separation of dansyl amino acids on a 
polyamide 
2nd 
1st_J 
sheet (after first and second solvent). 
ProlineQ:f:'D 
Isoleucine 
ValineeJ ~ Histidine 
Leucine (Orange) 
DNS-NH2 (Blue)~ Phenylalanin_~, ... :.:~ 
Alanine ®L:::) Q Tyrosine 
Methionine (Yellow) 
Glycine~ ~E~-Lys Met 
0 Threonine 
Argimne . ~ 
Lysine Q 
Trytophan x 
DNS-OH(Biue) 
Cf!J) = DNS- amino acids present in standard solution 
(Reverse side of sheet) 
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Figure 2: 
Two dimensional separation of dansyl amino acids on a 
polyamide 
2nd 3rd 
1stj f 
Arginine 
sheet (after first, second and third solvents). 
Proline . DNS-N~ ~~~~~~ne (Blue) · ··· .... ~ .. :g:f1 Histidine 
. .. ..... · r---...(Orange) 
Valine ~ 
Alanine Q ([!!jJJ})c::JTyrosine ~ Methionine Phe~~i~ianine (Yellow) 
LysineCJ 
Trytophan<::::) 
Aspartic acid 
C) 
~DNS-OH 
~(Blue) X 
® = DNS - amino acids present in standard solution 
(Reverse side of sheet) 
------------------------------------------------- -----------
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(DABITC)/phenylisothiocyanate (PITC) double coupling method of Chang 
et al. (1978) as described by Richardson et al. (1984). The double 
coupling technique is necessary due to the limited solubility of 
DABITC in organic solvents so, as a result, high temperatures would be 
necessary to achieve quantitative coupling and this causes hydrolysis 
of DABITC. At 52°C (the coupling temperature used in this study) 
approximately 25-50% of NH2 termini are coupled to DABITC and the 
addition of PITC serves to complete the coupling reaction. 
Samples of protein (-0.1 mg) or peptides (5-10 nmol), dissolved 
in 80 pl of 50% aqueous pyridine, were placed in a glass tube (0.5 x 
3.0 em) with ground glass stopper and 40 pl of the DABITC solution 
(2.82 mg/ml in pyridine) was added. The tube was flushed with 
nitrogen for 10 sec, stoppered, vortexed and incubated at 52°C for 50 
min. Then 10 pl PITC was added, the tube flushed with nitrogen, 
vortexed and incubated for 20-25 min at 52°C. By-products and excess 
reagents were removed by extracting 3-4 times with 0.5 ml of 
heptane/ethyl acetate 2:1 (v/v). After vortexing the phases were 
separated by centrifugation and the organic layer discarded. The 
aqueous layer was dried in vacuo over solid NaOH. Once dry 50 pl TFA 
was added, the tube flushed with nitrogen, vortexed, incubated at 52°C 
for 15 min and then dried in vacuo • The derivatised 4-N-N-
dimethylaminobenzene-4'-thiazolinone-amino acid (DABTZ-amino acid) was 
extracted by adding 200 pl butyl acetate and 50 pl dH20, vortexing and 
centrifuging for 2 min. The upper butyl acetate layer was removed and 
dried in vacuo. The aqueous layer containing the peptide was also 
dried in vacuo and then used in the next degradation cycle. Once dry 
the butyl acetate extract was dissolved in 50% aqueous TFA, incubated 
at 80°C for 10 min and dried in vacuo. The sample was dissolved in 1-
5 pl ethanol and microscale thin-layer chromatography performed to 
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identify the 4-N-N-dimethylaminobenzene-4'-thiohydantoin-amino acid 
(DABTH-amino acid). A standard of 4-N-N-dimethylaminobenzene-4'-
thiocarbamyl (DABTC)-diethylamine was used as a marker and spotted at 
the bottom left corner of a 3 x 3 em polyamide sheet. The DABTH-amino 
acid was spotted on top of the standard. The first dimension was run 
in acetic acid/water 1:2 (v/v), the sheets were then dried and the 
second dimension run in toluene/n-hexane/acetic acid 2:1:1 (v/v/v). 
After drying the sheets were exposed to HCl vapours to develop the 
temporary colours of the DABTH-amino acids (Fig. 3). 
2.18 Detection of tryptophan in a peptide. 
When using the DABITC/PITC double coupling method for sequencing, 
problems may occur where the presence of a tryptophan residue appears 
to give a. blank degradation cycle. In order to establish the presence 
of a tryptophan the peptide can be tested with Ehrlich's reagent. 
Small amounts of the peptide/protein were dissolved in 50% 
aqueous pyridine and spotted onto a sheet of Whatman No. 3MM filter 
paper. After drying, the paper was briefly immersed in a freshly 
prepared solution containing 1 g p-dimethylaminobenzaldehyde in 40ml 
acetone/ 10 ml cone. HCl. The paper was dried in a fume cupboard and 
the gradual appearance of a purple colouration indicated the presence 
of a tryptophan residue. Therefore wherever necessary the presence of 
tryptophan in peptides was detected by staining on paper with 
p-dimethylaminobenzaldehyde. 
Analysis of Protein secondary structure 
2.19 Predictive methods 
Two predictive methods were used: 
a) Chou and Fasman 
a) Chou and Fasman 
b) Robson and coworkers 
The Chou and Fasman method is the most widely used and simplest 
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Figure 3: 
Two dimensional separation of DABTH-amino acids on a 
polyamide sheet. 
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method to apply. Twenty-nine proteins of known tertiary structure 
were statistically surveyed in order to develop a set of parameters 
for each residue; according to the preference of the residue to adopt 
a structural type. Having established a hierarchical order for the 
amino acids for their a-helix and f3-sheet conformational potential 
(Pa, Pl3), they also formulated a set of empirical rules to govern the 
folding of the secondary structural regions of the proteins (Chou and 
Fasman, 1978a). The amino acids were divided into groupings e.g. 
strong a- or a-formers (H), ordinary formers (L), weak formers (I), 
indifferent (i), weak breakers (b) and strong breakers (B) . 
. A Summary of the prediction rules for a- and a-regions 
1) Along the protein sequence a cluster of four helical residues 
(Ha or La) out of six residues will nucleate a a-helix (weak 
helical residues Ia = 0.5La). The a-helix can be extended in 
either direction along the sequence until a a-tetrapeptide 
breaker is reached with a [Pa] < 1.0. Proline cannot be found in 
an inner helix position or at the C-terminal helical end. Any 
segment where <Pa> > 1.03 and where <Pa> > <PB> is to be 
predicted as a-helical. 
2) A cluster of three a-formers out of five residues will 
nucleate a a-sheet which can be extended until a a-tetrapeptide 
breaker is reached where <PI3> < 1. 0. Any segment where <P13> > 
1.05 and <Pa> > <Pa> is to be predicted as a-sheet. 
3) Overlapping analysis is carried out. When a region contains 
both a- and a-forming residues the overlapping region is helical 
if <Pa> > <Pa> or a-sheet if <Pa> > <Pa> using the a-helix and 13-
sheet boundary frequency tables (Chou and Fasman, 1978a,b). 
Secondary structure predictions were carried out using the method 
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of Chou and Fasman (1978a) with Levitt (1976) parameters; predictions 
were obtained from the No and Np of the residue parameters Po and Pa 
(Dufton and Hider, 1977), using search distances of 6 and 5 for 
(I 
helical and sheet structures, respectively. For a-turns, tetra-
peptides were selected with Pt > 1.0.10-4, 
b) Robson and co-workers 
The method of Robson and coworkers (Robson and Pain, 1974, Robson 
and Suzuki, 1977) using the computer prediction in Garnier et al. 
(1978) was also used. This method is presented as an algorith based 
on properties derived from a database and results in a four state 
prediction; a-helix (H), extended chain (E), reverse chain (T) or 
random coil (C). Amino acid residues up to eight residues in both 
directions along the chain are considered. The likelihood L(a,j) of a 
residue R at position j in a sequence adopting a a-helical conforma-
tion is calculated from the location of residue types in a section 
from j-8 to j+8 where: 
+8 
L (a,j) = I(a,Rj+m) 
m=-8 
I(a,Rj+m) is the effect of the residue type at position j+m on the 
conformation at position j except when m=O. The value of I for a-
helical, a-strand, turn and coil conformation is derived from 
information from proteins of known sequence and structure (see tables 
1-4 in Garnier et al 1978). Using this method an accuracy of %N =50% 
for prediction of H, E, T and C states for 26 proteins is observed. 
An improvement in the accuracy of this method is possible if the 
composition of a-helical and a-strands of the protein is known e.g. by 
circular dicroism or by sequence homology with proteins of a known 
secondary structure. This compositional data can be incorporated by 
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adding a known value to each L(a,j) and L(6,j). 
The secondary structures obtained by both the Chou and Fasman 
method and the Robson method were compared. 
2.20 Circular dichroism (cd) Spectroscopy 
Circular dichroism (cd) and optical rotary dispersion are two 
widely used forms of chiroptical spectroscopy although cd is now more 
popular due to advances in instrumentation and simpler interpretation 
(only cd is used in this study). Chiroptical is a term for the 
differential interactions between matter and the two forms of 
circularly polaris~~ light; right circularly polarised light (rep) and 
left circularly polarised light (lcp). A chiral medium will absorb rep 
and lcp to differing extents and this results in the phenomenon of 
circular dichroism. 
dA = AL - AR (EL - ER)c.l 
where AL and AR are the absorbances for lcp and rep respectively, EL 
and ER are the molar extinction coefficients, and c and 1 are terms 
for the concentration and length respectively. The molar circular 
dichroism can be defined as: 
dE = EL - ER 
since EL is not equal to ER then E will not trace a circle but will 
result in an ellipse. The difference in E is measured as: 
[8) = 3298 dE 
where (8] is the molar ellipticity. Thus cd data can be presented as 
either dE or [8], and in this study [8] will be used. Optical 
activity in polypeptides results from: 
a) all the amino acids, except glycine, being asymmetric 
around their Ca atoms. 
b) the aromatic rings of phenylalanine, tryptophan and tyrosine 
become asymmetric as a result of the interaction with an 
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asymmetric environment. 
For a detailed discussion of cd in peptides the reader should 
consult Woody (1985). Cd spectra for polypeptides are characterised 
by the following: 
1) The amide bond dominates the spectrum in the far-UV region 
(<250 nm), although other chromophores may also be important. 
2) The a-helical conformation has a highly distinctive spectrum 
characterised by negative bands at around 208 and 222 nm, and a 
positive band at around 192 nm. 
3) a-Sheet conformations are much more variable than a-helix in 
both band position and amplitude, but typical features are a 
negative band at 216 nm and a positive band between 195 and 200 
nm. 
4) a-turns ( or reverse turns) are structures where the 
polypeptide chain folds back on itself. However there is no one 
spectrum to characterise a a-turn and Woody (1974) proposed four 
classes. 
5) Random or unordered structures which generally have a negative 
band at around 200 nm and a weaker band (can be positive or 
negative) at 220nm. 
For each protein the proportion of each type of structure can be 
calculated by two types of method: 
a) A set of reference spectra based on model polypeptides of 
theoretically known structural conformations is used e.g. poly-lysine 
(Greenfield and Fasman, 1969; Brahms and Brahms, 1980). 
b) A set of cd spectra of proteins of known secondary structure 
is used (Saxena and Wetlaufer, 1971, Chen et al., 1974, Provencher and 
Glockner, 1981). 
For a detailed discussion of methods and their advantages and 
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disadvantages consult Yang et al. (1986). 
Circular dichroism measurements were made for both the trypsin 
and the a-amylase inhibitors using a Jasco J40 CS dichrograph at 20°C; 
absorption spectra of the same solutions were recorded on a Cary 210 
spectrophotometer. The proteins (1.0 mg/ml) were dissolved in 10 mM 
piperazine-HCl buffer (pH 5.0). Results are reported as mean residue 
ellipticities; with mean residue weights of 109 and 108 for the 
trypsin inhibitor and a-amylase inhibitor, respectively. 
Protein concentration was calculated from the Azao in 10 mM 
piperazine-HCl (pH 5.0) of 1.38 and 1.13 for 1 mg/ml solutions of the 
trypsin and a-amylase. inhibitors, respectively. 
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CONSTRUCTION OF A eDNA LIBRARY FROM RYE (Secale cereale cv. Gazelle) 
ENDOSPERMS 
General •etbods 
2.21 Extraction of nucleic acid solutions with phenol/chloroform to 
remove protein 
(Maniatis et al., 1982) 
Protein was removed from solutions by extracting with phenol 
(equilibrated with 0.1 M Tris-HCl, pH 8.0 unless otherwise stated) or 
a mixture of 50% phenol and 50% chloroform. The organic and aqueous 
phases were separated by centrifugation and the aqueous layer recov-
ered. This was repeated until all the protein had been removed. Any 
contaminating phenol was removed by extraction with an equal volume of 
chloroform. 
In eDNA synthesis the chloroform extraction was replaced by 
extracting twice with 2 volumes of diethyl ether. The residual ether 
was removed by incubating the open tube at 37°C for 5 min. Any 
alteration to the above generalised protocol is specified in the text. 
2.22 Precipitation of nucleic acids from aqueous solutions with 
ethanol 
(Maniatis et al., 1982) 
DNA was precipitated with ethanol in order to concentrate it, to 
change the buffer for digestion or to remove unwanted salts. One 
tenth volume of 3M NaOAc or 1/40th volume 4M NH40Ac was added followed 
by 2.5 volume ethanol (usually at -20°C). Plasmid DNA was precipit-
ated at -20°C overnight or at -70°C for 1 h and then centrifuged at 
13000 rpm to pellet the DNA. Genomic DNA precipitated immediately and 
was spooled out using a bent sterile pasteur pipette. 
Once precipitated the DNA was washed with 75% ethanol, centri-
fuged for 5 min, dried in vacuo and dissolved in TE or TLE buffer 
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(TE = 10 mM Tris-HCl, 1 mM EDTA pH8.0 and TLE = 10 mM Tris-HCl, 0.1 mM 
EDTA). 
Isolation, fractionation and in vitro translation of polysomes and 
RNA 
Ears of field grown rye (Secale cereale cv. Gazelle) were 
harvested 2-3 weeks after anthesis, the endosperms were collected by 
squeezing into liquid nitrogen and stored in 50 g batches at -80°C. 
Sterile glassware and solutions were used in all procedures 
for the isolation of RNA. Total, free and membrane- bound polysomes 
were isolated according to the method of Fox et al. (1977). 
2.23 Isolation of free and membrane-bound polysomal RNA 
50 g (fresh weight) of frozen endosperms were ground to a fine 
powder in a coffee mill. The powder was added to 150 ml grinding 
buffer B in a liquidiser, homogenised for one minute and centrifuged 
in 100 ml centrifuge tubes at 1000 rpm for 5 min at 2°C to pellet 
unbroken cells and cell debris. The supernatant was transferred to 50 
ml centrifuge tubes and spun for 25 min at 17000 rpm at 2°C. The 
supernatant containing free mRNA was kept on ice and loaded directly 
onto the sucrose gradient. The pellet was resuspended in 100 ml 
grinding buffer B containing 1% Triton X-100 ( which disrupts the 
membranes releasing any membrane bound RNA) and centrifuged for 25 min 
at 17000 rpm at 2°C • The membrane-bound and free RNA supernatants 
were both layered onto a 54% sucrose cushion (4 ml) and spun at 50000 
rpm for 4 h at 2°C. 
2.24 Isolation of total polysomal RNA 
50 g (fresh weight) of frozen endosperms was ground in a coffee 
mill, placed in a liquidiser with 150 ml grinding buffer B and 
homogenised for 1 min. The homogenate was centrifuged for 10 min at 
1000 rpm at 2°C and a 1/10 th volume of 10% triton X-100 (in grinding 
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buffer B) was added. The solution was stirred for 10 min at 4°e and 
centrifuged for 30 min at 17000 rpm at zoe. The supernatant was 
layered onto a 54% sucrose cushion and spun at 50000 rpm for 4 h at 
Z.Z5 Isolation of Poly(A)-rich mRNA 
The polysome fractions were each resuspended in a total of 5 ml 
phenol extraction buffer, extracted with phenol/chloroform (Wienard 
and Feix, 1978) by shaking vigourously for 5 min and centrifuged for 5 
min at 1000 rpm at 18°e. The aqueous layer was collected and the 
organic layer back-extracted with phenol extraction buffer. After 
centrifugation the two aqueous layers were pooled, extracted with 
phenol/chloroform and centrifuged. The aqueous layer was removed and 
the organic layer again back-extracted with buffer. The pooled 
aqueous layers were extracted with an equal volume of chloroform. The 
aqueous layer was ethanol precipitated overnight and centrifuged for 
Z5 min at 10000 rpm at zoe, The pellet was dried in vacuo, dissolved 
in 300 pl sterile distilled water and stored at -80°e. 
Poly(A)-rich RNA was prepared by oligo dT chromatography using 
the method of Bantle et al. (1976). Oligo-dT cellulose was prepared 
by washing with 0.1 M NaOH and then with binding buffer. The RNA was 
heated to 65°e for 5 min, cooled rapidly on ice, added to the oligo-dT 
cellulose with 25 ml binding buffer and stirred gently for 45 min. 
The column was poured and washed with binding buffer until the optical 
density at 260 nm was zero. The column was washed with approx. 30 ml 
washing buffer to remove any non-poly(A)-rich RNA. The poly(A)-rich 
RNA was then eluted from the column with 30 ml elution buffer which 
contained no Nael to stabilise the binding of the poly(A)-rich RNA to 
the oligo-dT. The poly(A)-rich fractions were precipitated with 
ethanol, dissolved'·in 100 pl sterile distilled water and stored at 
88 
-80°C. For some eDNA preparations the poly(A)+ RNA was applied to the 
oligo dT column twice, as described above, in order to ensure as pure 
a sample of poly(A)+ RNA as possible. 
Solutions 
Grinding buffer A (stored at 4°C) 
0.2 M Tris-HCl 
0.12 M KCl 
0.05 M MgOAc 
pH 9.0 Autoclaved 
500 ml 
12.11 g 
4.48 g 
5.37 g 
Grinding buffer·B (Made up fresh) 500 ml 
Grinding buffer A 
Sucrose 
DTT 
2'. 3'. AMP 
54% sucrose solution (made up fresh) 
Sucrose 
DTT 
2'. 3'. AMP 
Grinding buffer A 
Phenol extraction buffer (stored at R.T.) 
0.2 M Tris-HCl 
0.1 M NaCl 
0.01 M EDTA 
0.5% SDS 
500 ml 
43.0 g 
0.4 g 
0.4 g 
27 g 
0.04 g 
0.04 g 
23 ml 
200 ml 
4.84 g 
1.17 g 
0.75 g 
1.00 g 
pH 8.8 Autoclaved and also used to equilibrate phenol. 
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Buffers for Oligo-dT-cellulose column (stored at 4°C) 
Binding buffer 
Washing buffer 
Elution buffer 
10 mM Tris-HCl 
0.4 M NaCl 
1 mM EDTA 
0.1% SDS 
pH 8.5 Autoclaved 
10 mM Tris-HCl 
0.1 M NaCl 
1 mM EDTA 
0.1% SDS 
pH 8.5 Autoclaved 
10 mM Tris-HCl 
1 mM EDTA 
0.1% SDS 
pH 8.5 Autoclaved 
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400 ml 
0.48 g 
9.35 g 
0.15 g 
0.40 g 
400 ml 
0.48 g 
2.33 g 
0.15 g 
0.40 g 
200 ml 
0.24 
0.075 
0.20 
g 
g 
g 
2.26 In vitro Translation of RNA using the Wheat-germ system 
Total, free and membrane-bound polysomes were translated using 
wheat-germ cell-free extracts supplemented with [3H] leucine as 
described by Kreis et al. (1983). 
Basic Mixture:- 10 pl ATP/CP (40 mM ATP neutralised in Tris 
pH 7.6/320 mM creatine phosphate) 
10 pl 12 mM spermidine 
4 pl 5 mM GTP 
4 pl 200 mM DTT 
4 pl creatine phosphokinase (120U/mg, 5 mg/ml 
in 50% glycerol) 
4 pl amino acids (-leucine), 5 mM each in 
50 pl salts No.6 (Mg2+jK+) 
20 pl [3H]-leucine (1 mCi/ml) 
194 pl SDW 
5mM DTT 
Total Volume = 300 pl 
Reaction mixture:- 15 pl basic mixture 
2.5 pl RNA ( 10 pg total or 0.75 pg poly(A)) 
2.5 pl wheat-germ 
The reaction mix was vortexed gently and centrifuged for 2 sec to 
ensure the reactants were mixed and incubated at 28°C for 40 min. A 
cold carrier of 2 pl 1% leucine was added and 2 pl of reaction mixture 
was spotted onto 2 em discs of Whatman No.1 filter paper and allowed 
to air dry. The filters were placed in 100 ml 10% TCA and gently 
brought to boiling point. The heat was turned off and the filters 
left to stand for 20 min. The filters were then rinsed with 100 ml 
cold 10% TCA, then lOOm! 95% ethanol, then 100 ml ether and allowed to 
dry. The filters were then placed in vials with 3 ml non-aqueous 
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scintillant and counted by liquid scintilation to check for incorpora-
tion of label into translation products. 15 pl loading buffer (8 M 
urea/4% SOS/4% 2-mercaptoethanol/0.25 M Tris-HCl pH 6.8) and 10 pl 
BPB-glycerol (0.004% bromophenol blue in 50% glycerol) were then added 
to the remaining reaction mixture. The mixture was heated to 60°C for 
10 min, loaded on a 16% urea/80S/polyacrylamide gel and fluorographed 
2.27 80S-Polyacrylamide gel electrophoresis 
after running. 
For two· 16% separating gels: 
40 ml 8 M urea/0.2% SOS 
21.5 ml 60% acrylamide/0.9% bisacrylamide 
10 ml 3 M Tris-HCl pH 8.8 
1. 5 ml SOW 
24 mg OTT 
6 ml 0.8% ammonium persulphate 
+ 40 pl TEMEO 
The gel solution was mixed well, degased, poured to approximately 
1 em below the comb and overlaid with water-saturated butanol. When 
polymerised the butanol was washed away and the top of the gel dried 
with Whatman No. 1 filter paper. The comb was partially inserted, the 
stacking gel poured and then the comb fully inserted. 
For the stacking gel: 
12 ml 8 M urea/0.2% SOS 
3.3 ml 25% acrylamide/3.5% bisacrylamide 
6 ml 0.5 M Tris-HCl pH 6.8 
10 mg OTT 
3 ml 0.8% ammonium persulphate 
+ 30 pl TEMEO 
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For the running buffer: 
56.8 g glycine 
12.12 g Sigma 7-9 Tris 
4 g SDS 
pH 8.8. To 4 l with dH20 
After loading the gel, it was run at 40 mA until the bromophenol 
blue had entered the separating gel and then at 60-65 mA until the BPB 
reached the bottom of the gel. The gel was stained in 0.1% Coumassie 
Brilliant Blue R/10% TCA/40% methanol for at least 20 min and 
destained in 10% TCA. 
2.28 Fluorography of SDS-polyacrylamide gels 
After staining the gels were left in 10% TCA overnight. The gels 
were then washed twice in 500 ml 10% acetic acid/25% ethanol/65% dH20 
v/v/v for 20 min each time. They were then washed in 1 1 dH20 for 2 x 
30 min and the pH was checked to ensure that it was below 5.5. The 
gels were then washed with the fluorographing agent (1 M salicylic 
acid I 1 M NaOH) for 30 min, dried under vacuum at 60°C in a Biorad 
gel drier on 3 layers of Whatman 3MM filter paper and covered with 
clingfilm. Fugi X-ray film was placed directly over the gel and 
autoradiographed at -80°C for 3 to 15 days. 
2.29 Immunoprecipitation of in vitro translation products 
Immunoprecipitation of in vitro translation products using anti-
bodies raised against both the trypsin and the a-amylase inhibitors 
were performed using the method as described by Jonassen et al. 
(1981). 
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Immunoprecipitation buffer: 
50 mM Tris-HCl 
0.15 M NaCl 
2% Triton X-100 
10 mM proline 
10 mM leucine pH 7.7 
An in vitro translation reaction mix was diluted to a total 
volume of 600 pl with immunoprecipitation buffer in a 1.5 ml eppendorf 
tube and shaken gently for 30 min on a multimix at room temperature. 
The tubes were spun at 15000 rpm in a microfuge for 10 min. 50 pl 
antiserum to the trypsin or the a-amylase inhibitor was added to the 
supernatant and shaken on a multimix for 2 h at RT. Then 10 pl protein 
A sepharose (20 mg/ml in immunoprecipitation buffer) was added and the 
tubes were again shaken for 2 h at RT; The tubes were then spun at 
15000 rpm in a microfuge for 15 min, and the pellet washed 3 x with 
immunoprecipitation buffer and once with 10 mM Tris-HCl twice (by 
shaking on the multimix for 30 min and spinning for 15 min between 
each wash). The pellet was finally resuspended in 30 pl loading 
buffer and 5 pl BPB-glycerol. The samples were heated to 65°C for 20 
min, spun in a microfuge for 5 min and loaded onto a 16% SDS-
polyacrylamide gel. 
Synthesis and Purification of Oligonucleotide probes 
2.30 Synthesis and Purification of Oligonucleotide probes 
Two oligonucleotides with the sequences: 
Oligo 1 = 3'-ACCCTATACTTTTC-5' 
G CG 
Oligo 2 = 3'-ACAACACTACTTAA-5' 
G G G CG 
were synthesised for use as probes to screen a eDNA library. They 
were synthesised by M.Cornelius, Rothamsted, on a Biosearch Synthe-
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siser model 381 A, and were supplied attached to a controlled pore 
glass column. The beads were removed from the column and transferred 
to a 1.5 ml eppendorf tube together with 1 ml of concentrated ammonium 
hydroxide solution. The beads were allowed to stand for 4 h to 
release the oligonucleotides from the column. The supernatant con-
taining the oligonucleotide was transferred to another tube which was 
sealed with parafilm and incubated at 55°C overnight. This treatment 
causes the removal of protecting internucleotide methyl esters present 
on each phosphorus atom in order to generate the natural 3'-5' 
phosphodiester linkage. It was then frozen with liquid nitrogen and 
dried under vacuum. The dried residue was resuspended in 100 pl SDW. 
The concentration of the oligonucleotide solution was determined 
by assuming 1 ODzso = 25 pg oligonucleotide. An aliquot containing 
approximately 75 pg was taken for purification. To ensure complete 
deprotection the oligonucleotide was treated with acetic acid. To 75 
pg oligonucleotide in 20 pl SDW was added 80 pl glacial acetic acid, 
vortexed and incubated at room temperature for 20 min. It was then 
frozen in liquid nitrogen and evaporated to dryness under vacuum. The 
residue was then dissolved in 10 pl SDW, denatured by adding 20 pl 
recrystallised formamide, heated to 90°C for 3 min and then cooled 
rapidly on ice. 
The oligonucleotides were purified on a 16% polyacrylamide 
sequencing gel with both sequencing plates being previously siliconi-
sed. A formamide dye mix was run next to the two oligon~cleotide 
samples and the gel was run until the bromophenol blue in the dye mix 
was half way down the gel. The gel was carefully placed between two 
layers of clingfilm; and the oligonucleotide visualised by placing the 
gel on a silica TLC plate containing a fluor (Sigma-Fzs4) and 
illuminating with a long wavelength UV lamp. The major full-length 
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oligonucleotide bands were excised from the gel and placed in 1.5 ml 
eppendorf tubes each with 1 ml of 0.5 M ammonium acetate/10 mM 
magnesium acetate (elution buffer). The tubes were incubated at 37°C 
overnight then centrifuged for 5 min at 12000 rpm in a microfuge and 
the supernatant was removed. The gel slices were vortexed with 0.5 ml 
elution buffer, centrifuged at 12000 rpm for 5 min in a microfuge and 
the two supernatants combined. The oligonucleotide solution was 
filtered through a 1 ml syringe plugged with a small amount of 
siliconised glass wool to remove any gel fragments. The oligonucleo-
tide solution was reduced in volume to about 100 pl by repeated 
extraction with n-butanol and 1 ml of 95% ethanol added. The tubes 
were chilled for 2 h at -80°C and centrifuged at 4°C for 10 min at 
12000 rpm in a microfuge. The precipitate was washed twice with cold 
95% ethanol (0.5 ml at 0°C), centrifuged for 2 min, the ethanol 
removed and the precipitate dried under vacuum. The pellet was 
dissolved in 50 pl SDW and the concentration measured by reading the 
Azso and at Azao. 
eDNA synthesis 
2.31 eDNA synthesis method 1 
For first strand synthesis the following buffer and a NTP mix was 
prepared: 
Buffer mix NTP mix 
1 M Tris-HCl pH 8.6 12.5 pl 50 mM 1 pl dATP (10 mM) + 
4 M KCl 8.13 pl 130 mM 1 pCi p32 dATP 
1 M Mg Acetate 1.5 pl 6 mM 4 pl dGTP (10 mM) 
400 mM DTT 3.12 pl 5 mM 4 pl dCTP (10 mM) 
SDW 4.75 pl 4 pl dTTP (10 mM) 
30 pl 13 pl 
The poly(A)+ mRNA (0.9 pg in 2pl) was denatured by heating to 
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65°C for 5 min. The RNA was then spun for a few seconds in a 
microcentrifuge, 2 pl oligo dT12-lB (250 pg/ml) and 3pl buffer mix 
was added and incubated at 40°C for 15 min ( in order that the oligo 
dT12-18 could anneal to the poly(A)+ tail of the mRNA). The reaction 
was then put on ice and the following added in order: 
7 pl SDW 
0.5 pl lOx dil. BSA (10 mg/ml) 
6.5 pl NTP Mix 
1.0 pl Nuclease inhibitor (13U/pl) 
2.5 pl NaPP (40 mM) 
The reaction was mixed and spun, then 6.25U avian myoblast virus 
reverse transcriptase (AMY RT) was added and incubated at 42°C for 
60 min. The reaction was stopped by the addition of 2 pl 0.5 M EDTA. 
The unincorporated nucleotides were removed on a G50 fine 
Sephadex column (1 ml) in TEN (20 mM Tris-HCl pH 8.0/150 mM NaCl/1 mM 
EDTA). 50 pl fractions were collected and counted in a Cerenkov 
liquid scintillation counter. Five of the 50 pl fractions containing 
the ssDNA/RNA were pooled. The ssDNA/RNA was extracted with 
phenol/chloroform and then ethanol precipitated. 
Second strand synthesis 
The ss eDNA/RNA duplex was resuspended in up to 31 pl SDW (-10 
ng/ml). Two samples were taken; 1 pl for Cerenkov counting to 
calculate the incorporation (see p99)and 2 pl for an alkaline agarose 
gel to establish the size range of the eDNA. To the remaining 2~ pl 
the following were then added in order: 
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Final 
1 pl 1 M Tris-HCl pH 7.5 20 mM 
1.7 pl 1 M MgCl2 4 mM 
1 pl 0. 5 M ( NH4 ) 2 S04 10 mM 
1 pl 5 mM 13NAD 0.1 mM 
6.2 pl 1 M KCl 124 mM 
2.5 pl BSA nuclease free (1 mg/ml) 
5 pl dNTP mix (1 mM for each) 
ss eDNA/RNA in up to 25 pl 
cone. 
3 pl E.coli DNA Pol. 1 ( 15U for 250 ng single strand) 
Mixed and left on ice for 5 min. 
0.6 pl E.coli DNA ligase (0.5U for 250 ng single strand) 
1.0 pl RNAase H (0.5U for 250 ng single strand) 
The reaction mix was whirlymixed gently, spun in a micro-
centrifuge, and incubated at 15°C for 30 min. After this time a 
further 1 pl RNAase H was added and the reaction continued for 30 min. 
The incubation temperature was increased to 22°C for 1 h and 2 x 1 pl 
samples were then dried onto glassfibre (GF/C) discs and used to 
calculate the incorporation. The reactions were then stopped by the 
addition of 2.5 pl 0.5 M EDTA and 1.25 pl 20% SDS. To the stopped 
reaction 150 pl TEN and 200 pl phenol (saturated with TEN) were added, 
gently mixed and allowed to stand for 60 sec. Then 200 pl chloroform/ 
butanol 50:1 was added, mixed and left to stand. The eppendorf tube 
was then spun for 5 min in a microcentrifuge and the aqueous layer 
removed. The organic layer was back-extracted with 200 pl TEN and 
after centrifugation the two aqueous layers were pooled. Residual 
phenol was removed by extracting with an equal volume of chloroform 
and then x3 with ether. The reaction tube was then placed at 37°C for 
5 min to evaporate the ether. The ds eDNA was precipitated with 1/4 
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vol.10 M NH4Ac, 2 vol. ethanol at -20°C overnight. After centrifuging 
for 30 min the eDNA pellet was resuspended in 400 pl SDW and 
reprecipitated in 1/40 vol. 4 M NH4Ac, 2.5 vol. ethanol. 
Calculation of label incorporated into eDNA 
The following samples were taken during eDNA 
synthesis: 
a) 1 pl ss eDNA/RNA before second strand synthesis, 
washed to give incor~oration into first strand 
b) 1 pl ds eDNA after second strand synthesis, washed to 
give incorporation into second strand 
c) 1 pl ds eDNA to give total counts after second strand 
synthesis 
The 1 pl samples were spotted and allowed to air dry. The a) and 
b) filters were treated as for filters after in vitro translation of 
RNA. Then all filters a), b) and c) were placed in scintillation 
vials and Cerenkov counted. 
[c)-a)] = total counts present after second strand synthesis 
[b)-a)] = counts incorporated into ds eDNA 
~ x 100 = % incorporation of p32 added in second strand 
c)-a) 
synthesis 
2.32 eDNA synthesis method 2 
The protocol used was essentially as described in the Amersham 
booklet supplied with the kit (Amersham product No. RPN. 1256) and is 
based on the method of Gubler and Hoffman (1983). 
Amersham first strand eDNA synthesis 
The first strand synthesis reaction was set up for 5 pg poly(A)+ 
mRNA: 
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5 X 1st strand synthesis reaction buffer 
Sodium pyrophosphate solution 
Human placental ribonuclease inhibitor 
Deoxynucleotide triphosphate mix 
Oligo dT 
[a-32p]dCTP (dried in vacuo) 
Poly(A)+ mRNA 
SDW to a final volume(including enzyme) = 
10 pl 
2.5 pl 
2.5 pl 
5 pl 
2.5 pl 
10 pCi 
.L.l!1 
50 pl 
The reaction was mixed gently and spun for a few seconds in a 
microcentrifuge. Reverse transcriptase was added (20U/pg Poly(A)+ 
mRNA) and the reaction incubated at 42°C for at least 40 min. then 
placed on ice. A 1 pl sample was removed for analysis of 
incorporation. Sequential labelling was used whereby the first strand 
(10 pCi dCTP) is labelled to a lower specific activity than the second 
strand (50 pCi dCTP). 
To the first strand synthesis mix on ice the following were added 
in order: 
Second strand synthesis reaction buffer 93.5 pl 
(a-32p]dCTP (dried in vacuo) 50 pCi 
E. coli ribonuclease H 5 pl 
E. coli DNA polymerase 1 115U 
SDW to a final volume (including enzyme) of: 250 pl 
The reaction was mixed gently, incubated at 12°C for 1 h, then at 
22°C for 1 h, and then at 70°C for 10 min. The reaction was then spun 
fo~ a few seconds in a microcentrifuge and placed on ice. T4 DNA 
polymerase (2 U/pg poly(A)+ mRNA) was added, mixed, and incubated at 
37°C for 10 min. The reaction was stopped by adding 25 pl 0.25 M EDTA 
pH 8.0 and 25 pl 10% SDS. A further 1 pl sample was removed for 
analysis. 
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The ds eDNA was purified by phenol/chloroform extraction and 
ethanol precipitated. Ethanol precipition during eDNA synthesis was 
used to remove more than 99% of unreacted deoxynucleoside 
triphosphates. An equal volume of 4M NH40Ac was added then twice the 
combined volume of ethanol and chilled on dry ice for 15 min. The 
eDNA was then allowed to warm to room temperature with gentle shaking 
in order to dissolve the unreacted triphosphates. The solution was 
centrifuged as above and the pellet resuspended in 50 pl TE buffer and 
again precipitated with ethanol. The pellet was then washed with 200 
pl ethanol (-20°C), centrifuged for 2 min and dried in vacuo. The 
eDNA was resuspended in 10-20 pl TE and stored at -20°C. 
Calculation of percentage incorporation 
Samples (1 pl) were removed after first and second strand 
synthesis and added to 20 pl SDW. Aliquots (2 pl) of the diluted 
samples were spotted onto two 2.4 em discs of Whatman DE-81 paper and 
designated filter A and B. Filter B was washed 6 X (5 min. each) with 
0.5 M NazHP04, then twice with SDW (1 min. each) and twice with 95% 
ethanol (1 min. each). Both filters were allowed to dry and then 
Cerenkov counted. 
Filter A = total radioactivity in sample 
Filter B = radioactivity incorporated into nucleic acids. 
As the first strand reaction mix is 1/6th vol. of the second 
strand (stopped) mix then in the table below the A and B must be 
divided by six to compensate for this: 
First strand Second strand 
Total input radioactivity A/6 c 
Radioactivity in nucleic acid B/6 D 
Therefore % incorporation during second strand synthesis = 
/.~ l3'f?0~~\ 
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(D - B/6) 
(C - A/6) 
% of labelled [a-32 P] dNTP incorporated = X 
Amount of unlabelled dCTP in final reaction mix = 
25 nmoles 
Therefore assume the amount of unlabelled dCTP incorporated 
= X% of 25 nmoles 
= Y nmoles 
Therefore total amount of dNTPs incorporated 
= 4Y nmoles 
Assuming a residue molecular weight of dNTP (1 mole) 
= 350 g 
Therefore weight of eDNA synthesised = 350 g x 4Y nmoles 
= A ng 
Weight of poly(A)+ mRNA used = Z ng 
Therefore % yield of eDNA = A/Z X 100% 
2.33 Alkaline agarose gel electrophoresis 
The size of the eDNA was determined by electrophoresis on 1.2 -
1.4% agarose gels under denaturing conditions (50 mM NaOH). The 
agarose was mixed with 200 ml 50 mM NaCl/1 mM EDTA and dissolved by 
heating in a microwave oven. The gel was cooled to 50°C and cast into 
a tray of a Biorad midi-gel apparatus. Buffer (50 mM NaOH/1 mM EDTA) 
was added to cover the gel to a depth of 5 mm. The gel was then 
soaked for at least 30 min before loading. 
When eDNA samples were prepared using the Amersham kit, prior to 
gel electrophoresis, an alkaline hydrolysis step was performed. To 
the eDNA samples 20 pl carrier DNA (100 pg/ml salmon sperm DNA) and 
1/3rd vol. 1 M NaOH were added and incubated at 46°C for 30 min. 
After spinning for a few seconds in a microcentrifuge equal volumes 
(as 1 M NaOH) of 1 M HCl and 1 M Tris-HCl pH 8.0 were added. The eDNA 
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was then phenol/ chloroform extracted and ethanol precipitated. The 
pellet was resuspended in 10-20 pl alkaline loading buffer (50 mM 
NaOH/1 mM EDTA/2.5% Ficoll/0.025% bromophenol blue). Samples of ~X174 
RFI/Hae III and A/Hind III molecular weight markers were also run to 
give an estimation of the size of the eDNA. Prior to loading, the 
level of buffer was reduced to 1 mm. The gel was run at 60 rnA until 
the dye had migrated out of the wells. Then a glass plate was placed 
directly on top of the gel and the current adjusted to 50-60 rnA for 
the gel to run overnight. 
The gel was soaked for 30 min in 7% TCA with 2 changes of 
solution, then placed on two layers of Whatman 3MM filter paper, 
covered with clingfilm and dried in a Biorad gel drier. The gel was 
autoradiographed in contact with Fugi X-ray film at -80°C. 
Cloning of the rye eDNA into bacteriophage AgtlO 
2.34 eDNA cloning into AgtlO 
mRNA molecules have a size range from several hundred bases to a 
few kilobases. Therefore any cloning system needs to efficiently 
accept DNA fragments of this size. The AgtlO vector will accept 
fragments of DNA upto 7.6 Kb, assuming 105% of wild type phage length 
is packaged, which is ideal for most eDNA molecules. The AgtlO also 
has an efficient biological selection system whereby the parent phage 
can be suppressed when the library is plated out. This is because the 
parent phage is ci~imm434, This can be efficiently repressed on a 
high frequency lysogeny (hfl~) strain of E.coli (eg. NM514 or c600hfl) 
which forces the parent phage into the lysogenic pathway and as a 
result no plaques can be formed. The eDNA is inserted at a unique 
EcoRI site and, as a result of insertion, produces the ci- phenotype 
which is unable to enter the lysogenic pathway and so plaques are 
formed on the hfl~ strain. On a non hfl strain (eg. L87 or C600) the 
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ci+ phenotype results in a turbid plaque and the ci- in a clear plaque 
thus. giving a clear visual difference between plaques with parental 
and recombinant phage. 
The protocol used is essentially as described by Amersham. The 
cloning reactions can be divided into six steps described briefly 
below: 
1) Methylation of eDNA 
As the eDNA will be cloned into an EcoRI site (an EcoRI digestion 
being necessary to create "sticky" ends for ligation) it is necessary 
to protect, by methylation, any internal EcoRI sites within the eDNA. 
Methylation reaction 
Then add: 
20 pl eDNA (0.5 pg) 
6 pl M buffer 
3 pl 1 x SAM solution 
1 pl EcoRI methylase (20 U) 
The mixture was mixed gently, incubated at 37°C for 60 min, then 
the enzyme inactivated by heating to 70°C for 10 min. 
2) Addition of EcoRI cohesive termini to eDNA 
Phosphorylated EcoRI linkers (GGAATTCC) were ligated onto the 
ends of the eDNA. These linkers are subsequently used to generate 
"sticky" ends to ensure efficient ligation of the eDNA and the AgtlO 
arms at low concentrations of eDNA molecules. 
EcoRI linker reaction mix: 30 pl methylated eDNA 
4.5 pl L buffer 
3 pl EcoRI linkers 
0.5 pl SDW 
The reaction was gently mixed, spun for a few seconds in a 
microcentrifuge and 2 pl T4 DNA ligase (5 U) was added. The ligation 
reaction was placed at l5°C overnight, and then stopped by heating to 
70°C to inactivate the ligase. 
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3) EcoRI digestion of linkered eDNA 
During the ligation reaction multiple copies of the linkers may 
have been added to the end of each eDNA molecule or many linkers may 
have been ligated together. The cDNA/EcoRI linker ligation mix is 
therefore digested with EcoRI to produce a single EcoRI "sticky" end 
on the eDNA and also to break up any chains of linkers which may be 
packaged with the eDNA to give false recombinants. 
EcoRI digestion: 40 pl eDNA 
10 pl E buffer 
48.3 pl SDW 
1.66 pl EcoRI (100 U) 
The reaction was incubated at 37°C for 5-6 h and stopped by 
heating to 70°C for 10 min. 
4) Separation of eDNA from excess linkers 
As the linkers may be packaged it is necessary to separate the 
excess linkers from the eDNA molecules. A 3 ml column was washed with 
at least 15 ml STE buffer. The mixture of linkers and eDNA (100 pl) 
was applied to the top of the column and eluted with 100 pl aliquots 
of STE applied. 100 pl fractions were collected in 1.5 ml eppendorf 
tubes and the four fractions containing the peak of radioactive eDNA, 
as detected by Cerenkov counting, were pooled. The eDNA was ethanol 
precipitated and resuspended in 4 pl STE (100 ng/pl). 
5) Ligation into Agt10 vector arms 
The Agt10 was supplied digested with EcoRI and ready to ligate 
with the linkered eDNA. The following controls were also set up: 
Tube 1: 
Tube 2: 
Whole Agt10 vector DNA to monitor the efficiency of 
in vitro packaging. 
Agt10 arms to measure the efficiency of the ligation 
reaction and the plating efficiency of the hfl+ strain. 
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Ligation reactions 
Insert eDNA Agt10 AgtlO arms SDW 
(100 ng/ull (100 ng/ull (500 ng/ul) 
Tube 1 5 ul 4 ul 
Tube 2 2 ul 7 ul 
Tube 3 0.5 ul 2 ul 6.5 ul 
Tube 4 1.0 ul 2 ul 6.0 ul 
Tube 5 1.5 l!l 2 l!l 5.5 l!l 
1 pl L buffer and 2.5 U T4 DNA ligase were added to each of the 
above tubes. The ligation reaction was mixed gently and incubated 
overnight at 15°C. The ligations were ethanol precipitated and the 
pellets carefully resuspended in 2.5 pl TLE. 
6) In vitro packaging of the ligation reactions 
The packaging extracts from the Amersham kit were stored at -70°C 
until immediately prior to use. Once thawed 10 pl from the blue tube 
was transferred to a ligated reaction and immediately 15 pl from the 
yellow tube was added. The tube was centrifuged for 10 sec. and 
incubated at 20°C for 120 min. This was repeated for each ligation 
reaction. SM buffer (0.5 ml) was then added followed immediately by 
10 pl chloroform. The phage stocks were mixed gently and stored at 
4°C. 
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SCREENING OF THE RYE eDNA LIBRARY USING A OLIGONUCLEOTIDE PROBE AND 
SEQUENCING OF AN ISOLATED eDNA CLONE 
Screening of the Rye eDNA Library 
2.35 Preparation of cells for plating 
A single colony of each strain (NM514, L87, c600hfl or C600) was 
used to inoculate a culture of 10 ml L-broth + 0.2% maltose + 0.2% 
MgS04 in a 30 ml McCartney bottle and incubated at 37°C overnight. 1 
ml of overnight culture was added to 50 ml of prewarmed L-Broth + 0.2% 
maltose + 0.2% MgS04 in a 250 ml conical flask. The cells were then 
incubated at 37°C with shaking (250 rpm) until they were in the 
logarithmic phase of growth (ODsoo = 0.5), which took approximately 2-
3 h. The culture was cooled on ice and spun at 3000 rpm for 10 min at 
4°C. The cells were resuspended in 15 ml ice-cold 10 mM MgS04 and 
stored at 4°C for upto 48 h prior to use. 
2.36 Plating of Bacteriophage A 
The screening of plaques was carried out on 100 x 100 mm square 
or 90mm radius circular sterillin plates and was based on the method 
of Maniatis et al. (1982). For the larger plates approximately 1000 
plaque forming units (pfu) were mixed with 200 pl plating bacteria. 
The phage and bacteria were incubated for 15 min at 37°C then mixed 
with 5 ml molten top agarose (at 50°C) and poured onto the plates 
containing solidified bottom agar. The plates were incubated 
overnight at 37°C. On the second screening the plaque density was 
reduced to enable individual plaques to be easily distinguished and 
picked. 
2.37 Bacteriophage A Plague Lifts 
The bacteriophage particles were transferred onto precut Biodyne 
A nylon membrane filters (Benton and Davis, 1977) for screening with a 
radioactive oligonucleotide probe. After overnight incubation at 37°C 
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the plates were placed at 4°C for at least an hour prior to the lifts 
being taken to allow the surface agarose to harden. The filter was 
cut slightly smaller than the plate and was carefully placed directly 
onto the surface of the plate. The position of the filter was marked 
by 3 asymetric marks produced by stabbing the filter and agar with a 
hypodermic needle loaded with ink. The filter was left in contact 
with the surface for 90 sec and then was placed plaque side up in 
denaturing solution (0.5 M NaOH, 1.5 M NaCl) for 1 min. This causes 
disruption of the phage particle as well as denaturing the DNA. The 
filters were then placed in neutralising solution (0.5 M Tris/HCl pH 
7, 1.5 M NaCl) for 5 min. The filters were placed on filter paper to 
air dry and baked at 80°C for 1 h. 
The filters were then ready to be hybridised with the nucleic 
acid probe of interest. 
2.38 Preparation of filters for colony hybridisation 
After transformation of DNA into a pUC plasmid the colonies were 
grown on a nitrocellulose filter for colony hybridisation, in order to 
confirm the identity of colonies carrying the clone of interest. 
Colonies were picked using a sterile toothpick onto a nitrocellulose 
filter that was placed on a L-agar plate with ampicillin (100 pg/ml) 
and grown overnight at 37°C. The filter was placed sequentially in 5 
petri dishes each containing five Whatman No.1 filter paper circles 
soaked with the one of the following: 
No. 1 10% SDS for 3 min 
2 0.5 M NaOH for 5-10 min 
3 1 M Tris-HCl pH 7.4 for 5 min 
4 + 5 0.5 M Tris-HCl pH 7.4, 1.5 M NaCl for 5 min 
The filters were then placed on 3 layers of Whatman 3MM filter 
paper and covered with a fourth piece. The top filter paper was 
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gently pressed onto the nitrocellulose filters and then removed. The 
filters were allowed to air dry and then baked in a oven at 80°C in 
vacuo for 2 h. The filters were stored at 4°C prior to hybridisation. 
2.39 Preparation of 5'-end-labelled oligonucleotide probe 
The oligonucleotides were 5'-end-labelled with [a-32p] dATP as 
described in Maniatis et al. (1982). 
10 x Kinase buffer: 
Labelling reaction: 
0.5 M Tris/HCl pH 7.6 
0.1 M MgCl2 
50 mM DTT 
1 mM Spermidine 
1 mM EDTA 
200-300 ng oligonucleotide 
3 pl 10 x kinase buffer 
50 pCi dATP (dried in vacuo) 
0.5 pl T4 polynucleotide kinase (5U) 
SDW to 15 pl 
The reaction was incubated at 37°C for 50 min, then stopped by 
the addition of 1.5 pl 0.5 M EDTA pH 8 and put on ice. The mixture of 
labelled oligonucleotide and unincorporated nucleotides were separated 
on a 1 ml Sephadex G-50 column equilibrated with TEN. The reaction 
mix was applied to the top of the column, followed by one 35 pl and 
several 50 pl aliquots of TEN. Each 50 pl fraction was collected in a 
1.5 ml eppendorf tube and Cerenkov counted. The first 6 radioactive 
fractions were assumed to contain the oligonucleotide and were pooled. 
A 3 pl sample of the pooled fractions was Cerenkov counted to 
determine the specific activity of the probe. The count obtained was 
converted to dpm (assuming a counting efficiency of 45%) by multipling 
109 
by 2 and multiplied by 100 to give the dpm in the total volume. The 
specific activity of the probe was generally 107 to lOB cpm/pg. 
2.40 Preparation of a radioactive probe by Nick translation 
All reagents and buffers were as supplied in the kit by Amersham. 
10 pCi [a-32 P] dATP (Amersham 3000 Ci/mmol) was dried in vacuo in a 
1.5 ml eppendorf tube. The DNA fragment to be labelled (50 ng in 8 pl 
SDW) and 2 pl 5 x NTP mix were added to the tube, followed by 1 pl DNA 
polymerase and the reaction incubated at l5°C for 4 h. 
Unincorporated nucleotides were removed from the probe by 
fractionation on a 1 ml column of fine G 50 Sephadex equilibrated with 
TEN. Fractions (50 pl) were collected and the labelled DNA fractions, 
generally 7-12, were pooled. The specific activity of the probe was 
determined by Cerenkov counting 3 pl in a liquid scintillation counter 
and was generally between lOB-109 dpm/pg. 
2.41 Hybridisation of a radioactively labelled probe to DNA bound to 
Biodyne filters 
The hybridisation procedures were carried out using the Hybaid 
plastic mesh and bag system. Filters were placed between two plastic 
meshes in a sealable plastic bag to which was added 30-60 ml 
prehybridisation buffer (according to the number of filters). Once 
sealed the bag was placed in a shaking water-bath, at 32°C for 
oligonucleotide hybridisations or at 65°C for nick translated probes, 
for at least 5 h (for oligonucleotide probes an overnight 
prehybridisation was preferred). The prehybridisation buffer was 
removed and the probe was added in 10-30 ml hybridisation buffer. 
Hybridisation was carried out overnight with the same conditions as 
for prehybridisation. 
The formation of nucleic acid hybrids is a reversible process and 
the melting temperature (Tm) is affected by ionic strength, base 
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composition and concentration of helix destabilising agents. Short 
oligonucleotides (13-20 bp) and immobilized DNA show decreased 
stability (Wallace, 1983) and an empirical formula has been determined 
for the optimum temperature for hybridisation of short 
oligonucleotides (Wallace et al., 1979). The temperature at which 50% 
of these duplexes dissociate under standard conditions is: 
Td(°C) = 4(G + C) + 2(A + T) 
where G,C,A and T is the number of corresponding nucleotides in the 
oligomer. A temperature 5° below the Td was used for both oligomers 
in this study in order to detect only perfectly matched molecules 
(Meinkoth and Wahl, 1984). 
Prehybridisation/hybridisation buffer: 
5 X Denhardt's solution 
6 x sse 
50 mM Tris-HCl pH 7.5 
0.05% Sodium pyrophosphate 
5 mM EDTA 
0.05% SDS 
100 pg/ml denatured herring sperm DNA, boiled for 10 min 
immmediately prior to use 
*100 pg/ml wheat transfer RNA, heated to 65°C for 2 min prior 
to use. 
(*Only added for hybridisations with oligonucleotides). 
20 x sse: 175.3 g NaCl 
88.2 g Na citrate in 1 1 SDW, pH 7.0 
Denhardt's solution: 0.02% Ficoll, 
0.02% polyvinylpyrollidone, 
0.02% bovine serum albumin. 
Following hybridisation the filters were washed in the Hybaid 
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system with 6 X sse, 0.05-0.1% SDS at 32°e for oligonucleotide probes 
or with 2 X sse, 0.1% SDS at 65°e for nick translated probes. The 
stringency of the washes can be altered by adjusting the temperature 
or salt concentration. After washing, the filters were kept wet then 
wrapped in clingfilm and autoradiographed at -70°e with two fast 
tungstate intensifying screens and Fugi X-ray film. 
2.42 Purification of hybridising plagues 
The ink marker dots, used to mark the plaque lift filters, were 
marked on the autoradiograph film which was then aligned with the 
master plate. Any plaques which corresponded to a positive signal 
were picked by using a sterile pasteur pipette to remove a agar plug. 
The agar plug may contain more than one plaque, depending on the 
plating density, so a second screening is necessary to ensure that a 
phage stock can be generated from a plate containing plaques 
containing only the insert of interest. 
The agar plug was placed in a 1.5 ml eppendorf tube containing 1 
ml SM buffer (50 mM Tris-Hel, 8 mM MgS04, 100 mM Nael, 0.01% w/v 
gelatin) and 10 pl chloroform. The tube was then left to stand at 
room temperature for 1 h to enable the phage to diffuse into the 
buffer before storing at 4°e. Serial dilutions were plated out in 
order to determine the titre (generally 106 pfu/plaque) and to find a 
dilution with well spaced plaques for the second screening. 
2.43 Large-scale preparation of Bacteriophage A (Maniatis et al., 
1982) 
a) Plate lysis 
105 pfu, enough to give confluent lysis, were mixed with 150 pl 
of plating bacteria and plated on a 90 mm plate using top agar to give 
a soft surface. After overnight incubation at 37°e 5 ml SM buffer was 
added to the plate, shaken gently for 5 h at 4°e and then the SM 
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buffer (with phage particles) was removed with a pasteur pipette. The 
surface of the agar was rinsed with a further 1 ml SM buffer, pooled 
and centrifuged at 5000 rpm for 10 min at 4°C. The supernatant was 
recovered, 100 pl chloroform added and stored at 4°C. This method 
yielded 109-1010 pfu/ml. 
b) Liquid culture of Bacteriophage A for the extraction of DNA 
This method generates large amounts of pure phage for DNA 
extraction. A single colony of host bacteria was used to inoculate 
100 ml L-broth + 0.2% w/v MgS04 + 0.2% w/v maltose prewarmed to 37°C 
and was incubated at 37°C overnight with shaking (250 rpm). To 2 ml 
overnight culture was added 5 x 107 pfu in SM buffer. The ratio of 
bacteria to phage is important; too few phage will fail to lyse the 
cells, too many phage will cause cell lysis to occur very rapidly 
before the bacteria have multiplied (increasing the cells available 
for infection) so the yield of phage will also be low. Trial lysis 
experiments should be performed to determine the correct conditions. 
The bacteria/ phage mixture was incubated at 37°C for 20 min and then 
was used to inoculate 300 ml L-broth + 0.2% MgS04 + 0.2% maltose 
preheated to 37°C in a 500 ml conical flask. The flask was incubated 
at 37°C with shaking (220 rpm) until lysis had occurred (6-7 h). When 
lysis had occurred 6 ml chloroform was added and the incubation 
continued for 30 min to rupture any intact cells. The culture was 
then stored overnight at 4°C. 
The culture was allowed to warm to room temperature then DNAase 
and RNAase were added to a concentration of 1 pg/ml. The culture was 
incubated at room temperature for 30 min to degrade any bacterial 
nucleic acids. To the culture was added 17.5 g NaCl, the flask was 
swirled to dissolve the salt and then left to stand for 1 h on ice. 
The precipitate was removed by centrifugation at 3500 rpm for 20 min. 
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The supernatant was transferred to a sterile 500 ml flask containing 
.30 g PEG 6000. The solution was stirred until the PEG had dissolved 
and was then placed in an ice-water bath at 4°C overnight to allow the 
phage particles to be precipitated. 
The phage were recovered by centrifugation at 800 rpm for 20 min. 
The pellet was drained and resuspended in 8 ml SM buffer, the tube was 
rinsed with a further 4 ml and this was pooled. The PEG was removed 
by extraction with a equal volume of chloroform. The phage suspension 
was transferred to an ultracentrifuge tube, 0.75 glml solid caesium 
chloride was added and dissolved. The tube was topped up with SM 
buffer containing 0.75 glml caesium chloride and was centrifuged at 
38000 rpm for 21 h at 4°C. The phage particles were visible as a 
light blue band which was removed with a sterile pasteur pipette and 
stored at 4°C. 
The phage suspension was dialysed against 2 x 4 1 buffer (50 mM 
Tris-HCl pH 8.0, 10mM NaCl, 10mM MgCl2) for 1 h each to remove the 
caesium chloride. It was then transferred to 30 ml corex tubes, and 
0.5 M EDTA pH 8.0 (to a concentration of 20 mM), pronase (to 0.5 
mglml) and SDS (to 0.5%) were added. This was mixed and incubated at 
37°C for 1 h to disrupt and degrade the phage coat. Protein was 
removed by extraction with phenol and chloroform and the DNA was 
precipitated with ethanol. The pellet was dried in vacuo and 
resuspended in TLE (400-1000 pg DNAI300 ml starting culture). 
2.44 Cleavage of DNA with Restriction Endonucleases 
The reaction conditions and buffers were as specified by the 
manufacturer. 
Plasmid or phage DNA 
Plant Genomic DNA 
Amount of Enzyme 
1-5 U I pg DNA 
5-10 U I pg DNA 
The reaction volume was generally 10 pl, however this was varied 
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depending on the concentration and the quantity of DNA to be digested. 
2.45 Agarose gel electrophoresis of DNA 
Agarose gel electrophoresis was used to size fractionate A, 
plasmid, M13 and plant genomic DNA. eDNA was run under denaturing 
conditions as described in section 2.33. The concentration of agarose 
was varied from 0.8-1.5% depending on the size of DNA to be resolved. 
Most frequently 0.8% medium EEO agarose was used in 1 x TEA. 
20 x TEA: 
Trizma base 7-9 
Glacial acetic acid 
EDTA 
pH to 8.0 
96.8 g 
22.8 ml 
3.72 g 
1 1 
The agarose was melted in a microwave oven and then cast in the 
appropriate gel tray (30 ml for Biorad mini-gel apparatus, 150 ml for 
Biorad midi-gel apparatus or 300 ml for BRL horizontal gel 
electrophoresis system ). A 1/5th volume of 5 x loading buffer (25% 
v/v sterile glycerol, 25% saturated solution of bromophenol blue, 1 x 
TEA) was added to the DNA samples which were then loaded. The gel was 
run in 1 x TEA with varying time and voltage but the current was not 
allowed to exceed 120 rnA to avoid the melting of the gel. 
The gel was stained in a solution containing 1 pg/ml ethidium 
bromide for 30 min for large gels, 15 min for mini-gels and then 
destained in distilled water. Gels were viewed on a long wavelength 
(300-360 nm) UV transilluminator and photographed using a Polaroid 
land camera with a red filter. 
The size of the DNA was estimated by running the appropriate 
molecular weight standards: 
a) A digested with Hind III 
b) ~X174 digested with Hae III 
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c) BRL 123 bp Ladder 
2.46 Southern blotting (Southern, 1975) 
Following electrophoresis Southern blotting was used to transfer 
the DNA contained in the gel onto a membrane filter (either Biodyne A 
or Hybond-N). The gel was stained, photographed and then the wells 
were trimmed off. The exact dimensions of the gel were recorded. 
Plant genomic DNA was "acid-nicked" to ensure transfer of the large 
fragments of DNA, so the gel was depurinated by immersion in 0.2 M Hel 
for 15 min. The gel was then immersed in denaturing solution to 
denature the DNA for transfer (0.5 M NaOH, 0.8 M Nael) for 30 min and 
then in neutralising solution (0.5 M Tris-Hel, 1.5 M Nael pH 7.0) for 
at least 1 h. After each immersion the gel was rinsed with distilled 
water. 
The gel was placed on a wick of Whatman 3MM filter paper (which 
was the same width as the gel with the ends of the wick folded down 
into the reservoir) on a tray above a reservoir of 20 X SSe for 
Biodyne A or 6 X sse for Hybond-N. The membrane was cut to 2 mm 
larger than the dimensions of the gel, wetted in 2 X SSe, placed 
directly on top of the gel and any air bubbles were removed. Three 
layers of Whatman 3MM filter paper (4 mm larger than gel) were wetted 
and placed on the membrane. A 3 inch stack of absorbent paper towels 
and a weight (500 g for a mini-gel and 1 kg for larger gels) were 
placed on top of the filter paper. 
The transfer was left to proceed overnight, after which Biodyne A 
filters were air dried then baked at 80°e for 1 h. Hybond-N filters 
were air dried, wrapped in Saran wrap and the DNA side was UV 
irradiated for 4 min. The membranes were then ready to be probed with 
the DNA fragment or oligonucleotide of interest. 
' 
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2.47 Subcloning of DNA fragments into plasmid and M13 vectors 
The identities of A clones were confirmed by hybridisation to the 
oligonucleotide probe. The clones were digested with restriction 
enzymes to generate smaller fragments which were subcloned into M13 
vectors for sequencing. The A clone was also subcloned into pUC 
plasmid vectors for the generation of overlapping deletions. The 
products of the overlapping deletion reactions were also subcloned 
into pUC vectors for sequencing. 
2.48 Purification of DNA fragments 
Two methods were used to purify DNA fragments: 
2.48.1 Peacock gel Electrophoresis and Electroelution 
2.48.2 Recovery of fragments after electrophoresis in low 
melting point agarose. 
2.48.1 Peacock Gel Electrophoresis and Electroelution of DNA fragments 
from acrylamide or agarose gels 
For a good separation of small fragments of DNA (50 bp - 1.5 kb) 
a Peacock gel was used: 
20% w/v acrylamide, 1% w/v bisacrylamide 24 ml 
10 x TBE 8 ml 
SDW 27.2 ml 
Glycerol 20 ml 
10% w/v ammonium persulphate 0.8 ml 
Total volume = 80 ml 
The gel was mixed, filtered through Whatman No. 1 filter paper 
and 25 pl TEMED was added to catalyse the polymerisation. The running 
buffer used was 1 x TBE and the gel was run at 15 rnA overnight. The 
gel was stained in 500 ml of 1 x elution buffer with 100 pl ethidium 
bromide (10 mg/ml) for 30 min. 
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100 x Elution buffer: 0.5 M Tris-HCl 
0.25 M glacial acetic acid 
pH 8.0 
The gel was destained for 15 min in elution buffer and viewed on 
a long wavelength (300-360 nm) UV transilluminator. The fragment of 
interest was cut out with a razor blade and the gel slice was placed 
in a siliconised screw-capped eppendorf tube containing 1 ml elution 
buffer. The slice was then transferred to pre-washed dialysis tubing 
and the bag was sealed by tying after removing any air bubbles. The 
gel slices were then electroeluted in 1 x elution buffer (the bags 
were not totally immersed in buffer) at a voltage of 15 V/cm between 
the electrodes. The elution was continued for 1 h for agarose gels 
and for 2 h for acrylamide gels. After electroelution the current was 
reversed for 1 min. in order to detach any DNA which may have adherred 
to the side of the dialysis tubing. 
The buffer in the dialysis bag was then transferred to two 
siliconised 1.5 ml eppendorf tubes and the DNA precipitated with 
ethanol and resuspended in 20 pl TLE buffer. 
2.48.2 Recovery of fragments after electrophoresis in low melting 
point agarose (Weislander, 1979) 
DNA fragments were run in a 0.8% gel made with low melting point 
agarose. The fragment was cut out with a razor blade and the gel 
slice placed in a 1.5 ml eppendorf tube. The tube was placed in a 
waterbath at 60°C for 30 min or until the agarose had melted. The DNA 
was then recovered by extracting twice with phenol (equilibrated with 
1 x TEA) heated to 60°C and once with butanol, and finally 
precipitated with ethanol. The insert DNA and the vector DNA were 
precipitated together if the DNA fragment was to be ligated. 
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2.49 Ligation of a DNA fragment into Plasmid or bacteriophage M13 
vectors (Maniatis et al. 1982) 
The vector DNA was cut with the chosen restriction enzyme(s) was 
purified either by phenol/chloroform extraction or by Peacock gel 
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electrphoresis and electroelution. A three-fold excess of cohesive 
" free ends of target (insert) DNA was added to the vector DNA (50 ng) 
and wherever possible precipitated with ethanol prior to ligation. 
Ligations were generally carried out in a 1.5 ml eppendorf tube in a 
volume of 10 pl using 1 unit of T4 DNA ligase and the buffer supplied 
by the manufacturer. The ligation reaction was carried out at 14°C 
overnight, then diluted with 40 pl TLE and stored at -20°C. 
2.50 Preparation of competent E.coli cells (Dagert and Erlich, 1979) 
A single colony of E.coli (JM101 or JM83) was used to inoculate 
10 ml L-broth in a 30 ml McCartney bottle which was shaken briefly and 
then incubated at 37°C without further shaking. The overnight culture 
(0.5 ml) was used to inoculate a prewarmed 50 ml L-broth culture which 
was incubated at 37°C with shaking (250 rpm) until the cells were in 
the logarithmic phase of growth (ODsoo = 0.2-0.3 and about 2-3 h). 
The cells of JM83 were then chilled on ice for 10 min. The cells were 
pelleted by centrifugation at 5000 rpm for 5 min. at 4°C and then 
resuspended in ice-cold 20 ml 0.1 M CaCl2 for JM83 or 12.5 ml 50 mM 
CaCl2 for JM101. They were kept on ice for at least 1 h prior to use 
in a transformation experiment. Cells can be used for up to 48 h, the 
maximum transformation efficiency being obtained after 24 h. 
2.51 Transformation of competent E.coli (JM83) cells with pUC plasmid 
Transformation was carried out using E.coli strain JM83 (ara, 
D(lacroA,B), rpsLtBO, lacZ, DM15). The following controls were used: 
a) Self-ligation of vector DNA - to check ligation 
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efficiency, if using a linearised vector, as many blue 
colonies should result. 
b) Linearised DNA - to establish that the vector DNA has 
been efficiently digested by the restriction enzyme. Result 
should be no colonies. 
c) Target DNA and Vector ligated: result should be blue 
self-ligated colonies and white recombinant colonies 
For each 90 mm L-agar plate 5 ng of vector DNA was transformed (5 
pl diluted ligation reaction mix). Competent cells, 75 pl, were 
placed in a 1.5 ml eppendorf tube and the DNA added. The tubes were 
kept on ice for 10 min. and then placed in a 37°C waterbath for 5 min. 
as a heat shock. The cells and DNA were then transferred to 1.5 ml L-
broth in a sterile glass test-tube. They were then incubated at 37°C 
for 60 min. in order that the transformed cells could acquire the 
resistance to ampicillin conferred by the plasmid. During the 
incubation period 10 ml bottom agar (0.15 g agar in 10 ml 2YT, 2YT = 
for 1 1 16 g bactotryptone, 10 g bactoyeast extract, 5 g NaCl pH 7.0) 
was melted and kept at 54°C. After the incubation 1 ml bottom agar 
was mixed with the cells at 37°C and transferred to a waterbath at 
42°C. 50 pl 2% X-gal in N,N-dimethylformamide was added, mixed and 
poured onto an L-plate containing 100 pg/ml ampicillin. The plates 
were incubated at 37°C overnight. Insertion of the plasmid into the 
E.coli cell confers resistance to ampicillin and, because JM83 
contains the lacZ gene, a blue colony results. Insertion of foreign 
DNA into the plasmid inactivates the lacZ gene and so produces white 
recombinant colonies. White colonies were picked with a sterile 
toothpick onto another L-plate containing ampicillin. 
2.52 Transfection of E.coli with bacteriophage M13 RF or ssDNA 
Transfection was carried out using E.coli strain JM101 (supE, 
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thi, D(lac,proA,B)./F'traD36, porA,B, laqlq, ZdM15). Up to 25 ng of 
vector DNA was used for each 90 mm plate. 100 pl of competent cells 
and DNA were mixed and put on ice for 30 min. The cells were heat 
shocked for 2 min. at 42°C and plated directly as there is no 
selection for transfected cells. They were mixed with 3 ml top agar 
(0.7% agar in L-broth) at 42°C in a glass test-tube to which was then 
added 50 pl 2% X-gal and 10 pl 100 mM IPTG. The mixture was mixed, 
poured onto an L-plate and incubated overnight at 37°C. M13 forms 
opaque plaques as the infected cells continue to grow slowly but do 
not lyse. The phage with no insert DNA has a functional lacZ gene and 
so produces blue plaques when induced by IPTG. Insertion of DNA 
causes the lacZ gene to be inoperative and hence recombinants are 
white. 
2.53 Preparation of plasmid DNA- Rapid mini-prep 
One colony of E.coli containing the plasmid was picked into 3 ml 
L-broth with ampicillin (100 pg/ml) in a 30 ml McCartney bottle and 
incubated overnight at 37°C with shaking (250 rpm). The cells were 
pelleted at 6500 rpm at 4°C in two 1.5 ml eppendorf tubes. The pellet 
was washed with 200 pl 50 mM Tris-HCl pH 8.0/25% sucrose and was 
resuspended by vortexing in 100 pl of the same buffer. To the tubes, 
on ice, was added 600 pl ice-cold MSTET (Triton X-100 5% v/v, 50 mM 
EDTA, 50 mM Tris-HCl pH8.0, Sucrose 5% w/v) and 14 pl lyzozyme (40 
mg/ml). The tubes were mixed; then immediately placed in a boiling 
water bath for 45 sec. and replaced on ice. Cell lysis is indicated 
by whiteness of the solution at this point. Cell debris was pelleted 
at 15000 rpm for 30 min. at 4°C and removed from the tube with a 
sterile toothpick. To the supernatant 5 pl RNAase A (10 mg/ml) was 
added and incubated at 37°C for 20 min. After this time 3 pl 
proteinase K (20 mg/ml) was added and the incubation continued for a 
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further 15 min. The solution was extracted two or three times with 
phenol/chloroform as follows: 200 pl phenol was added, mixed and 
incubated at 37°C for 10 min; then 200 pl chloroform was added, mixed 
and spun at 15000 rpm for 5 min. The solution was then chloroform 
extracted. 
The DNA was precipitated by the addition of 400 pl isopropanol 
(-70°C for 30 min.), resuspended in 100 pl TE and reprecipitated by 
the addition of 1/10th vol. 3 M Na Acetate and 3 vol. ethanol (-20°C 
overnight or 1 h). The DNA (20-30 pg) was finally resuspended in 
25 pl TLE and stored at -20°C. 
2.54 Preparation of Bacteriophage M13 ss-DNA 
The filamentous coliphages (M13,fd and f1) are a group of closely 
related bacteriophages containing single-stranded circular DNA 
molecules of about 6.4 kb. When the phage infects a bacterium the DNA 
is converted to a double-stranded replicative form (RF). The RF form 
then synthesises copies of the single-stranded DNA (ss-DNA) by rolling 
circle replication. The progeny DNA molecules are only packaged upon 
extrusion through the cell wall of the bacterium, thus the cell is not 
killed but grows much more slowly than uninfected cells forming turbid 
'plaques'. The RF form can be isolated from the infected bacteria. 
The ss-DNA can be prepared by deproteinisation of a culture of 
infected bacteria after removal of the cells. The RF form can be used 
for subcloning and for the creation of deletions and the ss-DNA form 
for sequencing. 
To isolate ss-DNA an exponential culture of E.coli JM101 was 
prepared (as for competent cells). A 0.65 ml sample of exponential 
cells was placed in a 1.5 ml eppendorf tube, and inoculating with one 
plaque picked with a sterile toothpick. This was then incubated at 
37°C for 4 h with shaking (250 rpm). The cells were pelleted by 
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centrifugation in. a microfuge at 6500 rpm for 5 min. 500 pl of the 
supernatant was transferred to another eppendorf tube containing 100 
pl 20% PEG,2.5 M NaCl for phage extraction. (The remaining 
supernatant and cells ·were stored at 4°C with the addition of 50 pl 
chloroform in order to maintain a stock of any phage of interest). 
The tube was mixed and allowed to stand at room temperature for 30 
min. The phage was then pelleted by centrifugation at 13000 rpm for 
20 min. The pellet was briefly washed with 100 pl TE and then 
resuspended in 100 pl TE. The phage coat was removed by phenol/ 
chloroform extraction, and the DNA precipitated with ethanol and then 
resuspended in 16 pl TE. 
DNA Sequencing 
Sequencing reactions were carried out using the enzyme 
"Sequenase" which is a modified T7 polymerase. The reactions were 
carried out using [ 35 S] dATP which reduces the background on 
autoradiographs and produces longer readable sequencing reactions than 
[ 32 P] dATP. The sequencing reaction were based on the dideoxy chain 
termination method of Sanger et al (1977). Sequences of up to J50 bp 
could be obtained from a clone, the limiting factor being the 
electrophoresis equipment. 
Short regions of the DNA were sequenced by subcloning restriction 
fragments into M13mp1H or mp19. As suitable restriction sites were 
not available throughout the clone, it was subcloned into a plasmid 
vector (pUC18) and a series of overlapping deletions produced using 
exonuclease III and S1 nuclease. 
2.55 Generation of Overlapping Deletions 
The deletions were made using ds-DNA produced by a rapid mini-
preparation of the clone in pUC18. It was first established that the 
plasmid pUC18 can be cut in the polylinker region with at least two 
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restriction enzymes that do not cut the cloned DNA. The first enzyme 
was selected to cut close to the cloned DNA and produce a 3' recessed 
end; which would then be digested by exonuclease III and so produce 
deletions into the cloned DNA. The second enzyme would cut further 
away from the cloned DNA and produce a 3' overhang. The overhang is 
not susceptible to digestion by exonuclease III and would prevent 
deletions into the plasmid DNA. 
The DNA (10 pg) was digested with two restriction enzymes (Xba 
I/Pst I) and precipitated with ethanol. It was resuspended in 190 pl 
SDW. (A sample of 10 pl was removed for gel electrophoresis to act as 
a size marker for the intact DNA). To this was added 20 pl 10 x 
Exo III buffer (0.5 M Tris-HCl, 50 mM MgClz, 0.1 M mercaptoethanol), 
then 150 U exonuclease III and the reaction incubated at 30°C. The 
exonuclease III digests a single strand of DNA from the recessed end 
at a rate of about 200 bases per minute. 
Samples of 20 pl were taken every 2-5 min. (depending on DNA 
sample) and placed in a 1.5 ml eppendorf tube containing 20 pl 10 x S1 
buffer (0.3 M NaOAc, 0.5 M NaCl, 10 mM ZnS04). After all the samples 
had been taken 1,60 pl SDW and 50 U S1 nuclease were added to each and 
the reaction incubated on ice for 30 min. The reaction was stopped by 
the addition of 20 pl 10 x Stop buffer (1 M Tris-HCl pH 9.0, 0.2 M 
EDTA). The S1 nuclease removes the single strand left after 
exonuclease III digestion and leaves blunt ended DNA. 
The reactions were extracted with phenol/chloroform and the DNA 
precipitated with ethanol. The DNA was then resuspended in 7 pl SDW, 
ligated to recircularise the plasmid molecules and used to transform 
competent cells of E.coli JM83 cells. 
At least 12 colonies from each time period were streaked onto L-
agar plates containing ampicillin (100 pg/ml) and grown overnight at 
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37°C for mini-lysate analysis. A reasonable quantity of each streak 
was picked using a sterile toothpick and resuspended in 100 pl 1 x TEA 
in a 1.5 ml eppendorf tube. 
released by: 
The cells were disrupted and the DNA 
a) adding 50 pl loading buffer (5% w/v SDS, 0.2% w/v BPB, 
25% v/v glycerol), mixing and incubating at 65°C for 30 min. 
b) Vortexing samples for 30 sec. 
c) Passing through a broad needle (19G) attached to a 1 ml 
syringe four to six times. 
A sample of 25 pl was then electrophoresed on a 1. 2% agarose gel 
(200 ml) next to the sample of the plasmid containing full length 
insert DNA. 
2.56 DNA sequencing reactions using "Sequenase" 
Sequenase is a modified form of the bacteriophage T7 DNA 
polymerase (Tabor and Richardson, 1987). Reactions were carried out 
using [35S] dATP as the lower energy of 35S labelled nucleotides 
greatly improves the autoradiographic resolution (Biggio et al 1983). 
All buffers and reagents were as supplied by the manufacturer. As 
chain termination used in this method works best when single-stranded 
DNA templates are used, the double-stranded plasmid templates must be 
subjected to alkaline-denaturation prior to sequencing. Plasmid DNA 
(2-3 pg in 50 pl TE) was denatured by incubating in 0.2 M NaOH for 5 
min. at room temperature and then neutralised using 0.5 volume of 4 M 
NH40Ac. The DNA was precipitated with 4 volumes of ethanol at -20°C 
for 1 h and resuspended in 15 pl SDW (7 pl to be used for sequencing 
reactions) 
To anneal the sequencing primer 7 pl of DNA (ss- or ds-DNA) and 2 
pl 5 X Sequenase buffer were mixed in a 0.5 ml eppendorf tube and 0.5 
pmol (1 pl) universal primer (17 mer) was added. The capped tube was 
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placed at 65°C for 2 min. then the temperature was allowed to slowly 
cool to below 35°C (taking 30 to 60 min). To the annealed DNA mixture 
(10 pl) were added 1 pl DTT (0.1 M), 2 pl diluted labelling mix (1:5 
with SDW), 0.5 pl [ 35 S] dATP and 2 pl diluted Sequenase (1:8 with TE). 
The labelling reaction was incubated for 5 min. at room temperature. 
Four 1.5 ml eppendorf (termination) tubes containing 2.5 pl of the 
ddNTP mixes (A,C,G and T) were warmed to 37°C for at least 1 min. 
When the labelling reaction was complete, 3.5 pl was transferred to 
each termination tube and the reaction was incubated at 37°C for 5 
min. in a heating block. The termination reactions were stopped by 
the addition of 4 pl stop solution and the samples were heated to 75°C 
for 2 min. immediately before loading onto a 6% sequencing gel. 
Sequencing samples could be stored at -20°C for up to 1 week prior to 
loading. 
2.57 Sequencing Gels and Autoradiography 
Sequencing reactions were electrophoresed on 6% polyacrylamide, 
8M urea gels (400 x 200 x 0.4 mm). The 4mm thick glass plates were 
cleaned with a mild detergent (Teepol), then washed with dHzO followed 
by with ethanol. The top notched plate was also siliconised using 
"Repelcote" and then washed again with dHzO and ethanol prior to 
assembly. The two plates were taped together with a 0.4 mm spacer. 
The gel was prepared by dissolving 21.6 g urea in 4.5 ml 10 x TBE and 
6.25 ml 40% acrylamide mix in a total volume of 45 ml. 
40% acrylamide mix: 38 g acrylamide 
2 g bis acrylamide 
100 ml 
Dissolve by stirring then 2 g Biorad AG501-X8 mixed bed 
resin added and stirred for 30 min. to deionise. Filtered 
through Whatman No. 1 filter paper and stored in the dark at 
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4°C. 
The gel mix was stirred for 30 min. for the urea to dissolve, 
then 22.5 mg ammonium persulphate and 45 pl TEMED were added to 
catalyse polymerisation. The gel mix was poured and allowed to set 
for at least 30 min. prior to use. The gel was clamped into a Raven 
vertical slab gel apparatus, loaded with 5 pl sequencing reaction mix 
and electrophoresed at 1500 V. 
Two gels were run for each set of sequencing reactions in order 
to read as much sequence as possible; one short gel (2 h) run until 
the bromophenol blue (which runs at the same size as a DNA fragment of 
10 bp) had just run off the gel and one long gel (4-5 h) in order to 
extend the sequence. 
The gel was fixed in 10% v/v acetic acid, 10% v/v methanol for 30 
min, then transferred onto Whatman 3MM filter paper, covered with 
clingfilm and dried in vacuo at 80°C in a Biorad slab gel drier. The 
clingfilm was removed and Fuji X-ray film was placed directly on the 
gel. The gel was autoradiographed at room temperature. 
2.58 Analysis of DNA Sequence Data 
Alignment of DNA sequence data was carried out using the DBUTIL 
database system of Staden (1982). Analysis of the DNA data and the 
corresponding protein sequence was carried out using programs from the 
University of Wisconsin Genetics Computing Group (Devereux et al., 
1984). The sequence was compared to other sequences using the EMBL 
DNA and GENBANK databanks and the Brookhaven protein sequence databank 
using the NAQ and PSQ search programs. 
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CHAFfER 3 
PROTEIN RESULTS AND DISCUSSION 
1.28 
PROTEIN PURIFICATION AND SEQUENCING OF HOMOLOGOUS INHIBITORS OF 
TRYPSIN AND a-AMYLASE FROM SEEDS OF RYE (Secale cereale cv. Gazelle) 
3.1 Purification and characterisation of the Trypsin inhibitor from 
Rye seeds 
The trypsin inhibitor was purified using a modification of the 
method described by Boisen and Djurtoft ( 1981). The flow chart in 
Fig. 4 summarises the method with{} indicating the original method; 
and it also refers the reader to the figures of the column chromato-
graphy profiles {Fig. 5-9). 
The trypsin inhibitor was extracted from rye seeds which had been 
milled to a fine powder. The albumin-like inhibitor was extracted 
with an acid buffer {0.1 M sodium acetate pH 4.9). Trypsin inhibitors 
are known to be resistant to precipitation by heat; however the high 
content of polysaccharides in the rye extract prevented a heat 
treatment until after the ammonium sulphate precipitation {Boisen and 
Djurtoft, 1981). The heat treatment brings about the precipitation of 
heat-labile proteins. The 0-30% ammonium sulphate precipitate had 
been previously shown to contain the endosperm inhibitors, the embryo 
inhibitors remaining in solution (Boisen and Djurtoft, 1981). 
Ion-exchange chromatography has been used extensively in the 
purification of these inhibitors as they are present in the seed in 
multiple forms (isoinhibitors) differing in their isoelectric points 
(Richardson, 1990). A pure preparation of the rye trypsin inhibitor 
was obtained by applying the extract sequentially to cation exchange 
chromatography using SP-Sephadex (Fig. 5), gel filtration using Biogel 
P60 (Fig. 7) and a further cation exchange chromatography using CM-
Biogel (Fig. 9), The final purification step was reverse phase high 
performance liquid chromataography (RP-HPLC) (Fig. 10) which was also 
used to monitor purity during purification (Figs. 6, 8, 10). 
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Figure 4: 
A flow chart summarising the purification of a trypsin inhibitor 
from rye seeds (Secale cereale cv. Gazelle). 
Extraction 250g rye flour + 
11 0.1 M sodium acetate 
buffer (pH 4.9) 
16 h at :woe 
Centrifuge 10000 rpm x 15min 
I 
Pellet discarded 
Fractional precipitation 
Supernatant discarded 
Heat treatment 
Cation exchange chromatography 
Gel filtration 
{Ultra gel AcA54 LKB} 
Cation exchange chromatography 
Reverse-phase high performance 
liquid chromatography 
I 
{Not performed by Boisen and Djurtoft} 
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I Supernatant 
I 
Ammonium sulphate 0-30% 
Centrifuge 
Pellet dissolved in 200 
ml 0.05 M NaOAc buffer 
5 min. in a boiling water 
bath, cooled in ice-bath, 
filtered. 
SP-Sephadex 
(Elution profile Fig. 5, 
RP-HPLC Trace Fig. 6) 
Biogj P60 
(Elution profile Fig. 7, 
RP-HPLC Trace Fig. 8) 
CM Biogel 
(Elution profile Fig. 9) 
RP-HPLC 
(Trace Fig. 10) 
Figure 5: 
Cation-exchange chromatography of the rye trypsin inhibitor (0-
30% ammonium sulphate fraction) on SP-Sephadex (3 x 25cm) in 
0.05M sodium acetate buffer pH 5.5 eluted with a linear gradient 
of 0 - 0.5M NaCl (flow rate 35ml/h, fraction size, 3.5ml). 
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Figure 6: 
RP-HPLC separation of the rye trypsin inhibitor after cation 
exchange chromatography on SP-Sephadex, eluted with a gradient of 
acetonitrile in 0.1% trifluoroacetic acid at a flow rate of 
l.Oml/min. 
-------------------
2 
I 
0 10 20 
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Figure 7: 
Gel filtration of the rye trypsin inhibitor after SP-Sephadex on 
Biogel P-60 (2.5 x 87cm) in O.IM sodium acetate buffer pH 5.0 
(flow rate 30ml/h, fraction size 4ml). 
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Figure 8: 
RP-HPLC separation of the rye trypsin inhibitor after gel 
filtration on Biogel P-60 eluted with a gradient of acetonitrile 
in 0.1% trifluoroacetic acid at a flow rate of 1.0ml/min. 
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Figure 9: 
Cation exchange chromatography of the rye trypsin inhibitor after 
Biogel P-60 on CM-Biogel (1 x 25cm) in 0.05M sodium acetate 
buffer (pH 5.0) eluted with a linear gradient of 0 - 0.2M NaCl 
(flow rate 20ml/h, fraction size 3.5ml). 
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Fraction number 
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Figure 10: 
RP-HPLC separation of the rye trypsin inhibitor (3mg) after 
cation exchange chromatography on CM-Biogel eluted with a 
gradient of acetonitrile (right axis) in 0.1% trifluoroacetic 
acid at a flow rate of 1.0ml/min. 
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The main aim of the purification procedure was to obtain a 
protein preparation that gave a single N-terminal using the 
DABITC/PITC double coupling in order that a full sequence analysis 
could be carried out. RP-HPLC gave a single peak which yielded a 
single N-terminal sequence. A single peak on RP-HPLC suggests that 
there were no blocked contaminants present in the purified trypsin 
inhibitor which would not have been detected by N-terminal analysis 
and would prevent sequence analysis. The N-terminal sequence of the 
rye trypsin inhibitor was found to be: 
Ser-Val-Gly-Gly-Gln5 -Cys-Val-Pro-Gly-Leul 0 -Ala-Met-Pro-
The DABITC/PITC double coupling method is unable to distinguish 
leucine and isoleucine and their presence was determined using the 
dansyl chloride method for semi-quantitative analysis of peptides. The 
identity of Leu10 was confirmed by comparison to analysis of peptides 
T1, C1 and C2 {Fig. 15). The sequence of 13 amino acids represents 
the limit for manual sequencing using the DABITC/PITC method on the 
intact protein. In order to obtain the full protein sequence the 
protein was cleaved into peptides using chemical and enzymic methods. 
The homogeneity of the inhibitor was also established by 80S-
polyacrylamide gel electrophoresis (SDS-PAGE) and isoelectric focusing 
(IEF) {Fig. 11). SDS-PAGE in the presence of 2-mercaptoethanol 
yielded a single band of Mr 13000, which is typical of a·number of 
enzyme inhibitors isolated from other cereal seeds (Kashlan and 
Richardson, 1981, Odani et al., 1983, Mahoney et al 1984). This value 
is in close agreement with the Mr 12500 reported by Boisen and 
Djurtoft (1981). This confirmed the presence of only one major protein 
in sequence analysis of the rye trypsin inhibitor. 
IEF gave a number of bands with pi's in the region of 6.0- 7.0. 
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Figure 11: 
SDS-polyacrylamide gel electrophoresis and isoelectric focusing 
of the rye trypsin inhibitor (Tl) and the rye a-amylase inhibitor 
(AI). 
138 
M r 
SDS-PAGE 
6 -
5 -
4-
3 -
2-
1 -
AI T~ 
IEF 
+. 
'pH 3.5 
pH 10 
-AI Tl 
Boisen and Djurtoft (1981) reported the trypsin inhibitor as having a 
pi of about 9.0 but no bands were evident at that pl. A single N-
terminal sequence was obtained on sequencing but the multiplicity of 
bands revealed by IEF indicates the presence of isoinhibitors differ-
ing in only a few amino acids. The isoinhibitors were not effectively 
separated during the ion exchange chromatography steps in the purifi-
cation procedure. Some microheterogeneity of peptides was detected 
during sequencing, confirming the presence of various isoinhibitors in 
the purified preparation. 
3.2 Chemical Cleavage of the Rye Trypsin Inhibitor using cyanogen 
bromide (CNBr) 
Approx. 0.5-1.0 mg of reduced and S-carboxymethylated trypsin 
inhibitor was cleaved using cyanogen bromide. The peptides were 
separated using RP-HPLC (Fig. 12) using a programme (Prog.9) where the 
acetonitrile concentration increased by approx. 1% in 4 min. The 
profile can be divided clearly into four groups of peaks (the fourth 
peak is broader and hence may contain more than one group of 
peptides). The major peaks were sequenced by the DABITC/PITC manual 
sequencing method. The peptide sequences are shown in Table 4 in the 
order that the peptides occur in the full sequence, with the elution 
number of the peptide from the RP-HPLC column shown in brackets. 
In total five fragments were found indicating the presence of 
four methionine residues in the trypsin inhibitor, which was later 
confirmed by amino acid analysis of the protein (Table 7). High 
concentrations of CNBr can occasionally cause cleavage of any Trp-X 
peptide bonds (Ozols and Gerard, 1977) however no such cleavage 
occurred at the Trp38-Asp39 bond. The sequence obtained from the CNBr 
fragments established overlaps in two regions of the sequence; Lys41 -
Cys45 and Arg87 -Val&&, The longest fragments sequenced are 
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Figure 12: 
RP-HPLC separation of the rye trypsin inhibitor after chemical 
cleavage with cyanogen bromide, eluted with a gradient of 
acetonitrile in 0.1% trifluoroacetic acid at a flow rate of 
1. Oml/min . 
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Table 4: 
Peptides obtained by chemical cleavage of the rye trypsin 
inhibitor with cyanogen bromide 
Peptide Elution Peak 
CN1 75 First 
(CN-1) 
CN2 
(CN-22) 
133 Latter part 
of fourth 
2b 132 
(CN-21) 
Sequence 
Serl-Val-Gly-Gly-Gln-Cys-Val-Pro&-
Prol3-His-Asn-Pro-Leu-Gly-Ala-Cys-
-Arg-Thr-Tyr-Val-Val25_ 
Pro13 -His-Asn-Pro-Leu-Glyl&_ 
CN3 127 
(CN-18) 
Front part Lys41-Arg-Arg-Cys-Cys-Asp-Glu-Leu-
of fourth 
CN4 
(CN-5) 
95 
CN5 109 
(CN-12) 
5a 107 
(CN-11) 
5b 106 
(CN-10) 
Second 
Third 
-Leu-Ala-Ile-Pro-Ala-Tyr54_ 
Asp65-Gly-Val-Val-Thr-Gln-Gln-Gly-
-Val 7 L 
Pro83-Asn-Cys-Pro-Arg-Val-Thr-Gln-
-Arg-Pro-Tyr-Ala-Ala-Thr96_ 
Pro&3-His-Cys-Pro-Arg-Val-Thr-Gln-
-Arg9l_ 
Pro&3_ - -Cys-Pro-Arg-Val-Thr89_ 
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represented on the full sequence diagram as CN1-5 (Fig. 15). The 
identity of any Leu/Ile residue found during sequencing the CNBr 
fragments was established by comparison with tryptic and chymotryptic 
peptides of the same region. 
3.3 Enzymic Digestion of the Rye Trypsin Inhibitor by Trypsin 
Approx. 12 mg reduced and carboxymethylated trypsin inhibitor was 
digested by trypsin. The peptides were initially size fractionated by 
gel filtration on a Biogel P-6 column {Fig. 13). The six pooled size 
fractions were further purified by RP-HPLC {profiles of pools T1-T6 
not shown). Two HPLC programmes were used; Prog. 9 {T1-5) and Prog. 4 
(T6) where the acetonitrile concentration increased by 1% in 4 and 3 
min. respectively. The major peaks were sequenced using the 
DABITC/PITC method. The peptide sequences are shown in Table 5 in the 
order that they occur in the protein sequence diagram, where they are 
shown as T. Each peptide is also given the peak number from the 
Biogel P-6 column followed by its elution number from the RP-HPLC 
column in brackets {eg. T6-3). The identity of Leu/Ile residues for 
tryptic and chymotryptic peptides were determined using semi-
quantitative amino acid analysis by the dansyl chloride method and 
checked using a Waters PICO-TAG system. The presence of a tryptophan 
residue in T3 was confirmed by staining the peptide on paper with p-
dimethylaminobenzaldehyde. 
A number of anomalous cleavages were observed during sequencing. 
Cleavages after leucine and tyrosine were probably the result of 
residual chymotryptic activity, whilst cleavages after glutamine and 
histidine are examples of atypical enzyme hydrolysis as reported 
previously by Croft (1980). 
3.4 Enzymic Digestion of the Rye Trypsin Inhibitor by Chymotrypsin 
Approx. 15 mg reduced and carboxymethylated trypsin inhibitor was 
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Figure 13: 
Gel filtration of the rye trypsin inhibitor after enzymic 
digestion with trypsin on a Biogel P6 (1 x 200cm) column in 0.1M 
NH4HC03 (flow rate 4ml/h, fraction size lml). rl indicates 
fractions pooled. 
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Table 5: 
Peptides obtained by enzymic digestion of the rye trypsin 
inhibitor with trypsin 
Peptide Elution time Sequence 
T1 (T2-12) 94.4 Serl-Val-Gly-Gly-Gln-Cys-Val-Pro-
T1a (T2-14) 100.4 
T2 ( T3-23) 88.2 
T2a (T3-21) 79.9 
T3 (T4-15 83.3 
T4-18 91.5 
T3-28) 109.3 
T3a (T5-3 86.7 
T5-4) 89.1 
T4a (T1-15) 99.1 
T4 (T1-17 100.1 
T1-19) 101.6 
T4b (T4-8) 56.4 
T5 (T3-9) 44.3 
T6 (T4-22 107, 
T2-20) 107.2 
6b (T3-29) 121.7 
T7 (T3-13) 50.1 
-Gly-Leu-Ala-Met-Pro-His-Asnl5_ 
Serl-Val-Gly-Gly-Gln-Cys-Val-Pro-
-Gly-Leu-Ala-Metl2_ 
Thr22-Tyr-Val-Val-Ser-Gln-Ile-Cys-
-His-Val-Gly-Pro-Arg34 
Thr22-Tyr-Val-Asn-Ser-Gln-lle-
Leu35-Phe-Thr-Trp-Asp-Met-Lys41 
Phe36-Thr-Trp-Asp-Met-Lys41 
Arg43-Cys-Cys-Asp-Glu-Leu48_ 
Cys44-Cys-Asp-Glu-Leu-Leu-Ala-Ile-
-Pro-Ala-Tyr-Cys-Arg56 
Ala50-Jle-Pro-Ala-Tyr-Cys-Arg56 
Cys57-Glu-Ala-Leu-Arg61 
Ile62-Leu-Met-Asp-Gly-Val-Val-Thr-
-Gln-Gln-Gly-Val-Phe-Glu-Gly-Gly-
-Tyr78 -
Ile62-Leu-Met-Asp-Gly-Val-Val-
-Thr6L 
Aspbl-Met-Pro-Val-Cys-Pro-Arg87 
-Tyr-
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Table 5 cont: 
Peptide Elution time Sequence 
T8 (T6-5 6.6 
T6-6 7.8 
T6-7) 8.5 
T9 (T1-12 96.4 Ser92-Tyr-Ala-Ala-Thr-Leu-Val-Ala-
T1-22 104.2 
T1-23 105.6 -Pro-Glnl 01 
Tl-26) 109.3 
T9a (Tl-19) 101.6 Ala94-Ala-Thr-Leu-Val-Ala99-
T9b (T1-10 94.8, Val9&-Ala-Pro-Gln-Glu-Cys-Asn-
T1-13) 97.4 
-LeulOS_ 
T10 (T1-9 94.1 Glul02-Cys-Asn-Leu-Pro-Thr-Ile-His-
T1-12) 96.4 
-Gly-Ser-Pro112 -
TlOa (T2-4 76.4 GlyllO-Ser-Pro-Tyr-Cys-Pro-Thr-Leu-
T1-7) 77.5 
-Gln-Ala-Gly-Tyrl21 
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digested with chymotrypsin. The resultant peptides were separated 
according to size using a Biogel P-6 column (Fig. 14)~ Each pooled 
size fraction (C1-15) was further purified by RP-HPLC (profiles not 
shown) using the programmes; Prog 9 (C1-9) and Prog. 4 (C10-15). The 
major peaks were sequenced using the DABITC/PITC method. The peptide 
sequences are shown in Table 6 in the order that they occur in the 
protein sequence diagram (Fig. 15), where they are shown as C. In 
brackets each peptide is also given the peak number from the Biogel P-
6 column followed by its elution number from the RP-HPLC column (eg. 
C11-6). 
Anomalous cleavages occurred after glutamine, cysteine, histidine 
and threonine. These anomalous cleavages have been reported by Croft 
(1980). The cleavage after His30 established an overlap in the 
sequence. 
3.5 Amino acid analysis of the Rye Trypsin Inhibitor 
The results of .the amino acid analysis of the rye trypsin 
inhibitor are shown in Table 7; where they are compared with the 
values obtained by Boisen and Djurtoft (1981). The amino acid 
composition is very similar to that reported for the rye endosperm 
inhibitor by Boisen and Djurtoft (1981), except that the protein from 
the cultivar 'Gazelle' contains ten cysteines instead of the eight 
reported for the Danish variety. The rye trypsin inhibitor is similar 
to other protease inhibitors in having a high content of cysteine and 
this has resulted in the proposal that these proteins act as a sulphur 
store in the seeds (Hartl et al., 1986). Proline, glycine, cysteine 
and leucine are the predominant amino acids present in the rye trypsin 
inhibitor. 
• 
3.6 Sequence Analysis of the Rye Trypsin Inhibitor 
The complete amino acid sequence of the rye trypsin inhibitor is 
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Figure 14: 
Gel filtration of the rye trypsin inhibitor after enzymic 
digestion with chymotrypsin on a Biogel P6 (1 x 200cm) column in 
0.1M NH4HC03 (flow rate 4ml/h, fraction size lml). rl indicates 
fractions pooled. 
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Table 6: 
Peptides obtained by the enzymic digestion of the rye trypsin 
inhibitor with chymotrypsin 
Peptide Elution time Sequence 
C1 (C3-26) 99.4 Serl-Val-Gly-Gly-Gln-Cys-Val-Pro-
-Gly-Leu-Ala-Met-Pro-His-Asn-Pro-
-Leu17 -
C1a (C5-22) 70.3 Serl-Val-Gly-Gly-Gln-Cys-Val-Pro-
-Gly-Leu1o_ 
C1b (C6-21 68.6 Alall-Met-Pro-His-Asn-Pro-Leu17 
C7-12) 69.6 
C2 (C6-6 37.6 GlylB-Ala-Cys-Arg-Thr-Tyr23 
C7-6) 36.4 
C3 (C5-20) 66.9 Val24-Val-Ser-Gln-Ile-Cys-His-Val-
-Gly-Pro-Arg34 -
C3a (C4-10) 48.4 Val24-Val-Ser-Gln-Ile-Cys-His30_ 
C3b (C4-4) 24.4 Ile2LCys-His30 
C3c (Cll-12) 24.2 His30-Val-Gly-Pro-Arg34_ 
C3d (Cll-11) 20.7 Val31-Gly-Pro-Arg3 4 -
C3e ( Cll-17) 52.7 Val31-Gly-Pro-Arg-Leu-Phe36 
( 
C4 (C9-14) 36.7 Thr3 7-Trp-Asp39_ 
C4a (C7-l) 2.6 Asp39-Met-Lys-Arg-Arg43-
C5 (C3-17) 75.0 Arg42-Arg-Cys-Cys-Asp-Glu-Leu-Leu49 
C6 (C8-10 55.0 Ala50-Ile-Pro-Ala-Tyr54 
C7-10) 56.4 
C7 (C3-1 2.7 Cys55-Arg-Cys-Glu-Ala-Leu60 
C3-5) 54.8 
C8 (C3-22) 83.1 Met64-Asp-Gly-Val-Val-Thr-Gln-Gln-
-Gly-Val7 3 -
C8a (C8-5) 6.5 Gly7 2-Val-Phe14 
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Table 6 cont: 
Peptide Elution time 
C9 (C5-4 22.6 
C5-5) 26.4 
C10 (C5-18 59.6 
C5-22) 70.3 
C10a (C6-8 45.8 
C5-10) 47.8 
Cll (Cll-7) 10.6 
Clla (C12/ 21.3 
13-10) 
C12 (C2-6 75.2 
C2-10 83.3 
C3-23) 85.1 
C12a (C3-9 63.0 
C2-4) 64.2 
C12b (C7-8 45.6 
C6-9) 46.5 
C12c (C6-23) 80.0 
C12d (C8-7) 26.9 
C13 (C4-17 61.8 
C4-18) 65.2 
Sequence 
Glu75-Gly-Gly-Tyr78 
Leu79-Lys-Asp-Met-Pro-Asn-Cys-Pro-
-Arg87 
Lys80-Asp-Met-Pro-Asn-Cys-Pro-Arg87 
Val88 -Thr-Gln-Arg91 
Gln9°-Arg-Ser-Tyr93 
Val9B-Ala-Pro-Gln-Glu-Cys-Asn-Leu-
-Pro-Thr-Ile-His-Gly-Ser-Proll2_ 
Val9B-Ala-Pro-Gln-Glu-Cys-Asn-Leu-
-Pro-Thr107 -
Ile10 B-His-Gly-Ser-Pro-Tyr11 3 
Asnl04-Leu-Pro-Thr-Ile-His-Gly-Ser-
-Pro-Tyr113 
Gly11 o~ser-Pro-Tyrl 13 
Cysll4-Pro-Thr-Leu-Gln-Ala-Gly-Tyr121 
150 
Table 7: 
Amino-Acid Composition of the Rye Trypsin Inhibitor 
Residues per mol 
(mol%) 
from from from from 
sequence analysisa Boisen and analysis 
Djurtoft 
(1981)b 
Asp 4 
} 7 7 6.2 
Asn 3 
Thr 7 7 7 5.7 
Ser 4 4 4 3.6 
Glu 4 
12 11 10.1 
Gln 7 
Pro 11 13 11 10.4 
Gly 10 12 10 9.8 
Ala 9 8 8 6.4 
Val 10 7 9 5.9 
Cys 10 12 8 10.3 
Met 4 3 4 2.4 
Ile 4 4 4 3.0 
Leu 11 10 10 8.4 
Tyr 6 7 5 6.1 
Phe 2 2 2 1.6 
Lys 2 2 2 2.0 
His 3 3 3 2.1 
Arg 8 7 7 5.9 
Trp 1 n.d. c 2 n.d. 
Total 121 120 114 
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Table 7 cont: 
Analyses are the means of duplicate 21 h hydrolyses and 
determinations. 
a Nearest integers calculated for 121 residues/mol, 
b Nearest integers calculated for 114 residues/mol, 
c n.d. not determined. 
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shown in Fig. 15 together with details of the overlapping fragments 
and peptides from which it was deduced. The protein contains 121 
amino acids, corresponding to a Mr of 13753 which is in good agreement 
with the molecular weight estimates made by SDS-polyacrylamide gel 
electrophoresis (13000) and the values reported by previous workers 
(Hochstrasser and Werle, 1969, Mikola and Kirsi, 1972). The only part 
of the sequence not firmly established by overlapping peptides is the 
region Arg6 1-Ile6 2 , but the sequence presented in Fig. 15 is strongly 
supported by homology of the rye protein with other cereal enzyme 
inhibitors (Fig. 29). The sequence is also consistent with the 
results of amino acid analysis (Table 7). 
Minor examples (less than 10%) of microheterogeneity were detec-
ted only in three positions (underlined in peptide tables, see Tables 
4, 5); Val25 (replaced by Asn), Asn8 4 (replaced by Val, Tyr or His) 
and Ser92 (replaced by Pro). This microheterogeneity may account for 
some of the heterogeneity revealed by isoelectric focusing (Fig. 11). 
3.7 Purification and Characterisation of an a-Amylase Inhibitor from 
Rye 
A flow chart (Fig. 16) compares the purification procedure used 
with the method of Granum (1978). The inhibitor was extracted with 
70% ethanol, the gluten proteins being removed from the crude extract 
by dialysis against buffer (pH 6.9). The inhibitor purified by Granum 
was active against both human salivary and hog pancreatic a-amylases 
but the two inhibitors purified by Marshall (1977) were each active 
against only one of these enzymes. Hog pancreatic a-amylase was used 
to assay for amylase inhibitory activity throughout this study, which 
would result in selective purification of only one of the two inhibi-
tors purified by Marshall (1977). 
After ammonium sulphate fractionation (20-50%) the inhibitor was 
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Figure 15: 
Amino-acid sequence of the major trypsin inhibitor from seeds of 
rye ISecale cereale cv. Gazelle). CN, fragments obtained from 
cleavage with cyanogen bromide; T, tryptic peptides; C, 
chymotryptic peptides. ----, regions of the peptides sequenced 
by the DABITC/PITC double coupling method. Blank areas indicate 
residues which were not sequenced or yielded unsatisfactory 
results. 7 , indicates residues determined by direct DABITC 
sequencing of the intact protein. 
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1 10 20 
S-V-G-G-Q-C-V-P-G-L-A-M-P-H-N-P-L-G-A-C-R-T-Y-V-V-8-Q-
7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 
<--------------T1-------------- <-----------
<----------------C1------------ ><----C2----><-------
<------C1a------- ><----Clb--- > <----C3a 
<----------CN1-------- ><-------------CN2--------
30 40 50 
1-C-H-V-G-P-R-L-F-T-W-D-M-K-R-R-C-C-D-E-L-L-A-I-P-A-Y-
--T2---------><------T3------> <----------T4---------
<-----T3a----><------T4a-- ><----T4b--
----C3------- > <-C4- > <----C5--~- ><---C6---> 
<-C4a--> 
<-C3b><---C3c-- > 
<--------------CN3----------
60 70 80 
C-R-C-E-A-L-R-1-L-M-D-G-V-V-T-Q-Q-G-V-F-E-G-G-Y-L-K-D-
---><---T5---><---------------T6----------------- ><-
---> 
<---C7--- > <-------C8------- ><--C9--><-----
<C8a-> <---
<-----------CN4------
90 100 
M-P-N-C-P-R-V-T-Q-R-S-Y-A-A-T-L-V-A-P-Q-E-C-N-L-P-T-1-
---T7------><--T8--><--------T9--------><---------T10-
<--T9a-><----T9b-------
-C10-------><--C11- > <-----------C12-------
--C10a----- <-C11a > <-------Cl2a-------><-
<------------CN5-------------
110 120 
H-G-8-P-Y-C-P-T-L-Q-A-G-Y 
---------> 
<--------TlOa---------> 
---------><------Cl3----> 
--Cl2b---> 
---------> 
<-C12d-> 
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<---Cl2c---
Figure 16: 
A flow chart showing the purification of an a-amylase inhibitor 
from rye 
Technique Granum (1978) 1st purification Subseguentpurification 
Extraction 70% ethanol 
2h at 20°C 
70% ethanol 
2h at 20°C 
Acidified 70% 
2h at 20°C 
ethanol 
Ammonium 
Sulphate 
Fraction:-
ation 
Cation 
Exchange 
Chromato-
graphy 
I I I 
All centrifuged and pellet discarded 
I I 
Supernatant dialysed 16h against 
0.02 M NaP04 0.02 M NaP04 
pH 6.9 pH 6.9 
0.02 M Tris-HCl 
pH 6.9 
I I I All centrifuged and pellet discarded 
I I 
20-50% 20-50% 
I I 
All centrifuged and supernatant 
Pellet dissolved in 2!0 ml: 
0.005 M NaP04 0.005 M NaP04 
pH 6.9 pH 6.9 
I I 
DEAE-cellulose DEAE-Sepharose 
0.005 M NaP04 0.005 M NaP04 
pH 6.9 pH 6.9 
G=o.oo5~o.o2~o.2 G=o.oo5~o.o2~o.z 
I 
CM-cellulose 
0.05 M acetate 
buffer 
G=0.1-0.5 M 
acetate buffer 
I Repeat as above 
(Pool A)(Fig. 17) 
I 
DEAE-Sepharose 
0.05M Tris/HCl 
pH 8.6 
G=0-0.5 M NaCl 
(Pool B)(Fig. 18) 
I 
DEAE-cellulose 
0.0025 M Tris/HCl 
pH 8.6 
G=0-0.5 M NaCl 
(Pool C)(Fig.19) 
I 
CM-Biogel 
0.05 M acetate 
buffer pH 5.0 
G=0.05-0.5 M 
acetate buffer 
(Pool D)(Fig. 20) 
I 
I 
20-50% 
I 
discarded 
0.025 M Tris/HCl 
pH 8.6 
I 
I 
DEAE-cellulose 
0.0025 M Tris/HCl 
pH 8.6 
G=0-0.5 M NaCl 
(Pool E)(Fig. 22) 
I 
CM-Biogel 
0.05 M acetate 
buffer pH 5.0 
G=0.05-0.5 M 
acetate buffer 
(Pool F)(Fig. 23) 
I 
Reverse-phase high 
performance liquid 
chromatography 
RP-HPLC 
Pool D used 
for sequencing 
(Fig. 21) 
RP-HPLC 
Peak 2 used 
for SDS-PAGE, 
IEF, antibodies. 
(Fig. 24) 
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applied to DEAE-Sepharose at pH 6.9 (Fig. 17). The inhibitory 
fractions were found to have passed directly through the column 
without binding (Pool A). An assay was carried out to determine the 
optimum pH for binding of the inhibitor to a sample of DEAE-Cellulose 
(DE-52), which was found to be 8.6. As DEAE-Sepharose had been 
effectively used for the separation of trypsin inhibitors from 
buckwheat (Ikeda and Kusano, 1983), Pool A was applied to DEAE-
Sepharose at pH 8.6. The inhibitory fractions again passed through 
the column, remaining unbound (Pool B)(Fig. 18). Pool B was then 
applied to a column of DEAE-Cellulose at pH 8.6, the inhibitor bound 
and was eluted by a salt gradient at 0.14 M NaCl (Pool C)(Fig. 19). 
The inhibitor was then applied to a CM-Biogel column at pH 5.0 and 
eluted with a buffer gradient at 0.14 M acetate buffer (Pool D)(Fig. 
20). 
The homogeneity of the inhibitor (Pool D) was assessed by RP-HPLC 
which gave two inhibitory peaks (Fig. 21). Each peak from RP-HPLC was 
sequenced using the DABITC/PITC method and both had the same N-
terminal sequence: 
Thr-Gly-Pro-Tyr-Cys-Tyr-Ala-Gly-Met-Gly-
As the two peaks from RP-HPLC gave the same N-terminal sequence 
and the yield was low (3.5 mg), all of Pool D was used directly for 
sequence analysis. Further purifications were performed in order to 
characterise the inhibitor proteins by SDS-PAGE and IEF, and to raise 
antibodies. A modified procedure was used in the subsequent purifica-
tions. Acidified ethanol was used as the extraction media. The 20-
50% ammonium sulphate fraction was applied directly to a column of 
DEAE-Cellulose pH 8.6, and the inhibitor was eluted with a salt 
gradient at 0.14 M NaCl (Pool E)(Fig. 22). PoolE was then applied to 
a column of CM-Biogel pH 5.0, and eluted with a buffer gradient at 
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Figure 17: 
Cation exchange chromatography of the rye a-amylase inhibitor on 
DEAE-Sepharose (2.5 x 25cm) in 0.005M sodium phoshate buffer pH 
6.9, eluted with a step-gradient 0.005 ~ 0.02 ~ 0.2M buffer (Pool 
A) (flow rate 60ml/h, fraction size 8ml). 
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Figure 18: 
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Cation exchange chromatography of the rye a-amylase inhibitor on 
DEAE-Sepharose (2.5 x 25cm) in 0.05M Tris/HCl pH 8.6, eluted with 
a linear gradient of 0 - 0.5M NaCl (Pool B)(flow rate 60ml/h, 
fraction size 8ml). 
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Figure 19: 
Cation exchange chromatography of the rye a-amylase inhibitor on 
DEAE-cellulose (DE-52) (2.5 x 34cm) in 0.0025M Tris/HCl, eluted 
with a linear gradient of 0 - 0.5M NaCl (Pool C) (flow rate 
54ml/h, fraction size 7ml) . 
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Figure 20: 
Cation exchange chromatography of the rye a-amylase inhibitor on 
CM-Biogel (1.5 x 25cm) in 0.05M sodium acetate buffer pH 5.0, 
eluted with a linear buffer gradient 0.05 - 0.5M (Pool D) (flow 
rate 30ml/h, fraction size 4.5ml). 
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Figure 22: 
Cation exchange chromatography of the rye a-amylase inhibitor 
(further purifications) on DEAE-cellulose (2.5 x 34cm) in 0.025M 
Tris/HCl pH 8.6, eluted with a linear gradient of 0 - 0.5M NaCl 
(Pool E) (flow rate 38ml/h, fraction size 5ml). 
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0.075 M acetate buffer (Pool F)(Fig. 23). Pool F was applied to RP-
HPLC and inhibitory peak 2 collected (Fig. 24). 
Comparison of RP-HPLC profiles for Pools D and F indicate that 
Pool F was not as pure as Pool D. Thus the inhibitory peak 2 may have 
contained more impurities/isoforms than Pool D. SDS-PAGE of inhibitor 
peak 2 from Pool F under reducing conditions showed one major band of 
Mr about 14000 and two minor components with slightly lower Mr values. 
The Mr value is in good agreement with that obtained by Granum (1978) 
who also determined the isoelectric point as 5.8. Inhibitor peak 2 on 
IEF gave a number of bands in the pi range 6.0 - 9.0 with a major band 
at pi 8.6 which is considerably higher than that reported by Granum 
(1978). The pi of inhibitor peak 2 suggests that the main inhibitor 
isolated is different from that isolated by Granum (1978). 
3.8 Sequence analysis of the Rye a-Amylase Inhibitor 
Reverse-phase HPLC of the inhibitor fraction Pool D gave two 
major components (Fig. 21). N-terminal analysis showed that both 
components had identical and unambiguous sequences for the first ten 
residues. Pool D was used directly for all subsequent sequence 
analyses, however the amino acid composition of the inhibitor was 
carried out using a protein sample derived from a subsequent purifica-
tion, Pool F inhibitory peak 2 (Fig .. 24). Pool D was digested with 
trypsin and the mixture of peptides was separated by reverse-phase 
HPLC (Fig. 25). The tryptic peptides were then sequenced by the 
DABITC/PITC double coupling method (Table 8). The amino acid composi-
tion of the a-amylase inhibitor is shown in Table 9. The composition 
is similar to that of the trypsin inhibitor, the main difference being 
the higher content of proline. It is also in reasonable agreement 
with those previously reported for a-amylase inhibitors of rye 
(Granum, 1978) and wheat (Kashlan and Richardson, 1981, Maeda et al., 
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Figure 23: 
Cation exchange chromatography of the rye a-amylase inhibitor 
(further purifications) on CM-Biogel (1 x 25cm) in 0.05M sodium 
acetate pH 5.0, eluted with a linear buffer gradient of 0 - 0.5M 
(Pool F) (flow rate 30ml/h, fraction size 4.5ml). 
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Figure 24: 
RP-HPLC separation of the rye a-amylase inhibitor (Pool F) after 
cation exchange chromatography on CM-Biogel, eluted with a 
gradient of acetonitrile in 0.1% trifluoroacetic acid at a flow 
rate of l.Oml/min. Peak 2 was used for SDS-PAGE, IEF and 
antibody production. 
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Figure 25: 
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RP-HPLC separation of peptides obtained by the enzymic digestion 
of the rye a-amylase inhibitor (Pool D) with trypsin, eluted with 
a gradient of acetonitrile in 0.1% trifluoroacetic acid at a flow 
rate of 1.0ml/min. 
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Table 8: 
Peptides obtained by the enzymic digestion of the rye a-amylase 
inhibitor (Pool D) with trypsin (peptides shown in order of 
elution from RP-HPLC) 
PeQtide Elution time Seguence 
aT6 6.7 Ala-Gly-Cys-Arg 
aT15 33.6 (a) Cys-Glu-Ala-Val-Arg 
(b) Ala-Phe-Ala-Lys 
aT16 36.6 Thr-Gly-Pro-Pro-Gly-Asn-Thr-Pro-Arg 
aT18 39.1 Asn-Pro-Ser-Glu-Val-Arg 
aT23 44.5 (a) Cys-Glu-Ala-Leu-Arg 
Pro 
(b) Leu-Asn-Gly-Cys-Arg 
aT27 54.5 Ser-Arg-Pro-Glu-Ser-Gly-Val-(Leu-Lys) 
aT29 57.8 Asp-Leu-Pro-Gly-Cys-Pro-
aT30 59.0 Asp-Leu-Pro-Cys-Cys-Pro-Asn-
-Pro-Thr-
aT34, 62.8, Glu-Leu/Ile-Tyr-Asp-Ala-Ala-Gln-
35 64.3 
-His-Cys-Arg-Pro-
aT39 68.0 Tyr-Phe-Met-Gly-Pro-Ser-Asn-Pro-
aT44 77.8 Thr-Ala-Thr-Pro-Gly-Thr-Pro-Tyr-
-Asn-Gly-Pro-Gln-Arg 
aT45 80.6 (a) Glu-Tyr-Val-Ala-Gln-Gln-Thr-Cys-
-Gly-Val-Gly-Leu-Ala-Gly-
(b) Cys-Tyr-Ala-Gly-Met-Gly-Leu-Pro-
-Thr-Lys-Pro-Leu-Gly-Gly-
aT46 81.0 (a) Glu-Tyr-Val-Ala-Gln~Gln-Thr-Cys-
-Gly-Val-Gly-Leu-Ala-Gly-
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Table 8 cant: 
Peptide Elution time Sequence 
aT46 81.0 {b) Ser-Leu-Val-Thr-Val-Gly-His-Cys-
Val 
-Asn-Val-Met-Thr-
aT47 82.5 (a) Glu-Tyr-Val-Ala-Gln-Gln-Thr-Cys-
-Gly-Val-Gly-Leu-Ala-Gly-
(b) Ser-Tyr-Ala-Ala-Leu/Ile-Val-Thr-
-Pro-Gly-
aT48 83.8 Leu-Leu-Val-Thr-Pro-Gly-His-Cys-
-Asn-Val-Met-Thr-Val-
aT49 85.3 (a) Phe-Leu-Gly-Thr-Pro-Gly-Tyr-
(b) Glu-Tyr-Val-Ala-Gln-Gln-Thr-Cys-
Val 
-Gly-Val-Gly-Leu-Ala-Gly-
aT 50 86.2 Glu-Tyr-Val-Ala-Gln-Gln-Thr-Cys-
-Gly-Val-
aT 53 90.0 Cys-Tyr-Ala-Gly-Met-Gly-Leu-Pro-
-Thr-Lys-Pro-Leu-Gly-Gly-Cys-Arg 
aT 54 90.7 (a) Cys-Tyr-Ala-Gly-Met-Gly-Leu-Pro-
-Thr-Lys-Pro-
(b) Val-Leu-Val-Thr-Pro-Gly-His-Cys-
-Asn-Val-Met-Thr-Val-His-Asn-Ala-
aT 56 94.1 (a) Leu-Leu-Val-Thr-Pro-Gly-His-Cys-
Val 
-Asn-Val-Met-Thr-Val-His-Asn-Ala-
(b) Glu-Tyr-Val-Ala-Gln-Gln-Thr-Cys-
-Gly-Val-
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Table 8 cont: 
Peptide 
aT 57 
aT 58 
aT 59 
aT61 
aT65 
aT66 
aT68 
Elution time Sequence 
96.0 Tyr-Phe-Leu-Gly-Gln-Glu-Asn-Val-
97.8 
99.8 
102.2 
107.6 
109.8 
111.8 
Arg 
-Gly-Ala-Val-Met-Arg 
N-terminal 
Thr-Gly-Pro-Tyr-Cys-Tyr-Ala-Gly-
-Met-Leu-Pro-Thr-Lys 
Cys-Leu/lle-Gly-Thr- -Gly-Tyr-
-Cys-Gln-Leu/Ile-Thr-Thr-Leu/Ile-
-His-Asn-
Leu/Ile-Tyr-Cys-Cys-Gln-Glu-
-Leu/lle-Ala-Glu-Leu/Ile-Ser-Gln-
Tyr-Phe-Leu/Ile-Gly-Gln-Pro-Tyr-
-Cys-Pro-
Asn-Ala-Pro-Tyr-Cys-Pro-Gly-Pro-
Asp-Val-Ala-Thr-Leu/Ile-Pro-Gly-
Leu/Ile 
-Val-Gly-
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Table 9: 
Amino-Acid Composition of the Rye a-Amylase Inhibitor 
a-Amylase a-Amylase ·o.19b CMac Trypsin 
inhibitor inhibitora inhibitor 
mol X from mol X from mol X from mol X from mol X from 
analysis analysis sequence analysis analysis 
; 
Asp 5.6 
6.6 6.6 7.9 6.2 
Asn 0.8 
Thr 5.0 4.2 2.4 4.8 5.7 
Ser 3.3 5.9 5.6 8.4 3.6 
Glu 4.0 
10.0 12.3 13.3 10.1 
Gln 6.4 
Pro 13.3 7.7 7.3 10.4 10.4 
Gly 10.5 8.6 8.1 10.5 9.8 
Ala 6.1 9.6 3.7 5.8 6.4 
Val 6.5 8.7 8.1 7.4 5.9 
Cys 9.5 7.7 8.1 6.6 10.3 
Met 1.0 2.5 2.4 0.7 2.4 
Ile 2.3 2.4 2.4 2.2 3.0 
Leu 6.4 7.0 8.1 7.1 8.4 
Tyr 6.5 4.3 4.0 3.0 6.1 
Phe 1.4 1.8 1.6 1.8 1.6 
Lys 2.0 3.5 2.4 3.1 2.0 
His 3.7 1.0 1.6 2.0 2.1 
Arg 5.9 6.2 6.5 5.2 5.9 
a Boisen and Djurtoft, (1981) 
b Maeda et al., (1985) 
c Salcedo et al., (1982) 
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1983,1985). Extension of the N-terminal amino acid sequence to 34 
residues (Fig. 26) was achieved by sequence analysis of tryptic 
peptides (Table 8). Although the sequence Arg~O-Glu21 was not 
established by overlapping peptides, this is supported by close 
homology with the CM proteins CMa of barley and CM1 and CM2 of wheat 
(see Fig. 29). 
Further sequencing of the rye a-amylase inhibitor was not 
possible, because analysis of tryptic peptides revealed considerable 
sequence heterogeneity. Because of the low yields given by the 
purification procedure (1-3mg/230g seed meal) it was not realistic to 
attempt to purify a single molecular species for complete analysis. 
3.9 Antigenic Relationships of the rye inhibitors 
Polyclonal antibodies were raised against the purified trypsin 
and a-amylase inhibitors of rye and also the 0.28 a-amylase inhibitor 
of wheat (kindly supplied by Dr. M. Richardson). The antiserum to the 
0.28 inhibitor reacted strongly with the 0.19 and 0.28 a-amylase 
inhibitors of wheat (kindly supplied by Dr. M. Richardson), less 
strongly with the a-amylase inhibitor of rye, but not with the rye 
trypsin inhibitor (Fig. 27). The two antisera raised against the rye 
inhibitors reacted only with the proteins used for immunization. This 
indicates that there was limited antigenic relationship between the 
rye trypsin and a-amylase inhibitors and this was confirmed by the 
available sequence data. Boisen (1983b) reported partial immunochemi-
cal identity between purified trypsin inhibitors from barley and rye, 
with no immunochemical cross-reaction between wheat trypsin inhibitors 
and those of barley or rye. The protein sequences of the barley and 
rye trypsin inhibitors show very good homology (Fig. 29), so immuno-
chemical identity is more probable than between the wheat a-amylases 
inhibitors and the rye trypsin inhibitor. 
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Figure 26: 
N-terminal amino-acid sequence of an a-amylase inhibitor 
from seeds of rye (S. cereale cv. Gazelle). aT, tryptic 
peptides. -----, regions of peptides sequenced by the 4-N,N-
dimethylaminoazobenzene-4'~isothiocyanate (DAB1TC) method. 
7 , indicates residues determined by direct DAB1TC 
sequencing of the intact protein. 
1 5 10 15 20 
T-G-P-Y-C-Y-A-G-M-G-L-P-T-K-P-L-G-G-C-R-
7 7 7 7 7 7 7 7 7 7 
<----------aT58------------> 
<--------aT54--------
<-------------aT45,aT53--------> 
25 30 
E-Y-V-A-Q-Q-T-C-G-V-G-L-A-G-
<----aT50,aT56-----
<----aT45,aT46,aT47,aT49----
Other recognisable peptides: 
T15 C-E-A-V-R 
T23 C-E-A-L-R 
Cys57 - Arg61 in Rye trypsin 
inhibitor 
T61 L/1-Y-C-C-Q-E-L/1-A-E-L/I-S-Q 
Arg42 - Ala53 in Rye trypsin 
inhibitor 
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Figure 27 : 
Immunodiffusion studies of the rye trypsin and a- amylase 
inhibitors in 2.0% (w/v) agarose in phosphate- buffered saline . 
A) antisera raised against the wheat 0.28 a- amylase inhibitor . 
B) antisera raised against the rye a- amylase inhibitor. 
C) antisera raised against the rye trypsin inhibitor. 
1) wheat 0.28 a- amylase inhibitor. 
2) rye a- amylase inhibitor. 
3) rye trypsin inhibitor. 
4) wheat 0.19 a-amylase inhibitor. 
5) wheat 0.31 a- amylase inhibitor. 
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3.10 Secondary structures of the Rye Inhibitors 
The circular dichroism (CD) spectra of the rye inhibitors were 
determined in 10 mM piperazine buffer at pH 5.0 (Fig. 28). The far-
ultraviolet CD spectrum (below 250 nm) arises principally from the 
absorbance of the peptide bond, and is indicative of the backbone 
structure. The spectrum in the near-ultraviolet (250-300 nm) arises 
from aromatic and disulphide chromophores. 
The far-ultraviolet CD spectra are similar (Fig. 28a), with 
minima at about 208-209 nm, a shoulder at 220 nm and a cross-over to a 
positive absorbance above 200 nm. They are typical spectra for 
proteins rich in a-helix (Manavalan and Johnson, 1983), and similar to 
those reported for the homologous trypsin inhibitor of maize (Mahoney 
et al., 1984) and a-amylase inhibitors (0.19, 0.28 and 0.39) of wheat 
(Silano et al., 1973, Petrucci et al., 1976,1978). Calculation of the 
secondary structure·content (Chen et al., 1972) gave values of 36-37% 
a-helix, 18-20% a-sheet and 45-47% aperiodic structures (random coil 
and 13-turn) for the trypsin inhibitor; and 39-40% a-helix, 11-13% a-
sheet and 50-52% aperiodic structure for the a-amylase inhibitor. 
Prediction of the secondary structure of the rye trypsin inhibitor 
from the amino acid sequence using the Chou and Fasman method (Chou 
and Fasman, 1978a, Levitt, 1976) gave values of 39% a-helix, 25% 13-
sheet, 22% a-turn and 16% random coil; the Robson computer prediction 
(Garnier et al., 1978) gave values of 69% 13-sheet, no a-helix and 31% 
aperiodic structure (Fig. 29). The Chou and Fasman method resulted 
in values in close agreement to the values obtained by circular 
dichroism. 
The near-ultraviolet spectra of the two inhibitors showed clear 
differences (Fig. 28b). That of the trypsin inhibitor showed a broad 
absorbance (260-300 nm) due to disulphide chromophores and aromatic 
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Figure 28: 
Far-ultraviolet (a) and near-ultraviolet (b) circular dichroism 
spectra of the trypsin inhibitor (-----) and a-amylase inhibitor 
(-----) of rye dissolved in lOmM piperazine-He! buffer pH 5.0. 
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Figure 29: 
Chou and 
Fasman 
Robson 
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Robson 
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Kobson 
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KEY: 
Secondary structure content of the rye trypsin inhibitor using 
predictive methods. 
10 
S-U-G-6-Q-C-U-P-G-L-A-M-P-H-H-P-L-G-A-C-R-T-Y-U-U-
-~- 1-n 11111ln 
I U Ls---· U U -· U U ~ -- \/\_/\/\_A./\.1 
,-~I' 
. I I 
._____j . 
~-, 1-1 
1\ ./\ l\ .1\ 1\ /\ .1\ .J\ ;\ _/\ I - . I \ 1\ 1\ 1\ ;\ 1\ ;\ I 
v ·~ v './ \1 , v -~ .,. .______, ·..,.· v" "' ...,· --~· ·.,· '..,/ 
30 40 
S-Q-1-C-H-U-G-P-R-L-F-T-W-D-M-K-R-R-C-C-D-E-L-L-A-
n n 
\/\./\/\/\/\/ I I I 
VVVVV"·../ L__j 
n nnLilnn \ ./\. /\ 1\ _/\_ .1\ / I 1\ A. /\ / I I U I I \ _/\ 1\. .A ./\. / 
.,; v· v v v v L_____jv v v L-..-J L__J v v v v v 
60 70 
1-P-A-Y-C-R-C-E-A-L-R-1-L-M-D-G-U-U-T-Q-Q-G-U-F-E-
fl 1'1 n n ~-/\..A .A .. A .~'l I 
~ ~ ~ ~uuuuuuvvvvvuuuu ~ 
\ .A Fl. .A. .A. 1\ .A /\ .A .A. .A /\. ,A. .A .A 1\ 1\ /\ 1\ 1\ 1\ /\ .A 1\ / 
v v v v v v v v v v v v v v v v v v v v v v v v 
80 90 100 
G-G-Y-L-K-D-M-P-H-C-P-R-U-T-0-R-S-Y-A-A-T-L-U-A-P-
!I !I !I !I !I II 
I I l...../"_~/ I I u I I \. /\ /'- /\ /'--~-~../".~.~-~-~ -
~ uou ~ ~ vvvvuoouuuu 
!I !I !I !I 
I I I I I I ~. ) I ~- /\ /\ /\ /\ /\ /\ /\ /\ ·" /\ /\ /\ /\ 1\ /\_ / ~ ~ Uv ~vvvvvvvvvvvv·vvvv 
110 120 
Q-E-C-H-L-P-T-1-H-G-S-P-Y-C-P-T-L-Q-A-G-Y 
..... _______ /'-____ ..... _Jl n n n 'LJlun n n 
0000 ~ ~ ~ ~ ~ ~ 
il n /\ ,A Jl n r - n ' A. A. A ·" _A " ,-, / u vvv ~ u uvvvvvvvv 
n 
' I ! Ret a- tum ~ 
\/\/ Beta-sheet 
00 Alpha-helix 
Random coil 
177 
absorbances at 283 and 289 nm, probably corresponding to the single 
residues of tyrosine and tryptophan. · Phenylalanine band structure 
(262 and 268 nm) was not observed, but may have been obscured under 
the broad disulphide absorbance (Strickland, 1974). The spectrum of 
the a-amylase inhibitor differed from those of the trypsin inhibitor 
(Fig. 28b) and a-amylase inhibitors of wheat (Silano et al., 1973, 
Petrucci et al., 1976,1978) in the presence of clear absorbances at 
264 nm, 272 nm (probably due to phenylalanine residues) and 268 nm 
(probably due to tyrosine) (Strickland, 1974) and in the absence of 
the broad absorbance between 260 and 300 nm. The latter may result 
from the differences in dihedral angles of the disulphide groups 
(Beychok, 1965, Bayley, 1980). 
3.11 Discussion of Sequence homology of the Rye Trypsin and a-Amylase 
Inhibitors with other Seed Proteins 
Alignment of the amino acid sequence of the rye trypsin inhibitor 
and the N-terminal sequence of the rye a-amylase inhibitor (Fig. 30) 
showed clear sequence homologies with several other cereal seed 
proteins, most notably inhibitors of a-amylase and trypsin. The rye 
trypsin inhibitor showed greatest sequence similarity to the barley 
trypsin inhibitor (CMe) (Odani et al., 1983) with 92 out of 121 
residues being common to both proteins (76% identity) and with all ten 
cysteines being conserved. Significant homology also exists between 
the rye trypsin inhibitor and the ragi bifunctional trypsin/a-amylase 
inhibitor (Campos and Richardson, 1983)(59% identity) and the maize 
trypsin inhibitor (Mahoney et al., 1984) (50% identity), but homology 
with the wheat a-amylase inhibitors (Kashlan and Richardson, 1981, 
Maeda et al., 1983) is somewhat lower (24-26% identity). There is 
also limited homology with the short N-terminal sequences reported for 
the CM proteins of barley (Barber et al., 1986a) and wheat (Barber et 
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Figure 30: 
Alignment of the sequence of the rye trypsin inhibitor and the N-
terminal sequence of the rye a-amylase inhibitor with the 
sequences of other members of the cereal inhibitor superfamily. 
The sequences are aligned for maximum homology, resulting in some 
gaps (shown as dashes) which represent insertions/deletions. 
Positions in the alignment with identical amino acids in all or 
all but one of the sequences are boxed. The residue numbers 
refer to the rye trypsin inhibitor. Complete sequences: 1) Rye 
trypsin inhibitor; 2) barley trypsin inhibitor (Odani et al., 
1983a); 3) bifunctional trypsin/a-amylase inhibitor from ragi 
Eleusine coracana (Campos and Richardson, 1983); 4) maize trypsin 
inhibitor (Mahoney et al., 1984); 5) amino-acid sequence deduced 
from barley eDNA for CMd (Halford et al 1988); 6) amino-acid 
sequence deduced from barley eDNA clone pUP-13 (Paz-Ares et al., 
1986); 7) amino-acid sequence deduced from barley eDNA clone pUP-
44 (putative a-amylase inhibitor)(Lazaro et al., 1987); 8) wheat 
a-amylase inhibitor 0.19 (Maeda et al., 1983); 9) wheat a-amylase 
inhibitor 0.28 (Kashlan and Richardson, 1981); 10) wheat a-
amylase inhibitor 0.53 (Maeda et al., 1985). N-terminal 
sequences: 11) rye a-amylase inhibitor; 12), 13) and 14) the 
chloroform-methanol soluble (CM) proteins from barley (Barber et 
al., 1986a); 15), 16), 17) and 18) CM proteins from wheat (Barber 
et al., 1986b). The arrow indicates the locations of the 
reactive sites in the trypsin inhibitors. 
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Region A 
1 RYE TI 
2 BARLEY Tl(CMe) 
3 RAGI Tl/AI 
4 MAl ZE TI 
5 BARLEY CMd 
6 BARLEY plJP13 
7 BARLEY pL'P44 
8 WHEAT AI 0.19 
9 WHEAT AI 0.28 
10 WHEAT AI 0.53 
11 RYE AI 
12 BARLEY CMa 
13 BARLEY CMb 
14 BARLEY CMc 
15 WHEAT CM1 
16 WHEAT CM2 
17 WHEAT CM3 
18 WHEAT CM16 
Region B 
1 
2 
3 
4 
5 
6 
7 
8 
9 
SGPw1>1 
TGPY-
TGQY-
VGSE-
TSIYT 
TGPY-
TGPY-
SGS--
IGNE-
40 
KR 
KLY 
KQ 
-R 
-R 
-R 
10 -R 
Region c 
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4 -LED 
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7 E--v 
8 GTGA 
9 -1\EV 
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A 
10 
"PGLAMPHN 
PGDALPHN 
. PGMAI PHN 
PGVAFPTN 
VGKSIPIN 
PEMGHKVS 
PGQAFQVP 
PATGYKVS 
PGQAFQVP 
AGMGLPTK 
AGMGLPSN 
PWTATPIT 
EGMGLPVN 
"AGMGLPIN 
PGMGLPSN 
PGVAFRTNL 
50 
30 .1, 20 
YVVSQI 
YVVSQI 
lnc-lr-na.rvy AKR 
VG--PRLFTWDM--------------
QG--PRLLTSDM--------------
VG--PRLATQEM--------------
ST 
IGPRPRLPWPEL--------------
VFTPGSLLPEWMTSAELNYPGQPYLA 
1/G--DQQVPDVL--------------
LVKLE-- GNRVP£0---VL--------------
LLRLQ- GSQVPEA---VL--------------
VKLQ- GSQVPEA---VL--------------
LLKLQ- GSQVPEA---VL--------------
YVAQQ VGL 
YVAZQT 
YVEQQ 
YVAXQT 
YVASQX 
YVAQQT 
YVLQQT 
' YVEQQ 
60 70 
ALRILMD------GVVT G 
ALRIIMQ------GVVTW A 
AVRILMD------GVVTP R 
s 
ALSILMD------G-AIP DAQL A 
ALRYFMALPVPSQPVDPST s 
ALSILVN-----~GVITE 
DLGSMLR------SVYAAL --VG E 
ALYSMLD------SMYKEH -AQ- A 
DLSSMLR------SVAQEL --VR 
B y 
--vs 
90 100 110 120 
PTLQAGY 
PELQPGYG 
SLLGAGE 
RVT--QRSYAA--TLV-APQEC~LPTIHGSPY 
RER--QTSYAA--NLV-TPQECNLGTIHGSAY 
RQV--QRAFA--PKLV-TEVECNLATIHGGPF 
REV--QQGFAA--TLV-TEAECNLETIS 
REM--QRDFVR--LLV-APGQCNLATIHNVRY 
GER--IHSMGSY--LT-AYSECNPHNPGTPRG 
KDVMKLL--VAGVPALCNVPIPNEAAGTR-GV 
REVVKLT--AASITAVCRLPIVVDASGDGAYV-
KEVMKLT--AASVPEVCKVPI-PNPSGDRAGV-
GP 
AVEQPLWI 
LF-GGGS 
--WSASTDT 
·-oVAAYPDA 
GDWAAYPDV 
c 
REVVKLT--AASITAVCRLPIVVDASGDGAYV- ·-DVAYPDAA 
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al., 1986b), and the rye a-amylase inhibitor. TheN-terminal sequence 
of the rye a-amylase inhibitor is most closely related to CMa of 
barley (which is known to inhibit a-amylase from Tenebrio molitor) and 
to CM1 and CM2 of wheat (which have no known inhibitory activity). It 
is less closely related to the a-amylase inhibitors of wheat. 
Also noteworthy is the fact that the sequence of the rye trypsin 
inhibitor contains the peptide bond Arg3 4-Leu35 in an exactly homolo-
gous position to the Arg33-Leu34 of the barley trypsin inhibitor 
(Odani et al., 1983) and the Arg34-Leu35 of the ragi bifunctional 
inhibitor (Campos and Richardson, 1983), which have been identified 
as the reactive (inhibitory) sites of these proteins. It does not 
contain the Arg-Ala peptide bond , which was suggested as the reactive 
site of the apparently similar trypsin inhibitors isolated from rye by 
other workers (Hochstrasser and Werle, 1969, Mikola and Kirsi, 1972). 
Not shown in Fig. 30· is the limited homology which exists between 
the rye inhibitors and the HMW and sulphur rich (S-rich) cereal 
prolamins of barley, wheat and rye (Shewry et al., 1984) and with the 
2S storage albumins from non-cereal seeds such as castor bean (Sharief 
and Li, 1982), oil-seed rape (Crouch et al., 1983), lupin {Lilley and 
Inglis, 1986) and Brazil nut (Ampe et al., 1986) and a 2S albumin from 
sunflower (Allen et al., 1987). Comparison of the C-terminal domains 
of several S-rich prolamins showed three conserved regions named A, B 
and c. Regions similar to A, B and C are also present in HMW 
prolamins A and B in the N-terminal and C in the C-terminal domain. 
They are also present in three other types of seed proteins {Kreis and 
Shewry, 1989); the trypsin/a-amylase inhibitors, 2S storage albumins 
from a range of species (see above) and a 2S albumin from sunflower 
{Fig. 31). The 2S storage proteins of castor bean, oil-seed rape, 
brazil nut and lupin are composed of two subunits which are associated 
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Figure 31: 
Diagramatic comparison of the structures of the barley trypsin 
inhibitor (Odani et al., 1983) with those of related seed 
proteins: B gliadin, an S-rich prolamin of wheat (Bartels et al 
1986); rape seed napin, (Crouch et al., 1983); and sunflower 2S 
albumin, (Allen et al., 1987). The arrows indicate the sites of 
processing events which result in the co-translational cleavage 
of signal peptides, and in more extensive processing of the napin 
and 2S albumin. Figure adapted from Kreis and Shewry, 1989. 
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A) Enzyme Inhibitors 
Barley trypsin inhibitor 
1 121 
NH211 A I ~~:~ [§] ~COOH 
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t t 
N-terminus of 
mature protein 
by disulphide bonds; the small subunit (Mr 4000, containing region A) 
being homologous to the N-terminal region of the trypsin/a-amylase 
inhibitors and the larger subunit (Mr 7000 and 9000, containing 
regions B+C) with the C-terminal region. The subunits are synthesised 
as a single precursor which is then cleaved in the linker region 
(Crouch et al., 1983). 
Kreis et al. (1985) proposed that an ancestral gene encoding a 
protein of about 30 residues had triplicated resulting in a protein 
with three identical domains which then diverged to give regions A, B 
and C. The enzyme inhibitors (regions approximating to A, B, and C 
are shown on the sequence alignment diagram, Fig. 30) are probably the 
most closely related to the ancestral protein with only short 
insertions having been added between the regions whereas the cereal 
prolamins have the domains flanked or separated by long stretches of 
repeated sequences (Kreis et al., 1985). 
The three ancestral regions (A, B and C) contain sequences that 
are largely conserved compared to the regions that flank them. Within 
the conserved regions the cysteine residues are highly conserved (of 
the eight cysteine resid~es present in wheat gliadin, six are found in 
the barley and rye trypsin inhibitors including the double cysteine). 
Conservation of the cysteine residues is thought to play a role in 
stabilising the folded protein structure. Correct folding of the 
cereal prolamins and 2S storage proteins is presumably required for 
packaging of these proteins into the protein bodies for storage in the 
cell. The cysteine residues may also stabilise the active conforma-
tion of the enzyme inhibitors and could indicate an unknown enzymic 
activity for the prolamins (Kreis and Shewry, 1989) and other members 
of the cereal enzyme inhibitor family (eg. CM proteins, Shewry et al., 
1984). 
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Analysis of the chromosomal locations of the structural genes for 
these proteins has revealed a widely dispersed multigene family (Table 
10) resulting from translocation and intra-chromosomal duplication. 
The clearest example of an intra-chromosomal duplication is evident in 
the case of barley CMa and CMc. There is closer homology between CMa 
(a-amylase inhibitor) and CMc (trypsin inhibitor) which are located on 
the same chromosome (chromosome 1) than between CMa and any of the 
other known a-amylase inhibitors or CMc and any of the other trypsin 
inhibitors (CMe); indicating a intra-chromosomal duplication (Barber 
et al., 1986a). The genes encoding the barley CM proteins are located 
on chromosomes 1, 3 and 4 (Salcedo et al., 1984) so sequence homology 
to the prolamins (whose genes are all located on chromosome 5, Doll 
and Brown 1979, Jensen et al., 1980, Shewry et al., 1983) implies that 
the ancestral sequence must have dispersed over at least four of the 
seven pairs of barley chromosomes. The number and distribution of the 
genes encoding the members of this multigene family in rye is unknown. 
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Table 10: 
Chromosomal locations of the genes for the trypsin/a-amylase 
inhibitors of wheat and barley. 
Chromosome Genome 1 Species Protein Inhibitory Reference 
Group Activity 
3 B Wheat 0.53 a-amylase 1,2,3. 
dimeric 
D Wheat 0.19 a-amylase 1,2,3. 
dimeric 
H Barley CMe trypsin 4,5. 
4 A Wheat CM16 a-amylase 1, 2. 
tetrameric 
D Wheat CM17 a-amylase 1, 2. 
tetrameric 
H Barley CMb a-amylase 4. 
tetrameric 
A Wheat CM3 a-amylase 1,2. 
tetrameric 
H Barley CMd a-amylase 4 
tetrameric 
ti D Wheat 0.28 a-amylase 2,3,6. 
monomeric 
7 B Wheat CM2 a-amylase 1,2, 7. 
tetrameric 
D Wheat CM1 a-amylase 1,2, 7. 
tetrameric 
12 H Barley CMa a-amylase 4. 
tetrameric 
H Barley CMc trypsin 4. 
186 
Table 10 cont: 
1 Hexaploid wheat (T. aestivum) genome AABBDD and barley (H. vulgare) 
genome HH. 
2 Barley chromosome 1 is homologous to chromosome group 7 of wheat. 
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CHAPTER 4 
DNA RESULTS AND DISCUSSION 
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CONSTRUCTION OF A eDNA LIBRARY FROM RYE (Secale cereale cv. Gazelle) 
ENDOSPERMS 
4.1 In vitro translation and Immmunoprecipitation of RNA from Rye 
endosperm 
Paz-Ares et al. (1983) studied the in vitro synthesis of the eM-
proteins from barley which show sequence homology to the rye trypsin 
and a-amylase inhibitors. The eM-proteins of barley are synthesised 
most actively between 10-30 days after anthesis, with a maximum at 15-
20 days. They were shown to be synthesised on membrane-bound 
polysomes as precursors of higher apparent molecular weight (13000-
21000) than the mature proteins (12000-16000). The sequence homology 
between the eM-proteins from barley and the rye inhibitors suggests 
that the synthesis of the latter may follow a similar pattern. 
Initially free and membrane-bound polysomes were prepared from 
rye endosperms harvested 20 days after anthesis in order to prepare a 
eDNA library to be screened with oligonucleotide probes derived from 
protein sequence of an endosperm specific trypsin inhibitor (embryo 
inhibitors being selectively removed during the protein purification; 
Boisen and Djurtoft, 1981). Poly A+-rich RNA was isolated from the 
membrane-bound polysomes. The polysomes and the poly A+-rich RNA were 
translated in vitro using wheat-germ cell free extracts. The trans-
lation products were then immunoprecipitated using polyclonal anti-
bodies raised against the trypsin and a-amylase inhibitors from rye. 
Immunoprecipitation using both free and membrane-bound polysomes 
resulted in weakly labelled bands in the correct size range for the 
inhibitor proteins (results not shown). Total polysomes were then 
used for subsequent isolation of poly A+-rich RNA, which was purified 
by affinity chromatography using oligo-dT-cellulose (the RNA was 
applied to the column twice to ensure efficient purification of poly 
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A+-rich RNA). The in vitro translation products from both total and 
poly A+-rich RNA were also immunoprecipitated and gave clear bands 
with both the antibodies (Fig. 32 Lanes B; a,b). These bands appeared 
to be slightly larger on SDS-PAGE (Fig. 32 Lanes B; a,b) than the 
mature proteins (Fig. 32 Lanes A; a,b), possibly indicating the 
presence of signal peptides. Various plant proteinase inhibitors have 
been shown to be synthesised with an N-terminal signal peptide 
(soybean Kunitz inhibitor, Hoffman et al., 1984; tomato inhibitors I 
and II, Graham et al., 1985a,b; pUP-13 eDNA clone from barley 
corresponding to the CM-proteins, Paz-Ares et al., 1986) which is 
consistent with their synthesis on membrane-bound polysomes and their 
subsequent deposition in vacuoles. 
These studies demonstrate the presence in rye endosperms of mRNA 
whose translation products are precipitated by polyclonal antibodies 
raised against proteins belonging to the cereal inhibitor superfamily. 
The poly A+-rich RNA was therefore used to construct a eDNA library to 
be screened for further members of this inhibitor family. 
4.2 Synthesis of eDNA 
The two methods used for eDNA synthesis in this study are based 
on that of Gubler and Hoffman (1983), which first combined the 
classical oligo-(dT)-primed first-strand synthesis with RNase H-DNA 
polymerase I mediated second-strand synthesis. This method eliminated 
the S1-nuclease mediated cleavage of the hairpin loop (Land et al., 
1981; Okayama and Berg, 1982), which gave a low number of clones per 
pg of mRNA and often removed important 5'-terminal sequences from the 
cloned mRNA. 
A precise comparison of the two methods is not possible as the 
Amersham system does not contain details of the buffers used. The two 
methods do, however, vary in the enzymes used during second strand 
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Figure 32: 
Comparison of the in vivo extracted rye a-amylase and trypsin 
inhibitor proteins and the in vitro translation products of mRNA 
from the endosperm of rye. 
A 
SDS-PAGE, samples separated on a 16% polyacrylamide gel. 
RNA translated in the wheat germ system. 
B 
a) a-amylase inhibitor 
b) trypsin inhibitor 
c) Poly-A•-rich RNA (purified from total polysomes on two 
oligo-dT-cellulose columns) translation products 
d) Total polysomal RNA translation products. 
RNA translated in the wheat germ system using [JHj leucine with 
labelled products detected by fluorography. The in vitro 
translation products from Poly-A•-rich RNA were immunoprecipit-
ated using polyclonal antibodies raised against the trypsin and 
a-amylase inhibitors. 
a) Immunoprecipitated product using a-amylase inhibitor 
antibodies 
b) fmmunoprecipitated product using trypsin inhibitor 
antibodies 
c) Labelled Poly-A•-rich RNA translation products 
d) Labelled Total RNA translation products 
Position of molecular weight marker proteins are shown on the 
left: 1, 14200; ~. ~0100; 3, 24000; 4, 29000: 5, 36000; 6, 45000; 
7, 66000. 
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synthesis. Method 1 includes Escherichia coli DNA ligase. Gubler and 
Hoffman (1983) examined the effects of E. coli DNA ligase during the 
synthesis of small-size eDNA (globin mRNA, 600 bp) and found it to be 
unnecessary. Larger RNA's (2000-5000nt in length) were examined by 
Lapeyre and Amalric (1985), who found that inclusion of E.coli DNA 
ligase led to an increase in resistance of the second strand DNA to 
81-nuclease. Maximum incorporation into the second strand was obtai-
ned without DNA ligase (200%), but only 20% of the incorporated counts 
were resistant to 81-nuclease. This suggests the synthesis of abnor-
mal structures including regions of single-stranded DNA. With DNA 
ligase the incorporation was lowered to 100% and 70-80% of the eDNA 
was resistant to 81-nuclease. 
A summary of the results obtained using both methods is shown in 
Table 11. Method 1 gave widely varying efficiency of first-strand 
synthesis, indicating inefficient copying of the mRNA by reverse 
transcriptase. This may be due to a number of reasons including 
extensive secondary structure of the poly A~-rich RNA (the RNA was 
heated to 65°C immediately prior to first strand synthesis in order to 
denature any such structures) or purity of the RNA (which was assessed 
by in vitro translation). This method also showed poor incorporation 
into second-strand and resulted in an overall low yield of ds eDNA (67 
ng). As a result cloning was not attempted using eDNA produced by 
this method. 
Method 2 (Amersham) gave consistant results during first-strand 
synthesis but an improvement from the 13-14% mRNA transcribed was 
obtained by further purification of the poly A~-rich RNA through 
another column of oligo-(dT)-cellulose. The purer RNA gave 40% mRNA 
transcribed. The efficiency of double-strand synthesis was higher 
than in method 1, but percentages higher than 100 indicate the 
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Table 11: 
Summary of the results of eDNA synthesis 
Method 
1 
2 
(Amersham) 
pg mRNA 
used 
0.9 
0.9 
0.9 
0.9 
5 
5 
2 
% of mRNA % of second strand 
transcribed transcribed from 
first strand eDNA 
3.1 } 
Yield 
(ng) 
} Pooled and used for second 
4.5 } strand synthesis 
} 
8.0 } 
} 53 67 
22.3 } 
13.8 
14.5 83.4 1330 *A 
14.0 158 434 *B 
40.0 152 3045 *C 
a RNA purified by affinity chromatography by application to two 
columns of oligo-(dT)-cellulose 
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formation of some anomalous single-stranded structures. These struct-
ures may have an effect on the efficiency of cloning which relies on 
having blunt ended ds DNA for the efficient ligation of linker 
molecules. However, the T4 DNA polymerase added during double-strand 
synthesis removes any 3' overhangs on the first strand eDNA to produce 
flush ends. Although an S1-nuclease treatment would remove any other 
single-stranded anomalies it would also reduce the yield of full 
length DNA and so was not carried out. 
The products of eDNA synthesis (*B and *C from Table 11 are 
shown) were examined by gel electrophoresis on a 1.4% agarose gel 
under denaturing conditions (50 mM NaOH). To establish whether RNA 
has been fully replaced by DNA the samples were analysed after 
alkaline hydrolysis. The RNA purified by two oligo-(dT)-cellulose 
columns gave slightly longer eDNA transcripts (Fig. 33). The products 
of second-strand synthesis (both the control globin and the rye eDNA) 
contain eDNA's which migrate at molecular weights greater than those 
of the corresponding first-strand products (Fig. 33, tracks B & E). 
This is probably the result of a small amount of hairpin loop priming 
of second strand synthesis and will not affect any subsequent cloning 
(Gubler and Hoffman, 1983). 
There is a good size-range of eDNA molecules obtained by this 
method, with many in the expected size-range from 0.4 to 1.0 kb for 
clones belonging to the cereal inhibitor superfamily (eg. pUP-13, 0.49 
kb; Paz-Ares et al., 1986). Two eDNA libraries were constructed in 
Agt10 using eDNA produced by this method using fractions from *A and 
*C from Table 11. 
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Figure 33: 
Comparison of products of eDNA synthesis using Poly-A+-rich RNA 
purified by one or two oligo-(dT)-cellulose.columns. 
AI First strand control globin eDNA 
B) First strand rye eDNA from Poly-A+-rich RNA purified by 
one oligo-(dT)-cellulose column (B*I 
C) First strand rye eDNA from Poly-A+-rich RNA purified by 
two oligo-(dT)-cellulose column (C*I 
D) Second strand control globin eDNA 
E) Second strand rye eDNA from Poly-A+-rich RNA purified by 
one oligo-(dT)-cellulose column (B*) 
F) Second strand rye eDNA from Poly-A+-rich RNA purified by 
two oligo-(dT)-cellulose column IC*) 
The position of molecular weight DNA markers IKbl are shown on 
the left. 
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·sCREENING OF THE RYE eDNA LIBRARY AND SEQUENCING OF AN ISOLATED eDNA 
CLONE 
4.3 Cloning and Screening of the Agt10 rye endosperm eDNA library 
A rye endosperm eDNA library was initially constructed in Agt10 
using EcoRI linkers (see Methods). The eDNA was synthesised from poly 
A•-rich RNA which had been purified by affinity chromatography on one 
column of oligo-(dT)-cellulose (Table 11 *A). Amersham control 
samples of A and A arms failed to package in vitro so the efficiency 
of the packaging reactions could not be ascertained. Only one of the 
eDNA reactions sucessfully packaged (100 ng), resulting in a library 
of 3.6 x 104 recombinants. Aliquots of this library containing 
approx. 500 pfu were plated out onto twenty 10 em x 10 em plates using 
E. coli strain c600/hfl as a host. Plaque lifts were made and 
screened using oligonucleotide probes (1 or 2), prepared without the 
acetic acid deprotection step, and 5'-end labelled with [)13 :lP) dATP. 
Five plaques were found to hybridise to probe 2 but all failed to 
hybridise on the second screening. Having screened approx. 1.0 x 104 
plaques and found no positive clones, a new eDNA library was 
constructed from eDNA prepared from RNA purified by passage through 
two columns of oligo-(dT)-cellulose (Table 11 *C). 
Three eDNA libraries were made, varying in the concentrations of 
eDNA used in the in vitro packaging reactions (50, 100 and 150 ng), 
and with the cloning efficiencies of 1.9 x 105 , 4.4 x 104 and 2.6 x 
104 respectively. These efficiencies are lower than expected 
(Amersham reports efficiencies of 106) and could be the result of a 
number of factors. Due to the failure of the in vitro packaging of 
the control Agt10 DNA, which is used as an indication of the 
efficiency of the in vitro packaging reactions, no evaluation of the 
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efficiency of the eDNA packaging is possible. However, plating the 
eDNA library on the high frequency lysogeny (hfl) strain gives a 
highly selective system whereby only recombinants, where insertion of 
eDNA produces the ci- phenotype, can form plaques. 
Screening of the three new libraries was carried out using both 
oligonucleotide probes, which had been deprotected by acetic acid in 
order to increase the efficiency of the end labelling reaction and 
result in a higher specific activity. Approx. 2.0 x 104 clones were 
screened and fourteen hybridising plaques were picked for second 
screening. On second screening two clones (AA and AB) were found to 
weakly hybridise only to probe 2 (indicating that they did not 
correspond to the rye trypsin inhibitor eDNA as they did not hybridise 
• 
to probe 1) and one clone was found to hybridise to both probes 
(AC)(Fig. 34). AC hybridised more strongly to probe 1 than to probe 
2. This may be due to the fact that probe 2 is a more complex mixture 
of sequences (32) compared to probe 1 (8). As a result any one 
sequence in probe 2 would have a lower specific activity and would 
result in a weaker hybridisation signal. 
DNA was purified from all three clones(AA, Band C), cut with 
EcoRI and the resultant fragments separated by agarose gel electro-
phoresis. AA contained a eDNA insert which contained an EcoRI site 
and so gave two bands of approx. 1.3 and 1.0 kb, AB contained no 
insert, and AC contained an insert which was not cut by EcoRI so gave 
a single band of approx. 1.8 kb. The fragments were transferred to a 
"Biodyne" filter by "Southern blotting". The blot was probed with 
probe 1 which hybridised only to the insert in AC. This suggested 
that it encoded the rye trypsin inhibitor, as the initial screening 
had shown that it also hybridises to probe 2. AC clearly contains 
regions which hybridise to the two areas of the rye trypsin inhibitor 
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Figure 34: 
Second screening of three eDNA clones found to hybridise to 
oligonucleotide probes corresponding to regions of the rye 
trypsin inhibitor. 
1) eDNA clone AA 
2) eDNA clone AB 
3) eDNA clone AC 
A) Probe 1 
mixture of 8 
B) Probe 2 
mixture of 32 
38 42 
- W - D - M - K - R -
ACC CTA TAC TTT TC 
G C G 
44 48 
- C - C - D - E - L -
ACA ACA CTA CTT AA 
G G G C G 
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Al 81 
A2 
82 
83 I 
from which the oligonucleotide probes were derived, however this clone 
is larger than expected (1.8 kb compared to 0.49 kb for barley clone 
pUP-13 from the cereal inhibitor superfamily) and as such could 
represent an interesting new member of the cereal inhibitor super-
family which may have arisen by gene duplication. This clone was 
taken forward for sequencing. 
4.4 Sequencing of the eDNA clone AC 
The clone, AC, was digested with EcoRI to release the 1.8 kb eDNA 
insert (C.In), which was subcloned into M13mp18 and pUC18. Restric-
tion digests were carried out on C.In (in pUC18) in order to create a 
partial restriction map (Fig. 35). All sequences were determined 
using the dideoxy method (Sanger et a.l., 1977) using "Sequenase". 
Parts of the sequence were obtained by direct sequencing of the insert 
DNA (C.In) in M13mp18 and by subcloning various restriction fragments 
into M13mp18 or mp19 (Fig. 36). The rest of the sequence was obtained 
by generating deletions of C.In (in pUC18) in both directions (5' ~ 3' 
and 3' ~ 5'). The deletions were made using ds-DNA produced using a 
rapid mini-preparation procedure. Deletions were generated by dig-
estion first with the restriction endonucleases Xba I and Pst I, and 
then with exonuclease III for periods up to 50 min. The fragments 
were then digested with S1 nuclease to produce blunt ends which were 
religated with DNA ligase. Clones of the desired size were identified 
by mini-lysate analysis on 1.2% agarose gels. ds-Plasmid DNA was 
denatured prior to sequencing. The deletions used in the sequencing 
of C.In are shown in Fig. 36. 
The sequence of C.In is fully established by overlapping dele-
tions on one strand. Two gaps of approximately 100 bp each occur in 
the sequence on the other strand as the appropriate size deletions 
were not identified. 
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Figure 35: 
Restriction digests of the clone C.In in order to generate a 
partial restriction map (following subcloning into pUC18 two 
hybridising colonies were digested). 
A) 0.8% agarose gel B) Southern blot of gel hybridised with 
probe 1 
1 ) pUC18/C.In (1) digested with Kpn1/Sstl 
2) pUC18/C.In ( 1) digested with Kpn1/Hindii I 
3) pUC18/C.In (1) digested with Hindii I/Ssti 
4) pUC18/C.In (1) digested with Kpni/EcoRI 
5) pUC18/C.In (1) digested with EcoRI/Ssti 
6) pUC18/C.In ( 2) digested with Kpni/Ssti 
7) pUC18/C.In ( 2) digested with Kpni/Hindiii 
8) pUC18/C.In ( 2) digested with Hindi I I /Sstl 
9) pUC18/C.In ( 2) digested with Kpnl/EcoRI 
10) pUC18/C.In ( 2) digested with EcoRI/Ssti 
11) pUC18/C.In (1) 
12) pUC18/C.In ( 2) 
13) pUC18 digested with EcoRI 
14) pUC18 
15) .A digested with Hindiii molecular weight markers (Kb) 
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A 
1 2 3 4 5 6 7 8 9 10 1112 13 14 15 kb 
B 
23.5 
9.7 
6.6 
2.2 
2.1 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 kb 
- 23.5 
9'.7 
6.6 
2.2 
2.1 
Figure 36: 
Partial restriction map of the clone AC (C.In). Arrows show 
deletions and restriction fragments used in the sequencing of the 
clone. 
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The nucleotide and derived amino acid sequences of C.In are given 
in Figs. 37 & 38 and the corresponding amino acid composition is shown 
in Fig. 39. In total 1709 bp of C.In were sequenced. An open reading 
frame extends from the 5' end to 1621 bp, encoding for a protein of 
540 residues. The amino acid composition of the protein is rich in 
leucine, arginine and lysine. A methionine residue at position 39 in 
the amino acid sequence may constitute the initiation codon. 
There are no 
stop codons in the nucleotide sequence prior to the ATG of Met3 9 so 
the open reading frame starts from the beginning of the clone. A stop 
codon is present at 1621 bp. No polyadenylation signal is evident in 
the sequence after this stop codon, but in plants a variety of 
sequences appear to be recognised as signals (Joshi, 1987). A poly-A+ 
tail was evident when the full insert was sequenced in the 3' to 5' 
orientation in pUC18 although "Sequenase" was unable to resolve the 
sequence immediately after the poly-A+ tail. 
4.5 Identification and Analysis of the Protein encoded by the eDNA 
clone C.In 
To gain an insight into the possible functions of the product of 
C.In the predicted amino acid sequence was compared to the sequences 
of other proteins in the EMBL DNA and GENBANK databanks and the 
Brookhaven protein sequence databank using the NAQ and PSQ search 
programs. This comparison revealed that the C.In protein showed 
striking sequence similarity to members of the protein kinase family, 
which is a large family of proteins thought to mediate the response of 
eukaryotic cells to external stimuli (Hunter and Cooper, 1986, Edelman 
et al., 1987). The sequence similarity suggests that C.In is most 
closely related to the SNFl subfamily of protein kinases (Hanks et 
81.,1988). 
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Probable binding site for oligonucleotide Probe 1 
Probe 1 13 A A A A G . T A T A G G G 2 
C.In 788 A A A A G A T A A A G G G 800 
Figure 37: 
Nucleotide sequence of the clone AC {C.In). 
P P N L S R F G C E A S S A P L G R R S 
1 CCCCCAAACCTCTCTCGATTCGGGTGCGAGGCCTCCTCCGCTCCACTGGGCCGGCGCTCT 
R R L P P S G R L I D H G I W P V K M D 
61 CGGCGACTCCCTCCGTCCGGGCGGTTGATCGACCACGGGATTTGGCCAGTGAAAATGGAT 
G G G E H S E A L K N Y Y L G K I L G V 
121 GGAGGAGGCGAACATTCTGAAGCATTGAAAAACTACTATCTGGGTAAAATATTAGGTGTA 
G T F A K V I I A E H K H T R H K V A I 
181 GGCACATTTGCAAAAGTAATAATTGCAGAGCATAAGCATACAAGACACAAAGTTGCTATA 
K V L N R R Q M R A P E M E E K A K R E 
241 AAGGTTCTGAACCGCCGTCAAATGCGAGCTCCAGAAATGGAAGAGAAAGCAAAGAGAGAA 
I K I L R L F I D L I H P H I I R V Y E 
301 ATCAAGATATTGAGGTTGTTCATTGACTTAATTCACCCTCATATCATCCGGGTTTATGAG 
V I V T P K D I F V V M E Y C Q N G D L 
361 GTCATTGTGACACCGAAAGATATTTTTGTTGTGATGGAATATTGCCAAAATGGTGACCTA 
L D Y I L E K R R L Q E D E A R R T F Q 
421 TTGGACTACATTCTTGAGAAACGGCGGTTACAGGAAGACGAGGCTCGTCGAACCTTCCAG 
Q I I S A V E Y C H R N K V V H R D L K 
481 CAGATTATATCTGCTGTTGAATACTGCCACAGAAACAAGGTTGTTCATCGTGATCTAAAG 
P E N L L L D S K Y N V K L A D F G L S 
541 CCAGAAAACCTGTTACTTGATTCCAAATATAATGTGAAACTTGCTGACTTTGGGTTAAGT 
N V M H D G H F L K T S C G S L N Y A A 
601 AATGTGATGCATGATGGCCATTTTTTGAAGACTAGCTGCGGGAGTCTAAACTATGCTGCA 
P E V I S G K L Y A G P E I D V W S C G 
661 CCAGAGGTCATCTCAGGTAAATTGTACGCTGGACCTGAGATTGATGTTTGGAGCTGTGGG 
V I L Y A L L C G A V P F D D D N I P N 
721 GTGATACTTTATGCTCTTCTTTGTGGTGCTGTTCCATTTGATGATGACAACATTCCCAAC 
L F K K I K G G S Y I L P I Y L S D L V 
781 CTGTTCAAAAAGATAAAGGGAGGATCCTACATCCTTCCAATTTATTTATCTGATCTTGTA 
R D L I S R M L I V D P M K R I T I G E 
841 AGGGATTTGATCTCAAGAATGCTTATTGTTGATCCGATGAAGAGAATCACAATTGGTGAA 
I R K H S W F Q N R L P R Y L A V P P P 
901 ATTCGAAAACACTCATGGTTTCAGAATCGCCTTCCTCGCTACCTGGCAGTGCCTCCACCA 
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Figure 37 cont: 
D M M Q Q A K M I D E D T L R D V V K L 
961 GATATGATGCAGCAAGCCAAAATGATTGATGAAGATACACTTCGAGACGTTGTCAAACTG 
G Y D K D H V C E S L C N R L Q N E E T 
1021 GGATATGATAAAGATCATGTGTGTGAATCGCTGTGCAATAGGCTGCAAAACGAGGAAACT 
V A Y Y L L L D N R F R A T S G Y L G A 
1081 GTTGCATATTACTTGCTCTTGGACAATCGGTTCCGGGCTACTAGTGGCTATTTGGGGGCT 
H Y Q Q P M E S A S P S T R S Y L P G S 
1141 CACTATCAACAACCAATGGAATCAGCAAGCCCAAGTACCAGGAGTTATCTTCCAGGAAGC 
N D S Q G S G L R P Y Y R V E R K W A L 
1201 AATGATTCTCAAGGCAGTGGCTTGCGGCCATATTACCGCGTTGAAAGAAAATGGGCTCTT 
G L Q Q S RAP P RA I M IE V L KA L 
1261 GGGCTCCAGCAGTCTCGAGCTCCCCCTCGTGCGATAATGATTGAGGTTCTAAAGGCACTT 
K E L N V C W K K N G D C Y N M K C R W 
1321 AAGGAATTAAATGTCTGTTGGAAGAAGAATGGAGACTGCTACAACATGAAATGCAGGTGG 
C P G F P R V S D M L L D A N H S F V D 
1381 TGCCCTGGGTTTCCTCGGGTCAGTGATATGTTGTTAGATGCCAACCACAGTTTTGTTGAT 
D C A I K D N G D A N S R L P A V I K F 
1441 GACTGTGCCATCAAGGATAATGGCGATGCTAATAGTAGGCTACCTGCTGTGATCAAGTTT 
E I Q L Y K T K D D K Y L L D M Q R V T 
1501 GAAATTCAGCTTTACAAGACCAAGGATGACAAGTACCTGCTAGATATGCAGAGAGTTACT 
G P Q L L F L E F C A A F L T N L R V L 
1561 GGACCTCAGCTCCTCTTCCTGGAATTTTGTGCGGCCTTCCTTACCAACCTTAGGGTTCTA 
* 
1621 TAGCTAGTGCATTTTCTGGTTGAGTGGTGAATAGCAAAACATAAGACTGTCCCGTGCAGT 
1681 GTGTTTCAGCGCTGCGACAGTGAGTAAGT 1709 
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Figure 38: 
Deduced amino-acid sequence of the clone AC (C.In). 
1 PPNLSRFGCE ASSAPLGRRS RRLPPSGRLI DHGIWPVKMD GGGEHSEALK 
51 NYYLGKILGV GTFAKVIIAE HKHTRHKVAI KVLNRRQMRA PEMEEKAKRE 
101 IKILRLFIDL IHPHIIRVYE VIVTPKDIFV VMEYCQNGDL LDYILEKRRL 
151 QEDEARRTFQ QIISAVEYCH RNKVVHRDLK PENLLLDSKY NVKLADFGLS 
201 NVMHDGHFLK TSCGSLNYAA PEVISGKLYA GPEIDVWSCG VILYALLCGA 
251 VPFDDDNIPN LFKKIKGGSY ILPIYLSDLV RDLISRMLIV DPMKRITIGE 
301 IRKHSWFQNR LPRYLAVPPP DMMQQAKMID EDTLRDVVKL GYDKDHVCES 
351 LCNRLQNEET VAYYLLLDNR FRATSGYLGA HYQQPMESAS PSTRSYLPGS 
401 NDSQGSGLRP YYRVERKWAL GLQQSRAPPR AIMIEVLKAL KELNVCWKKN 
451 GDCYNMKCRW CPGFPRVSDM LLDANHSFVD DCAIKDNGDA NSRLPAVIKF 
501 EIQLYKTKDD KYLLDMQRVT GPQLLFLEFC AAFLTNLRVL 
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Figure 39: 
Molecular weight and amino-acid composition of AC (C.In) obtained 
using the program PEPTIDESORT (Devereux et al 1984). 
Summary for whole sequence: 
Molecular weight = 61860.19 Residues = 540 
Average Residue Weight = 114.556 Charged 13 
Residue Number Mole Percent 
A Ala 32 5.926 
B Asx 0 0.000 
c Cys 14 2.593 
D Asp 36 6.667 
E Glu 28 5.185 
F Phe 17 3.148 
G Gly 32 5.926 
H His 15 2.778 
I Ile 35 6.481 
K Lys 37 6.852 
L Leu 62 11.481 
M Met 15 2.778 
N Asn 23 4.259 
p Pro 30 5.556 
Q Gln 17 3.148 
R Arg 40 7.407 
s Ser 30 5.556 
T Thr 13 2.407 
v Val 34 6.296 
w Trp 6 1.111 
y Tyr 24 4.444 
z Glx 0 0.000 
A + G 64 11.852 
s + T 43 7.963 
D + E 64 11.852 
D + E + N + Q 104 19.259 
H + K + R 92 17.037 
D + E + H + K + R 156 28.889 
I + L + M + v 146 27.037 
F + w + y 23 4.259 
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The clone, AC, was chosen for sequencing as it was found to 
hybridise to both oligonucleotide probes 1 and 2 suggesting that it 
encoded the rye trypsin inhibitor. It was then intended to use the 
eDNA for the trypsin inhibitor to rescreen the eDNA library for 
further members of the cereal inhibitor superfamily. Sequence 
analysis showed that the eDNA C.In showed no sequence similarity to 
any member of the cereal inhibitor superfamily. Probe 1 gave strong 
hybridisation to C.In. This probe was an oligonucleotide 
corresponding to a five amino acid residue sequence of the rye trypsin 
inhibitor (Trp3B-Asp-Met-Lys-Arg4l) which was not highly conserved in 
any of the other members of the cereal inhibitor superfamily (see Fig. 
30) and as such was unlikely to select for any other member of the 
family. Probe 1 should have been selective for the rye trypsin 
inhibitor but probe 2 corresponded to the Cys43-Cys44 region which is 
highly conserved in all the members of this family. Probe 2 (32) was 
a more complex mixture of oligonucleotide sequences than probe 1 (8) 
and hybridisation above background was difficult to detect. 
Hybridisation was detected with probe 2 for AA, B and C when compared 
to AA and AB with probe 1 (see Fig. 34). However AB contained no 
insert hence this level of hybridisation with probe 2 suggests that it 
was due to non-specific binding and as such was not a reliable 
indicator of the rye trypsin inhibitor eDNA. Probe 1 gave stronger 
hybridisation of AC with no hybridisation evident for either AA or B. 
As the· clone C.In did not apparently encode an inhibitor it appears 
that probe 1 was not specifically selective for the cereal inhibitor 
family but selected for a protein kinase. 
4.6 Discussion of protein kinases 
Phosphorylation of specific proteins represents an important 
control element in the regulation of protein and enzymic activity 
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involved in the transduction of environmental, metabolic and develop-
mental signals in animals and simple eukaryotes (Krebs, 1985). The 
number of protein kinases characterised and sequenced from these 
sources exceeds a hundred and they can be classified according to 
their ability to phosphorylate either tyrosine or serine/threonine. 
The protein kinases are further grouped into families based on 
characteristic structural features, the regulatory ligand used, sub-
strate specificity and cellular function (Hanks et al., 1988). 
The identification of C.In as a protein kinase was based on the 
conservation of several characteristic amino acid sequences present in 
the catalytic domains of eukaryotic protein kinases. The positions of 
these catalytic domains vary between proteins of the protein kinase 
family. The catalytic domain of C.In is near the amino terminus of 
the protein (Fig 40), whereas in most single subunit enzymes it occurs 
near the carboxyl terminus with the amino terminus playing a regula-
tory role. All the highly conserved residues (* on Figs. 40, 41 & 42) 
of the catalytic domain occur in the amino terminal half of C.In. The 
catalytic domains of 65 protein kinases have been aligned manually 
(Hanks et al., 198H) indicating the presence of eleven major sub-
domains. The subdomain structure of the SNFJ subfamily is shown in 
Fig 40. The conserved subdomains are separated by regions of lower 
conservation within which any large inserts or deletions are present 
(note the occurence of an insert between the subdomains II and III in 
KINJ and KIN2). Alternating regions of high and low conservation are 
known to be a common feature of homologous globular proteins (Chothia 
and Lesk, 1986). The conserved subdomains are presumed to be 
important for the maintenance of catalytic function either directly as 
part of the active site or indirectly by contributing to the secondary 
structure necessary for an active protein conformation. 
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Figure 40: 
C. In 
SNFl 
niml + 
KINl 
KIN2 
C. In 
SNF1 
nim1• 
KIN1 
KIN2 
Amino-acid sequence alignment of the SNF1 subfamily of serine/ 
threonine protein kinases including AC (C.In). The number of 
additional amino- and carboxyl- terminal flanking residues lying 
outside the catalytic domains are shown at the beginning and end, 
respectively, of each sequence. Gaps have been introduced (-) in 
the sequence to optimise the alignment and to show clearly the 
conserved subdomains (indicated by Roman numerals). Residues 
conserved in all sequences are boxed. Asterisks indicate 
residues that are conserved in most known protein kinases. SNF1, 
(Celenza and Carlson 1986); niml•, (Russell and Nurse 1987bl; 
KIN1 and KIN2, (Levin et al 1987). 
49 
52 
9 
117 
96 
I II 
* * * * * ' KNYYLGKIL H--- HKVA LNRRQMRAPE------------
GNYQIVKTL LA IINKKVLAKSD------------
GVWRLGKTL TS LA K--- IIPIR------------------
GDWEFVETV LA IVNRATKAFLHKEQMLPPPKNEQ 
GDWEFLET LV IVNRASKAYLHKQHSLPSPKNES 
III IV 
--------------MEEKAK 
--------------MQGRIE 
--------------~YASIG 
DVLERQKKLEKEISRDKRTI 
EILERQKRLEKEIARDKRTV 
* IKILRLFIDL----I 
ISYLRLL-------
ILMMRLL-------
SLGQIL-------~1p ICRLFEMCTLS----
SLGQIL-------~P I RLFEMCTMS----
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Figure 40 cont. 
v VI 
C. In KOIFVV RTF ISAVEY 
SNFl OEIIMVI GN-
nim!+ QHMYLA FRF 
KINl NHFYML IQHGS----1 SALlY 
KIN2 NHFY~L IQHGS----L SALQY 
VI VII VIII 
* *** * C. In LLOSKY----NVKL I----
SNFl LLOEHL----NVKI 
n i ml• ILIKVNEQ---QIKI v----
KINl LSNIYOSRK L----
KIN2 IMISSSG----EIKII LSNIFDYRK L----
IX X 
* * C. In SGK ALLCGA 0----0NIPNLFK GGSYILPIY----
SNFl SGK YMLCRR 0----ESIPVLFK NGVYTLPKF----
niml• SHK "SLLSNK G----QNTOVIYN HGAYDLPSS----
KINl KAN VLVCGK 0----ENSSVLHE 
KIN2 KAQ VLVCGK~ 0----ENSSILHE KKGKVDYPSH----
XI 
C. In LSDLVR s ITIGEIRKHSWFQNR 230 
SNFl LSPGAA ISIHEIMQDDWFKVO 324 
n imP ISSAAQ TIPEFFSHPFLMGC 109 
K!Nl LSIEYI TLKQVVEHHWMVRG 663 
KlN2 LSIEVI TLKNVVEHPWMNRG 773 
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Hanks et al. (1988) found that a number of amino acid residues 
are highly conserved within the catalytic domain and as such are 
characteristic of a protein kinase. Eleven residues were found to be 
invariant and another five were identical in all but one of the 65 
sequences (shown as asterisks in Figs. 40, 41 and 42). Many of these 
conserved residues are thought to play a role in phosphotransfer or to 
form part of the ATP binding region. 
A consensus Gly50-X-Gly52-X-X-Gly55 can be found in subdomain I 
(residue numbers are for the catalytic subunit of bovine cAMP-
dependent protein kinase, cAPK-a, which is used as a reference 
standard). In C.In residues corresponding to cAPK-a Gly5° and Gly52 
are present (Gly21 and Gly23) although the Glyss residue is replaced 
by an Ala26, A three-dimensional model of the binding of ATP to v-Src 
(a cellular homolog of oncogene product from Rous avian sarcoma virus) 
(Sternberg and Taylor, 1984) showed that the first two Gly residues 
are important in binding of the ATP with the first glycine in contact 
with the ribose moiety and the second glycine close to the terminal 
pyrophosphate. Hence the third glycine is not essential for ATP 
binding and has been replaced by another amino acid residue in a 
number of protein kinases (eg. calcium-calmodulin-dependent protein 
kinase type II, a subunit from rat brain eDNA where Gly55 is replaced 
by a serine residue). 
Within subdomain II lies an invariant cAPK-a Lys72 residue (Lys43 
in C.In) which if substituted by any other amino acid by site directed 
mutagenesis leads to the loss of protein kinase activity (Kamps and 
Sefton, 1986). This lysine appears to be involved in the phospho-
transfer reaction. 
The greatest concentration of conserved residues falls into the 
central core (subdomains VI to IX). The cAPK-a Asp166 and Asp171 (VI) 
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and Aspl&4-Phel85-Glyl86 (VII) have been implicated in ATP binding, 
with Aspl66 and AsplB4 thought to interact with the phosphate groups 
of ATP through Mg2+ salt bridges (Brenner, 1987). 
The sequence comparisons suggest that the C.In product is likely 
to be a serine/threonine specific kinase as it contains many residues 
that are conserved only among the serine/threonine kinases (Hunter and 
Cooper, 1985). The sequence Aspl39-Leu-Lys-Pro-Glu-Asnl44 present in 
C.In is characteristic of a serine/ threonine kinase whereas in 
tyrosine kinases the following sequences are found: Asp-Leu-Arg-Ala-
Ala-Asn or Asp-Leu-Ala-Ala-Arg-Asn. These regions have been used to 
construct degenerate oligonucleotide probes for screening eDNA librar-
ies to identify new members of these families (Lawton et al., 1989). 
Functions for the other invariant or nearly invariant amino acid 
residues (eg. cAPK-a Val57 , Ala7o, Glu91, AsplZO, Gly225 and Arg2BO) 
have still to be established. 
The sequence similarity that extends throughout the eukaryotic 
protein kinases genes suggests that they have all arisen from a single 
archetypal gene which has then evolved by gene duplication and 
divergence events, speciation events (when functional homologues from 
vertebrate and invertebrates are compared) or a mixture of both. 
Amino acid alignments have been used to establish phylogenetic rela-
tionships within the protein kinase family. Hanks et al. (1988) 
constructed a phylogenetic tree which reflects the evolution of the 
catalytic domains of the protein kinase family. The tree produced 
five major clusters which reflect protein kinases with similar 
regulation or substrate specificity: 
i) tyrosine protein kinases 
ii) cyclic nucleotide- and calcium-phospholipid 
dependent protein kinases 
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iii) calcium-calmodulin dependent protein kinases 
iv) protein kinases related to SNFl 
v) protein kinases related to CDC28. 
Sequence similarity suggests that C.In falls into the cluster of 
protein kinases related to SNFl. This is a small cluster of four 
protein kinases from budding or fission yeast: SNFl (Celenza and 
Carlson, 1986), niml+ (Russell and Nurse, 1987b) and KINl and KIN2 
(Levin et al., 1987). C.In displays a very high level of sequence 
similarity to the catalytic domain of SNFl (62% identity) (Fig. 41) 
and niml+ (48% identity)(Fig. 42). The majority of the sequence 
similarity occurs within the catalytic domain of the proteins, with 
lower sequence identity occuring in other regions. The large gaps 
introduced during sequence comparison are also outside the catalytic 
domains, indicating that conservation of these regions is not necess-
ary for the maintenance of enzymic activity. 
4.7 Discussion of the Functions of the SNFl Subfamily of Protein 
Kinases 
Sequence comparisons revealed significant homology between C.In 
and the catalytic domain of the SNFl subfamily of protein kinases. 
The SNFl (sucrose-nonfermenting) gene plays an important role in 
carbon catabolite repression in the yeast Saccharomyces cerevisiae. 
SNFl function is required for the expression of many glucose-
repressible genes in response to glucose deprivation, so SNFl mutants 
are unable to utilise sucrose, maltose, galactose, melibiose or 
nonfermentable carbon sources. 
SNFl was initially identified by screening for genes involved in 
the regulation of invertase expression. The inability of SNFl mutants 
to utilise sucrose is a result of failure to derepress the SUC2 
messenger RNA encoding secreted invertase (Carlson and Botstein, 
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Figure 41: 
Amino-acid sequence alignment of C.In and SNFl (Celenza and 
Carlson 1986). Conserved residues are boxed. Asterixs indicate 
residues conserved in most known protein kinases. Amino-acids 
are numbered on the left and at the end of each sequence. Gaps 
have been introduced (-) to optimise the alignment. 
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C. In 
SNFl 
C. In 
SNFl 
C. In 
SNFl 
C. In 
SNFl 
C. In 
SNFI 
C. In 
SNFl 
C. In 
SNF1 
C. In 
SNFl 
C. In 
SNFl 
* * * * * 
4 0 DGGGEHSEALfl'L~I pt~I rffftiiff\llft' tfi'<RQMRAP~EKAf 
43 KSSLADGAHI~I~r!M:lr~~~I~KVLAKSrtPGRI~ 
* 
100 EllKipuf'I 
103~se-
PH I I 11fl1VT PKrffvftff'ffrfiffYrltEKRRL~ 
L:..:....:-=....;JK~KSKDE{JI~l~~-~VQRDKM~ 
* * ---------. 220 APEVISGKLYAGP 
218 APEVISGKLYAGP nAcFD ni r:mF I ~minL R FD E I ' F I SN G .____ _ ~ 
* 280 f!MifrfRKHfiNfm1tPDMMQQAKMIDEflfLnff--
L~~~QD~V~~LKPHPEEENEN~K~SS 278 
338 ---------------VK~9fDrvcfSLFNRLQ---~T\~LDNRF-------
340 PDNDEIDDNLVNILSST~~I~SSEDTPA~IR~KENKSLIKDMKA 
401 ---""'~<ff"ffPYYRVERKWALG~PRAIMIEV*LKELNVCWKKNGDCY~M 
459 QYKE~~I~TSLPQIHRANML~SKISPLVT~KTRWHFGIRSRSYPLDV 
45 7 KCRWCPGFPRVSDMLLDANH------SFVDDCfrDNGDWRrrf V IrfMKTKDO 
521 MGEIYIALKNLGAEWAKPSEEDLWTIKLRWKY~NKTN~K~L~~QIETN 
511 fitftt---------------------QRVTGPQLLffFCAAFLTNfffl 
579 ~~KFDGWESSYGODTTVSNISEDEMSTFSAY~LTTKLIM~ 
220 
539 
628 
Figure 42: 
Amino-acid sequence alignment of C.In and niml+ (Russell and 
Nurse 1987b). Conserved residues are boxed. Asterixs indicate 
residues conserved in most known protein kinases. Amino-acids 
are numbered on the left and at the end of each sequence. Gaps 
have been introduced (-) to optimise the alignment. 
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C. In 42 
nim1• 2 
C. In 92 
nim1 • 45 
C.In 142 
nim1+ 92 
C.In 191 
nim1 + 142 
C.In 241 
nim1 + 192 
C. In 291 
nim1 + 242 
C.In 341 
nim1+ 292 
C. In 391 
nim1 + 340 
* * * * * GGJJ:EALKNY~~FAJJ:~:ttHK~LNRRQMR~ 
VK NTIGVW G TS DL I 1------
* EMEEKAK!t n 1 amr 1 VTPKD1 FVlrl 
IRYASIG I M -- VWTDHQHMYLA P 
nEKRwRTF~ln· 0H 'KV\ KHG HYL L \ H RF ._______.J 
*** * * * N\~SNfttHDGH1ifT~IFfRrfHtEI VWSCG 
QI~I~A~EPNDS~N~I\~wP. VWSCG 
'GAvfpnrff PNLFfiKaftf!r P1 YLrfLVfiili fMLP~ 
r NK~a<4:froviY1JR~~sr~AA~u~rh] 
* rff'tfTTrlcf¥ RK{fWFQNRLPRYLAVPPPDMMQQAKMI D~DVVKL 
~S~~F~PFLMGCTSLSSMDSTTPPTPSLSIDE~VDCMC 
GY9RDHVCESLC~EETVAYYLLLDNRFRATSGYLGAHY9fFMESAS 
VL~SSSKKVV~RDDNDEKYVYKVLSEILRDDMLK--~FDENK 
PSTRS~G~SQGS~PYYRVERKWR 
YLSLY~H~NLFTK~KFRTKASEN~ 
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1982). SNFl is known to affect SUC2 expression at the transcriptional 
level as it is required for expression from a heterologous yeast 
promoter under the control of the SUC2 upstream regulatory region 
(Sarokin and Carlson, 1985). In order to establish that the product 
of the SNFl gene was a protein kinase a fusion between the E.coli trp 
E gene and a portion of the SNFl gene was constructed by Celenza and 
Carlson (1986). The protein was expressed in E. coli and used to 
raise antiserum against the SNFl gene product. Immunoblot analysis of 
total yeast proteins was used to identify the SNFl protein and further 
studies showed that it was phosphorylated in an autophosphorylation 
reaction. The autophosphorylation reaction required either Mg2 + or 
Mn2+, SNFl was shown to transfer phosphate from ATP to serine and 
threonine but not to tyrosine. 
As SNFl function is required for derepression of glucose-
repressible genes this suggests that protein phosphorylation may serve 
as a signal in the regulatory circuitry of carbon catabolite 
repression in yeast. As C.In was isolated from a eDNA library 
prepared from cereal endosperms the sequence similarity suggests that 
a carbon catabolite repression system may be operating in cereal 
endosperm. This system may become important during germination as a 
means of controlling genes involved in starch breakdown. Another 
regulatory gene in yeast, STE7, (a member of the STE7 subfamily of 
protein kinases) has been implicated in the control of cell-type-
specific gene expression (Teague et al., 1986). 
Another member of the SNFl subfamily for which a function has 
been proposed is niml+. niml+ has been implicated in the initiation 
of mitosis. Studies of the cell cycle have been undertaken using 
yeast mutants including cell division mutants (CDC) and the so-called 
'wee' mutants, which delay mitosis until the cells reach a larger size 
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as a result these mutants divide more slowly producing smaller 
colonies. The cell cycle is regulated at three transition points: 
entry into mitosis, exit from mitosis, and passage through G1 (Start) 
which commits the cell to DNA synthesis (S phase), Regulation of the 
active state of one protein, pp34 which is a product of the cdc2 gene, · 
controls the entry into mitosis and Start. pp34 is the catalytic 
subunit of the mitosis-inducing protein kinase known as maturation 
promoting factor (MPF) or growth-associated H1 kinase. The other main 
components of MPF are cyclin and cyclin homologues, which are proteins 
that accumulate in interpase and are degraded at the end of mitosis 
(Murray, 1987). 
The cdc2+ gene is known to interact with a number of genes for 
correct mitotic control; these include sucJ+ (Hayles et al., 1986), 
cdcJJ+ (Booher and Beach, 1987), cdc25+ (Russell and Nurse, 1986), 
wee]+ (Russell and Nurse, 1987a) and nimJ+ (Russell and Nurse, 1987b). 
A model of cell cycle control and the role of protein phoshorylation 
has recently been proposed by Murray (1989) and is shown in Fig. 43. 
As shown in the figure the wee]+ and cdc25+ gene functions are 
counteractive at G2, with wee]+ acting as a mitotic inhibitor and 
cdc25+ acting as an inducer of mitosis (Russell and Nurse, 1986). 
WeeJ+ is further regulated by nimJ+ which acts as a negative regulator 
of weeJ+ and hence an inducer of mitosis. The nimJ+ gene encodes a 50 
kd protein and increased expression of niml+ rescues mutants that lack 
the mitotic inducer cdc25+. Both nimJ+ and wee]+ contain the 
consensus sequences of protein kinases. Russell and Nurse (1987b) 
proposed that initiation of mitosis in the cell cycle is controlled by 
protein kinases functioning in a regulatory network, probably acting 
in a cascade of negative regulation as shown below: 
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Figure 43: 
A model of the cycle of pp34 (outer ring) during the cell cycle. 
The pp34 molecule lacks kinase activity during most of the cell 
cycle but becomes active as MPF at mitosis and as a Start-
specific kinase at Start as a result of association with 
phosphorylated cyclins. Note that the active forms can also 
stimulate their own activation (and/or) inactivation ( ~ ~ ~ ). 
The dashed line between post-Start Gl and S phases indicates that 
no change in pp34 accompanies the onset of replication. Figure 
taken from Murray (1989). 
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In this cascade model niml+ blocks the function of the wee]+ 
mitotic inhibitor and weel+ blocks the essential mitotic induction 
function of cdc2+. This remains to be confirmed by direct analysis of 
the proteins. Recent studies in fission yeast, using a temperature 
sensitive cdc25+ mutant which froze the cell cycle in G2, showed that 
pp34 (the product of the cdc2+ gene) was phosphorylated on tyrosine 15 
and an unidentified threonine (Gould and Nurse, 1989). Substitution of 
the Tyr 15 residue advances the cell prematurely into mitosis. This 
suggests that tyrosine phosphorylation/dephosphorylation directly 
regulates pp34. However both wee]+ and nim]+ show sequence similarity 
to serine/threonine protein kinases rather than to tyrosine kinases. 
KINl and KIN2, two other members of the SNFl subfamily, were isolated 
by screening a genomic library with mixed oligonucleotide probes for 
the consensus sequences found in tyrosine protein kinases. KINl and 
KIN2 were found to contain sequences representative of both ser-
ine/threonine and tyrosine protein kinases although to date no 
functions has been identified for their gene products (Levin et al., 
1987). 
In order to stimulate pp34, cdc25+ product would be predicted to 
be a tyrosine phosphatase but the sequence of cdc25+ shows no 
relationship to any known phosphatase. It is still necessary to 
discover whether wee]+ activity affects tyrosine phosphorylation. 
However as fission yeast are able to divide in the absence of both 
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cdc25+ and wee]+ functions (Russell and Nurse, 1987a) it would appear 
that other mitotic control factors (probably protein kinases/ phospha-
tases) exist for cell cycle control. 
C.In could possibly be used as a probe to screen for niml+, Yeast 
genes for niml+ do not hybridise to plant homologues at the DNA level 
(Halford, N. personal communication). The sequence similarity between 
C.In and niml+ at the protein level is reflected but less at the DNA 
level, due to different codon usage. As niml+ is a mitotic inducer 
C.In could be a useful tool to facilitate studies of the cell cycle in 
higher plants. 
Initiation of mitosis represents only one step in the cell cycle 
although it is evident from the scheme proposed by Murray (1989) that 
a variety of events are under the control of protein kinases. 
Phosphorylation control has also been implicated in a number of other 
mitotic events including nuclear membrane breakdown and reformation 
(Burke and Gerace, 1986), chromosome condensation (Yamashita et al., 
1984), microtubule reorganisation and spindle formation (Piras and 
Piras, 1975) and activation of microtubule organizing centres (Vandre 
et al., 1984). Many other types of control circuits are also 
regulated by protein phosphorylation, including transmembrane signal 
transduction. With many protein kinases being situated in the plasma 
membrane they are in an ideal position to transduce external stimuli 
and protein synthesis where initiation factors are affected by 
phosphorylation. Therefore it would appear that protein kinases act 
as major components in the regulatory processes of the cell. 
To take this study further a number of lines of experimentation 
could be undertaken. Southern blots of restriction enzyme-digested 
genomic DNA from various cereals could be probed using C.In to 
establish any related genomic sequences that may encode other protein 
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kinases. The chromosomal location of C.In gene in rye could be 
investigated by probing genomic DNA isolated from wheat/rye addition 
lines. Northern blot analysis would reveal the abundance of the C.In 
mRNA in the rye endosperm and could be used to investigate the tissue 
specificty of C.In. Northern blot analysis also would establish the 
size of the mRNA corresponding to C.In, a eDNA clone, and would show 
whether C.In was a nearly full length eDNA. To determine whether C.In 
produces a functional mRNA and to define the AUG codon at which 
protein synthesis starts in vitro, C.ln could be cloned into a in 
vitro transcription vector. mRNA transcripts can be made from the 
eDNA using T7 polymerase and then this transcript in the wheat germ in 
vitro translation system. 
A number of experiments could be undertaken to establish whether 
C.In acts as a protein kinase. SNFl from yeast was investigated by 
forming a fusion product with E. coli trp E gene which was then 
expressed in E. coli and used to generate antisera against the SNFl 
gene product. The antisera was then used to identify SNFl protein on 
a Western blot of total yeast proteins and an autophosphorylation 
reaction carried out on the blot (Celenza and Carlson 1986). This 
experiment showed that SNFl was phosphorylated, it was then eluted 
from the blot and phospho amino acid analysis carried out to identify 
the amino acid residues that had been phosphoylated (Cooper et al 
1983). Identification of the phosphorylated amino acid residues 
confirmed the protein kinase as a member of either the serine/ 
threonine or the tyrosine family of protein kinases. A similar set of 
experiments could be carried out for C.In. 
Complementation of mutants in yeast has been used to identify 
genes of similar function. A human homolog of cdc2+ gene has been 
cloned by expressing a human eDNA library in fission yeast and then 
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selecting for clones that complemented a mutant of cdc2+ (Lee and Nurse 
1987). This approach could be used to establish the function of C.In 
as mutants of both SNFl (Carlson and Botstein 1982) and niml+ (Russell 
and Nurse 1987b) have been identified. If C.In can complement either 
of these genes it is reasonable to assume that it performs a similar 
function within the rye endosperm. 
Further studies could include expression of C.In in tobacco to 
investigate any phenotypic effects of this gene in a transgenic plant 
( eg. niml + affects the cell cycle and if C. In has similar effects then 
cell division may be altered either in the whole plant or in the seed 
during development). Anti sense RNA transcripts could be used to 
generate dominant mutations in rye by inhibiting the expression of 
C.In which may help to elucidate the function of this cloned plant 
gene. 
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